IL225058A - Converted imidazopyridazines, methods for their preparation and pharmaceutical preparations containing them - Google Patents
Converted imidazopyridazines, methods for their preparation and pharmaceutical preparations containing themInfo
- Publication number
- IL225058A IL225058A IL225058A IL22505813A IL225058A IL 225058 A IL225058 A IL 225058A IL 225058 A IL225058 A IL 225058A IL 22505813 A IL22505813 A IL 22505813A IL 225058 A IL225058 A IL 225058A
- Authority
- IL
- Israel
- Prior art keywords
- amino
- pyridazin
- crc6
- cyclopropyl
- alkyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 59
- 239000008194 pharmaceutical composition Substances 0.000 title abstract description 13
- 150000005233 imidazopyridazines Chemical class 0.000 title abstract description 5
- 238000002360 preparation method Methods 0.000 title description 9
- 150000001875 compounds Chemical class 0.000 claims abstract description 708
- -1 or a HO- Chemical group 0.000 claims description 446
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 300
- 125000002206 pyridazin-3-yl group Chemical group [H]C1=C([H])C([H])=C(*)N=N1 0.000 claims description 254
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 247
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 187
- UTCSSFWDNNEEBH-UHFFFAOYSA-N imidazo[1,2-a]pyridine Chemical compound C1=CC=CC2=NC=CN21 UTCSSFWDNNEEBH-UHFFFAOYSA-N 0.000 claims description 132
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 123
- 125000005843 halogen group Chemical group 0.000 claims description 122
- 239000000203 mixture Substances 0.000 claims description 117
- 239000001257 hydrogen Substances 0.000 claims description 87
- 229910052739 hydrogen Inorganic materials 0.000 claims description 87
- 150000003839 salts Chemical class 0.000 claims description 47
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 44
- 239000012453 solvate Substances 0.000 claims description 29
- KXDAEFPNCMNJSK-UHFFFAOYSA-N benzene carboxamide Natural products NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims description 13
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 11
- HEFYOJVDTAFTJD-UHFFFAOYSA-N 4-[6-(3-fluorophenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methyl-n-(1-methylcyclopropyl)benzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1(C)CC1 HEFYOJVDTAFTJD-UHFFFAOYSA-N 0.000 claims description 6
- 125000005620 boronic acid group Chemical group 0.000 claims description 6
- 238000010511 deprotection reaction Methods 0.000 claims description 6
- 229910052740 iodine Inorganic materials 0.000 claims description 4
- QXDTVUDZULCANS-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-methoxy-3-propan-2-ylphenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C1=CC=C(C(C)C)C(OC)=C1OC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCC(F)(F)F)=C1 QXDTVUDZULCANS-UHFFFAOYSA-N 0.000 claims description 4
- CRTKOUIDKLSOAT-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-methoxyphenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound COC1=CC=CC=C1OC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCC(F)(F)F)=C1 CRTKOUIDKLSOAT-UHFFFAOYSA-N 0.000 claims description 4
- UICZQHUJEIPITP-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluorophenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 UICZQHUJEIPITP-UHFFFAOYSA-N 0.000 claims description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 4
- PMRKHBMUYNHAFR-UHFFFAOYSA-N 4-[6-(2-aminophenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C(=CC=CC=4)N)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 PMRKHBMUYNHAFR-UHFFFAOYSA-N 0.000 claims description 3
- YNBJPBVAMFNGIR-UHFFFAOYSA-N 4-[6-(3-chlorophenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(Cl)C=CC=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 YNBJPBVAMFNGIR-UHFFFAOYSA-N 0.000 claims description 3
- SNENIFJNYLLFEG-UHFFFAOYSA-N 4-[6-(3-fluorophenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-n-(1-methoxycyclopropyl)-2-methylbenzamide Chemical compound C=1C=C(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCCC(F)(F)F)C3=NC=2)C=C(C)C=1C(=O)NC1(OC)CC1 SNENIFJNYLLFEG-UHFFFAOYSA-N 0.000 claims description 3
- VEFZDJHWJIPNKA-UHFFFAOYSA-N 4-[6-(4-chlorophenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=CC(Cl)=CC=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 VEFZDJHWJIPNKA-UHFFFAOYSA-N 0.000 claims description 3
- OFRNYEFBUSPDRM-UHFFFAOYSA-N 4-[6-(4-chlorophenoxy)-8-(thian-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=CC(Cl)=CC=4)C=C(NCC4CCSCC4)C3=NC=2)=CC=C1C(=O)NC1CC1 OFRNYEFBUSPDRM-UHFFFAOYSA-N 0.000 claims description 3
- DUTIKJXKJAEAKY-UHFFFAOYSA-N N-cyclopropyl-2-methyl-4-[6-phenoxy-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=CC=CC=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 DUTIKJXKJAEAKY-UHFFFAOYSA-N 0.000 claims description 3
- IZBOTABDXABHID-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[6-(3-propan-2-yloxyphenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CC(C)OC1=CC=CC(OC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCCC(F)(F)F)=C2)=C1 IZBOTABDXABHID-UHFFFAOYSA-N 0.000 claims description 3
- XWFSLPKDRXOSRS-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[6-[2-(methylamino)phenoxy]-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CNC1=CC=CC=C1OC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCC(F)(F)F)=C1 XWFSLPKDRXOSRS-UHFFFAOYSA-N 0.000 claims description 3
- SQAVLMZWPSPVBJ-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-fluoro-4-methoxyphenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound FC1=CC(OC)=CC=C1OC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCC(F)(F)F)=C1 SQAVLMZWPSPVBJ-UHFFFAOYSA-N 0.000 claims description 3
- XKBJPGKHHKSNLO-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-fluorophenoxy)-8-(thian-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C(=CC=CC=4)F)C=C(NCC4CCSCC4)C3=NC=2)=CC=C1C(=O)NC1CC1 XKBJPGKHHKSNLO-UHFFFAOYSA-N 0.000 claims description 3
- XITDDHPTQKIAHT-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-hydroxyphenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C(=CC=CC=4)O)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 XITDDHPTQKIAHT-UHFFFAOYSA-N 0.000 claims description 3
- ANMATZBITLZDNB-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3,4-difluorophenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C(F)=CC=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 ANMATZBITLZDNB-UHFFFAOYSA-N 0.000 claims description 3
- HESRLTXDFMIMTL-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluorophenoxy)-8-(thian-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCC4CCSCC4)C3=NC=2)=CC=C1C(=O)NC1CC1 HESRLTXDFMIMTL-UHFFFAOYSA-N 0.000 claims description 3
- FFQOZRAGNHSXQW-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-methoxyphenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound COC1=CC=CC(OC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCCC(F)(F)F)=C2)=C1 FFQOZRAGNHSXQW-UHFFFAOYSA-N 0.000 claims description 3
- JGYRKMWORQQRPO-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-fluorophenoxy)-8-(thian-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=CC(F)=CC=4)C=C(NCC4CCSCC4)C3=NC=2)=CC=C1C(=O)NC1CC1 JGYRKMWORQQRPO-UHFFFAOYSA-N 0.000 claims description 3
- LJCJRRKKAKAKRV-UHFFFAOYSA-N (2-amino-2-methylpropyl) 3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoate Chemical group CC(C)(N)COC(=O)CCC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 LJCJRRKKAKAKRV-UHFFFAOYSA-N 0.000 claims description 2
- FDRAHQXLFJXXMK-UHFFFAOYSA-N 4-[6-(2-amino-4-fluorophenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C(=CC(F)=CC=4)N)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 FDRAHQXLFJXXMK-UHFFFAOYSA-N 0.000 claims description 2
- IAZDIPNNMVZSAK-UHFFFAOYSA-N 4-[6-(3-chloro-4-fluorophenoxy)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(Cl)C(F)=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 IAZDIPNNMVZSAK-UHFFFAOYSA-N 0.000 claims description 2
- LCKCCPOQSOZOLF-UHFFFAOYSA-N 4-[6-(3-chlorophenoxy)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(Cl)C=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 LCKCCPOQSOZOLF-UHFFFAOYSA-N 0.000 claims description 2
- RPKMLDXUNAJFCS-UHFFFAOYSA-N 4-[6-(3-cyanophenoxy)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(C=CC=4)C#N)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 RPKMLDXUNAJFCS-UHFFFAOYSA-N 0.000 claims description 2
- XHZFEEZRJSIXPK-UHFFFAOYSA-N 4-[6-(4-chloro-3-fluorophenoxy)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C(Cl)=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 XHZFEEZRJSIXPK-UHFFFAOYSA-N 0.000 claims description 2
- BMHMHLXQEJEQIW-UHFFFAOYSA-N 4-[6-(4-chlorophenoxy)-8-[(1,1-dioxothian-4-yl)methylamino]imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=CC(Cl)=CC=4)C=C(NCC4CCS(=O)(=O)CC4)C3=NC=2)=CC=C1C(=O)NC1CC1 BMHMHLXQEJEQIW-UHFFFAOYSA-N 0.000 claims description 2
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 claims description 2
- 125000004185 ester group Chemical group 0.000 claims description 2
- DAOROHJNNPQZPI-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[6-(4-propan-2-yloxyphenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound C1=CC(OC(C)C)=CC=C1OC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCC(F)(F)F)=C1 DAOROHJNNPQZPI-UHFFFAOYSA-N 0.000 claims description 2
- GWJPOUNGPRLVIB-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2,3-difluorophenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C(=C(F)C=CC=4)F)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 GWJPOUNGPRLVIB-UHFFFAOYSA-N 0.000 claims description 2
- RPYZFOPOKJTIAH-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2,3-difluorophenoxy)-8-(thian-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C(=C(F)C=CC=4)F)C=C(NCC4CCSCC4)C3=NC=2)=CC=C1C(=O)NC1CC1 RPYZFOPOKJTIAH-UHFFFAOYSA-N 0.000 claims description 2
- SJFBZRHPPXOKBO-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2,3-difluorophenoxy)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C(=C(F)C=CC=4)F)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 SJFBZRHPPXOKBO-UHFFFAOYSA-N 0.000 claims description 2
- DSSYFYRKOOMSBH-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-fluoro-3-methylsulfanylphenoxy)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CSC1=CC=CC(OC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCC(C)(C)O)=C2)=C1F DSSYFYRKOOMSBH-UHFFFAOYSA-N 0.000 claims description 2
- NVPCBOQJOOAJTG-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-fluoro-4-methoxyphenoxy)-8-(oxan-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound FC1=CC(OC)=CC=C1OC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCC2CCOCC2)=C1 NVPCBOQJOOAJTG-UHFFFAOYSA-N 0.000 claims description 2
- CUERSJUVWODDIV-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-fluoro-5-methylphenoxy)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC=C(F)C(OC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCC(C)(C)O)=C2)=C1 CUERSJUVWODDIV-UHFFFAOYSA-N 0.000 claims description 2
- UIIBZLYLRDUCBY-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-fluorophenoxy)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C(=CC=CC=4)F)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 UIIBZLYLRDUCBY-UHFFFAOYSA-N 0.000 claims description 2
- BIWBYNZZGMUILD-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-hydroxy-3-propan-2-ylphenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC(C)C1=CC=CC(OC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCCC(F)(F)F)=C2)=C1O BIWBYNZZGMUILD-UHFFFAOYSA-N 0.000 claims description 2
- KDBGHFSTGHMLCA-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3,4-difluorophenoxy)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C(F)=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 KDBGHFSTGHMLCA-UHFFFAOYSA-N 0.000 claims description 2
- ZERKWWBTNONCCE-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3,5-difluorophenoxy)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=C(F)C=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 ZERKWWBTNONCCE-UHFFFAOYSA-N 0.000 claims description 2
- DTGCZEAGSDIYFM-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3,5-dimethylphenoxy)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C)=CC(OC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCC(C)(C)O)=C2)=C1 DTGCZEAGSDIYFM-UHFFFAOYSA-N 0.000 claims description 2
- XCHLKOYBBLFTME-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluoro-5-methylphenoxy)-8-(4,4,4-trifluorobutylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(F)=CC(OC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCCCC(F)(F)F)=C2)=C1 XCHLKOYBBLFTME-UHFFFAOYSA-N 0.000 claims description 2
- ZJPYPUOKBZKBIN-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluoro-5-methylphenoxy)-8-(thian-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(F)=CC(OC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCC3CCSCC3)=C2)=C1 ZJPYPUOKBZKBIN-UHFFFAOYSA-N 0.000 claims description 2
- XODNYIVQIRRXRE-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluoro-5-methylphenoxy)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(F)=CC(OC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCC(C)(C)O)=C2)=C1 XODNYIVQIRRXRE-UHFFFAOYSA-N 0.000 claims description 2
- YLASFKKWWVWGPB-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluorophenoxy)-8-(2-hydroxyethylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCCO)C3=NC=2)=CC=C1C(=O)NC1CC1 YLASFKKWWVWGPB-UHFFFAOYSA-N 0.000 claims description 2
- UISCUPDKVBCQMK-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluorophenoxy)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 UISCUPDKVBCQMK-UHFFFAOYSA-N 0.000 claims description 2
- WDQGQXRVEBRSKH-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-fluorophenoxy)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=CC(F)=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 WDQGQXRVEBRSKH-UHFFFAOYSA-N 0.000 claims description 2
- YADUGVCQKYSQBL-UHFFFAOYSA-N n-cyclopropyl-4-[6-(5-fluoro-2-methylphenoxy)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC=C(F)C=C1OC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCC(C)(C)O)=C1 YADUGVCQKYSQBL-UHFFFAOYSA-N 0.000 claims description 2
- OTRLJOKVMOJRFG-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(1,1-dioxothian-4-yl)methylamino]-6-(2-fluorophenoxy)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C(=CC=CC=4)F)C=C(NCC4CCS(=O)(=O)CC4)C3=NC=2)=CC=C1C(=O)NC1CC1 OTRLJOKVMOJRFG-UHFFFAOYSA-N 0.000 claims description 2
- HYJPDSVZWWUUOK-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(1,1-dioxothian-4-yl)methylamino]-6-(3-fluorophenoxy)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCC4CCS(=O)(=O)CC4)C3=NC=2)=CC=C1C(=O)NC1CC1 HYJPDSVZWWUUOK-UHFFFAOYSA-N 0.000 claims description 2
- QTLFEEXOUPJCMD-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(3-methylphenoxy)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC=CC(OC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCC(C)(C)O)=C2)=C1 QTLFEEXOUPJCMD-UHFFFAOYSA-N 0.000 claims description 2
- ROXFZBULEMIWOR-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(3-propan-2-yloxyphenoxy)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC(C)OC1=CC=CC(OC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCC(C)(C)O)=C2)=C1 ROXFZBULEMIWOR-UHFFFAOYSA-N 0.000 claims description 2
- HBLLQTQSVUFGBA-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(3-propan-2-ylphenoxy)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC(C)C1=CC=CC(OC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCC(C)(C)O)=C2)=C1 HBLLQTQSVUFGBA-UHFFFAOYSA-N 0.000 claims description 2
- KIZAHVVNHOVQPI-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(4-methoxyphenoxy)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C1=CC(OC)=CC=C1OC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCC(C)(C)O)=C1 KIZAHVVNHOVQPI-UHFFFAOYSA-N 0.000 claims description 2
- JMBBJYAAYUADKO-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(4-propan-2-yloxyphenoxy)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C1=CC(OC(C)C)=CC=C1OC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCC(C)(C)O)=C1 JMBBJYAAYUADKO-UHFFFAOYSA-N 0.000 claims description 2
- IGYWWZFIEZDSTF-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-phenoxyimidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=CC=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 IGYWWZFIEZDSTF-UHFFFAOYSA-N 0.000 claims description 2
- WQQFXRBEZQKZFI-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-fluorophenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C(=CC=CC=4)F)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 WQQFXRBEZQKZFI-UHFFFAOYSA-N 0.000 claims 2
- VLPSGUKEPWQJDX-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-fluorophenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=CC(F)=CC=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 VLPSGUKEPWQJDX-UHFFFAOYSA-N 0.000 claims 2
- NEBDRACCUHZROA-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-methoxyphenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C1=CC(OC)=CC=C1OC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCC(F)(F)F)=C1 NEBDRACCUHZROA-UHFFFAOYSA-N 0.000 claims 2
- 125000004484 1-methylpiperidin-4-yl group Chemical group CN1CCC(CC1)* 0.000 claims 1
- 125000004778 2,2-difluoroethyl group Chemical group [H]C([H])(*)C([H])(F)F 0.000 claims 1
- OLBYYKSLVBXLGO-UHFFFAOYSA-N 2-[[3-[4-(cyclopropylcarbamoyl)-3-methylphenyl]-6-(3-fluorophenoxy)imidazo[1,2-b]pyridazin-8-yl]amino]ethanesulfonic acid Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCCS(O)(=O)=O)C3=NC=2)=CC=C1C(=O)NC1CC1 OLBYYKSLVBXLGO-UHFFFAOYSA-N 0.000 claims 1
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 claims 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims 1
- VEFITGNUTVJNHZ-UHFFFAOYSA-N 3-[[3-[4-(cyclopropylcarbamoyl)-3-methylphenyl]-6-(3-fluorophenoxy)imidazo[1,2-b]pyridazin-8-yl]amino]propane-1-sulfonic acid Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCCCS(O)(=O)=O)C3=NC=2)=CC=C1C(=O)NC1CC1 VEFITGNUTVJNHZ-UHFFFAOYSA-N 0.000 claims 1
- FEVQGUVVMHKSLJ-UHFFFAOYSA-N 4-[6-(4-chlorophenoxy)-8-[2-(dimethylamino)ethylamino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound N=1N2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCN(C)C)=CC=1OC1=CC=C(Cl)C=C1 FEVQGUVVMHKSLJ-UHFFFAOYSA-N 0.000 claims 1
- LEHYJCDIBXRPSE-UHFFFAOYSA-N 4-[8-(2-acetamidoethylamino)-6-(3-fluorophenoxy)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound N=1N2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCNC(=O)C)=CC=1OC1=CC=CC(F)=C1 LEHYJCDIBXRPSE-UHFFFAOYSA-N 0.000 claims 1
- BXUJUYSMAXTKDZ-UHFFFAOYSA-N 4-[8-(3-acetamidopropylamino)-6-(3-fluorophenoxy)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound N=1N2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCCNC(=O)C)=CC=1OC1=CC=CC(F)=C1 BXUJUYSMAXTKDZ-UHFFFAOYSA-N 0.000 claims 1
- UARCDGBIDIEUHG-UHFFFAOYSA-N 4-[8-(azetidin-3-ylmethylamino)-6-(5-fluoro-2-methylphenoxy)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC=C(F)C=C1OC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCC2CNC2)=C1 UARCDGBIDIEUHG-UHFFFAOYSA-N 0.000 claims 1
- WEYGWYYIBYOQBZ-UHFFFAOYSA-N 4-[8-[(2-amino-2-methylpropyl)amino]-6-(3,4-difluorophenoxy)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C(F)=CC=4)C=C(NCC(C)(C)N)C3=NC=2)=CC=C1C(=O)NC1CC1 WEYGWYYIBYOQBZ-UHFFFAOYSA-N 0.000 claims 1
- YATSLNPDPJNQGR-UHFFFAOYSA-N 4-[8-[(2-amino-2-methylpropyl)amino]-6-(3-fluorophenoxy)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCC(C)(C)N)C3=NC=2)=CC=C1C(=O)NC1CC1 YATSLNPDPJNQGR-UHFFFAOYSA-N 0.000 claims 1
- GTJHPSHJNPXEDD-UHFFFAOYSA-N 4-[8-[(3-amino-3-oxopropyl)amino]-6-(3-fluorophenoxy)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCCC(N)=O)C3=NC=2)=CC=C1C(=O)NC1CC1 GTJHPSHJNPXEDD-UHFFFAOYSA-N 0.000 claims 1
- CXIPPKWJXPDXLV-UHFFFAOYSA-N N-cyclopropyl-2-methyl-4-[6-[2-(methylamino)phenoxy]-8-(2-morpholin-4-ylethylamino)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CNC1=CC=CC=C1OC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCN2CCOCC2)=C1 CXIPPKWJXPDXLV-UHFFFAOYSA-N 0.000 claims 1
- DIIHUPKICCVKFB-UHFFFAOYSA-N N-cyclopropyl-2-methyl-4-[8-(methylamino)-6-[2-(methylamino)phenoxy]imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CNC1=CC=CC=C1OC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NC)=C1 DIIHUPKICCVKFB-UHFFFAOYSA-N 0.000 claims 1
- XPRLINZSJSKLQF-UHFFFAOYSA-N N-cyclopropyl-4-[6-(2-fluoro-4-methoxyphenoxy)-8-(methylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound N=1N2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NC)=CC=1OC1=CC=C(OC)C=C1F XPRLINZSJSKLQF-UHFFFAOYSA-N 0.000 claims 1
- GQGMDNODXYSARF-UHFFFAOYSA-N N-cyclopropyl-4-[6-(3,4-difluorophenoxy)-8-(2-morpholin-4-ylethylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C(F)=CC=4)C=C(NCCN4CCOCC4)C3=NC=2)=CC=C1C(=O)NC1CC1 GQGMDNODXYSARF-UHFFFAOYSA-N 0.000 claims 1
- QHKJKAQBWQVWBI-UHFFFAOYSA-N N-cyclopropyl-4-[6-(3-fluoro-4-methoxyphenoxy)-8-(methylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound N=1N2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NC)=CC=1OC1=CC=C(OC)C(F)=C1 QHKJKAQBWQVWBI-UHFFFAOYSA-N 0.000 claims 1
- IRJHKPURLIGHDP-UHFFFAOYSA-N N-cyclopropyl-4-[6-(3-fluorophenoxy)-8-(2-methylsulfonylethylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCCS(C)(=O)=O)C3=NC=2)=CC=C1C(=O)NC1CC1 IRJHKPURLIGHDP-UHFFFAOYSA-N 0.000 claims 1
- INZBLSIDZVTFGG-UHFFFAOYSA-N N-cyclopropyl-4-[6-(3-fluorophenoxy)-8-(2-pyrazol-1-ylethylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCCN4N=CC=C4)C3=NC=2)=CC=C1C(=O)NC1CC1 INZBLSIDZVTFGG-UHFFFAOYSA-N 0.000 claims 1
- GCIURORLLBSRJU-UHFFFAOYSA-N N-cyclopropyl-4-[6-(3-fluorophenoxy)-8-(2-pyrrolidin-1-ylethylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCCN4CCCC4)C3=NC=2)=CC=C1C(=O)NC1CC1 GCIURORLLBSRJU-UHFFFAOYSA-N 0.000 claims 1
- VEQGUOXRDBHJMV-UHFFFAOYSA-N N-cyclopropyl-4-[6-(3-fluorophenoxy)-8-(2H-tetrazol-5-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCC=4NN=NN=4)C3=NC=2)=CC=C1C(=O)NC1CC1 VEQGUOXRDBHJMV-UHFFFAOYSA-N 0.000 claims 1
- CTYAGBHXHDLDFI-UHFFFAOYSA-N N-cyclopropyl-4-[6-(3-fluorophenoxy)-8-(3-methylsulfonylpropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCCCS(C)(=O)=O)C3=NC=2)=CC=C1C(=O)NC1CC1 CTYAGBHXHDLDFI-UHFFFAOYSA-N 0.000 claims 1
- UHAJZVDTFRORSD-UHFFFAOYSA-N N-cyclopropyl-4-[6-(3-fluorophenoxy)-8-(3-morpholin-4-ylpropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCCCN4CCOCC4)C3=NC=2)=CC=C1C(=O)NC1CC1 UHAJZVDTFRORSD-UHFFFAOYSA-N 0.000 claims 1
- FEOSZJCOOKXGGC-UHFFFAOYSA-N N-cyclopropyl-4-[6-(3-fluorophenoxy)-8-(3-pyrrolidin-1-ylpropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCCCN4CCCC4)C3=NC=2)=CC=C1C(=O)NC1CC1 FEOSZJCOOKXGGC-UHFFFAOYSA-N 0.000 claims 1
- CDTNBQDJZACDTE-UHFFFAOYSA-N N-cyclopropyl-4-[6-(3-fluorophenoxy)-8-[(2-methyl-2-morpholin-4-ylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCC(C)(C)N4CCOCC4)C3=NC=2)=CC=C1C(=O)NC1CC1 CDTNBQDJZACDTE-UHFFFAOYSA-N 0.000 claims 1
- MWEZIXUMOHLIPE-UHFFFAOYSA-N N-cyclopropyl-4-[6-(3-fluorophenoxy)-8-[2-(2H-tetrazol-5-yl)ethylamino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCCC=4NN=NN=4)C3=NC=2)=CC=C1C(=O)NC1CC1 MWEZIXUMOHLIPE-UHFFFAOYSA-N 0.000 claims 1
- PJKXHKXXJSWHLQ-UHFFFAOYSA-N N-cyclopropyl-4-[6-(3-fluorophenoxy)-8-[[3-(hydroxymethyl)oxetan-3-yl]methylamino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCC4(CO)COC4)C3=NC=2)=CC=C1C(=O)NC1CC1 PJKXHKXXJSWHLQ-UHFFFAOYSA-N 0.000 claims 1
- HQIZTHZPXFCPFY-UHFFFAOYSA-N N-cyclopropyl-4-[6-(5-fluoro-2-methylphenoxy)-8-(methylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound N=1N2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NC)=CC=1OC1=CC(F)=CC=C1C HQIZTHZPXFCPFY-UHFFFAOYSA-N 0.000 claims 1
- UPWUIUXMCVXMAI-UHFFFAOYSA-N N-cyclopropyl-4-[8-(2,3-dihydroxypropylamino)-6-(3-fluorophenoxy)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCC(O)CO)C3=NC=2)=CC=C1C(=O)NC1CC1 UPWUIUXMCVXMAI-UHFFFAOYSA-N 0.000 claims 1
- OABBXJWGUGAJQB-UHFFFAOYSA-N N-cyclopropyl-4-[8-[4-(dimethylamino)butylamino]-6-(3-fluorophenoxy)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound N=1N2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCCCN(C)C)=CC=1OC1=CC=CC(F)=C1 OABBXJWGUGAJQB-UHFFFAOYSA-N 0.000 claims 1
- QEGJHGFVZOSDFP-UHFFFAOYSA-N N-cyclopropyl-4-[8-[[2-(dimethylamino)-2-methylpropyl]amino]-6-(3-fluorophenoxy)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound N=1N2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCC(C)(C)N(C)C)=CC=1OC1=CC=CC(F)=C1 QEGJHGFVZOSDFP-UHFFFAOYSA-N 0.000 claims 1
- JYGMWAIXMJZSPC-UHFFFAOYSA-N N-cyclopropyl-4-[8-[[3-(dimethylamino)-3-oxopropyl]amino]-6-(3-fluorophenoxy)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound N=1N2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCC(=O)N(C)C)=CC=1OC1=CC=CC(F)=C1 JYGMWAIXMJZSPC-UHFFFAOYSA-N 0.000 claims 1
- JAYPJRQAIXAGJX-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2,3-difluorophenoxy)-8-(2-methylsulfonylethylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C(=C(F)C=CC=4)F)C=C(NCCS(C)(=O)=O)C3=NC=2)=CC=C1C(=O)NC1CC1 JAYPJRQAIXAGJX-UHFFFAOYSA-N 0.000 claims 1
- FKEYZRMTYOUZHZ-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2,3-difluorophenoxy)-8-(2-morpholin-4-ylethylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C(=C(F)C=CC=4)F)C=C(NCCN4CCOCC4)C3=NC=2)=CC=C1C(=O)NC1CC1 FKEYZRMTYOUZHZ-UHFFFAOYSA-N 0.000 claims 1
- LDCLEHWGXRNODE-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2,3-difluorophenoxy)-8-(methylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound N=1N2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NC)=CC=1OC1=CC=CC(F)=C1F LDCLEHWGXRNODE-UHFFFAOYSA-N 0.000 claims 1
- RLGBVWDZTHNIMA-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2,3-difluorophenoxy)-8-[(1-methylazetidin-3-yl)methylamino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C1N(C)CC1CNC1=CC(OC=2C(=C(F)C=CC=2)F)=NN2C1=NC=C2C(C=C1C)=CC=C1C(=O)NC1CC1 RLGBVWDZTHNIMA-UHFFFAOYSA-N 0.000 claims 1
- WGDVEJRCLSAPKN-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2,3-difluorophenoxy)-8-[(1-methylpiperidin-4-yl)methylamino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C1CN(C)CCC1CNC1=CC(OC=2C(=C(F)C=CC=2)F)=NN2C1=NC=C2C(C=C1C)=CC=C1C(=O)NC1CC1 WGDVEJRCLSAPKN-UHFFFAOYSA-N 0.000 claims 1
- JFKCTKMMFMTQKJ-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-fluoro-4-methoxyphenoxy)-8-(2-methylsulfonylethylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound FC1=CC(OC)=CC=C1OC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCS(C)(=O)=O)=C1 JFKCTKMMFMTQKJ-UHFFFAOYSA-N 0.000 claims 1
- WMCOKEBNQSACSX-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3,4-difluorophenoxy)-8-(methylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound N=1N2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NC)=CC=1OC1=CC=C(F)C(F)=C1 WMCOKEBNQSACSX-UHFFFAOYSA-N 0.000 claims 1
- GVCVEPCWDJOSSA-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3,4-difluorophenoxy)-8-[2-(dimethylamino)ethylamino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound N=1N2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCN(C)C)=CC=1OC1=CC=C(F)C(F)=C1 GVCVEPCWDJOSSA-UHFFFAOYSA-N 0.000 claims 1
- SKVHLRDWBPFLDJ-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluoro-4-methoxyphenoxy)-8-(2-methylsulfonylethylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C1=C(F)C(OC)=CC=C1OC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCS(C)(=O)=O)=C1 SKVHLRDWBPFLDJ-UHFFFAOYSA-N 0.000 claims 1
- HQIKRGYWVOQEFV-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluorophenoxy)-8-(1h-pyrazol-5-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCC4=NNC=C4)C3=NC=2)=CC=C1C(=O)NC1CC1 HQIKRGYWVOQEFV-UHFFFAOYSA-N 0.000 claims 1
- AQNSRKMCVMCYHS-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluorophenoxy)-8-(2,2,2-trifluoroethylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 AQNSRKMCVMCYHS-UHFFFAOYSA-N 0.000 claims 1
- GBHCSNZBRSOJMI-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluorophenoxy)-8-(2-morpholin-4-ylethylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCCN4CCOCC4)C3=NC=2)=CC=C1C(=O)NC1CC1 GBHCSNZBRSOJMI-UHFFFAOYSA-N 0.000 claims 1
- KUORWNYCYLJPCJ-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluorophenoxy)-8-(2-piperidin-1-ylethylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCCN4CCCCC4)C3=NC=2)=CC=C1C(=O)NC1CC1 KUORWNYCYLJPCJ-UHFFFAOYSA-N 0.000 claims 1
- KNRBZVUJPHSLBD-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluorophenoxy)-8-(3-piperidin-1-ylpropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCCCN4CCCCC4)C3=NC=2)=CC=C1C(=O)NC1CC1 KNRBZVUJPHSLBD-UHFFFAOYSA-N 0.000 claims 1
- KOMFVSHZKYSMRR-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluorophenoxy)-8-(methylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound N=1N2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NC)=CC=1OC1=CC=CC(F)=C1 KOMFVSHZKYSMRR-UHFFFAOYSA-N 0.000 claims 1
- MRXTVEOGKURJNP-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluorophenoxy)-8-(oxolan-3-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCC4COCC4)C3=NC=2)=CC=C1C(=O)NC1CC1 MRXTVEOGKURJNP-UHFFFAOYSA-N 0.000 claims 1
- RTDOEUXGOUJIII-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluorophenoxy)-8-[(1-methyl-5-oxopyrrolidin-3-yl)methylamino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C1C(=O)N(C)CC1CNC1=CC(OC=2C=C(F)C=CC=2)=NN2C1=NC=C2C(C=C1C)=CC=C1C(=O)NC1CC1 RTDOEUXGOUJIII-UHFFFAOYSA-N 0.000 claims 1
- AKOHZMQPCSZUKA-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluorophenoxy)-8-[(3,3,3-trifluoro-2-hydroxypropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCC(O)C(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 AKOHZMQPCSZUKA-UHFFFAOYSA-N 0.000 claims 1
- MNGUBSHTSKMYJC-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluorophenoxy)-8-[(3-hydroxy-3-methylbutyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 MNGUBSHTSKMYJC-UHFFFAOYSA-N 0.000 claims 1
- SNJSOIKEGVKRSG-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluorophenoxy)-8-[3-[methyl(methylcarbamoyl)amino]propylamino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound N=1N2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCCN(C)C(=O)NC)=CC=1OC1=CC=CC(F)=C1 SNJSOIKEGVKRSG-UHFFFAOYSA-N 0.000 claims 1
- XONYHFIXMOYPHH-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(1,1-dioxothian-4-yl)methylamino]-6-(4-fluorophenoxy)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=CC(F)=CC=4)C=C(NCC4CCS(=O)(=O)CC4)C3=NC=2)=CC=C1C(=O)NC1CC1 XONYHFIXMOYPHH-UHFFFAOYSA-N 0.000 claims 1
- KDSAUMNSZUFGLM-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(1,1-dioxothiolan-3-yl)methylamino]-6-(3-fluorophenoxy)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCC4CS(=O)(=O)CC4)C3=NC=2)=CC=C1C(=O)NC1CC1 KDSAUMNSZUFGLM-UHFFFAOYSA-N 0.000 claims 1
- CDILJPGHIAKWLS-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(4-piperazin-1-ylphenoxy)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=CC(=CC=4)N4CCNCC4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 CDILJPGHIAKWLS-UHFFFAOYSA-N 0.000 claims 1
- PYXFUEFJAVRMIU-UHFFFAOYSA-N n-cyclopropyl-4-[8-[2-(dimethylamino)ethylamino]-6-(3-fluorophenoxy)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound N=1N2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCN(C)C)=CC=1OC1=CC=CC(F)=C1 PYXFUEFJAVRMIU-UHFFFAOYSA-N 0.000 claims 1
- IAYZNYHWGWOPSA-UHFFFAOYSA-N n-cyclopropyl-4-[8-[3-(dimethylamino)propylamino]-6-(3-fluorophenoxy)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound N=1N2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCCN(C)C)=CC=1OC1=CC=CC(F)=C1 IAYZNYHWGWOPSA-UHFFFAOYSA-N 0.000 claims 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 claims 1
- 125000000725 trifluoropropyl group Chemical group [H]C([H])(*)C([H])([H])C(F)(F)F 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 29
- 201000010099 disease Diseases 0.000 abstract description 15
- 238000011282 treatment Methods 0.000 abstract description 13
- 238000011321 prophylaxis Methods 0.000 abstract description 8
- 239000003795 chemical substances by application Substances 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 239000004480 active ingredient Substances 0.000 abstract description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract description 2
- 102000009516 Protein Serine-Threonine Kinases Human genes 0.000 abstract description 2
- 108010009341 Protein Serine-Threonine Kinases Proteins 0.000 abstract description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 abstract description 2
- 230000033115 angiogenesis Effects 0.000 abstract 1
- 230000003463 hyperproliferative effect Effects 0.000 abstract 1
- 229940043355 kinase inhibitor Drugs 0.000 abstract 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 description 627
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 424
- 238000000746 purification Methods 0.000 description 393
- 238000005160 1H NMR spectroscopy Methods 0.000 description 357
- 125000001072 heteroaryl group Chemical group 0.000 description 237
- 125000004093 cyano group Chemical group *C#N 0.000 description 171
- 125000003118 aryl group Chemical group 0.000 description 158
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 description 133
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 88
- 125000005418 aryl aryl group Chemical group 0.000 description 77
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 73
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 61
- 239000000243 solution Substances 0.000 description 53
- 229910052717 sulfur Inorganic materials 0.000 description 52
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 46
- LOZRYLSDXSNUMZ-UHFFFAOYSA-N 4-[6-bromo-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(Br)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 LOZRYLSDXSNUMZ-UHFFFAOYSA-N 0.000 description 44
- 239000002904 solvent Substances 0.000 description 44
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 43
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 42
- 229910052736 halogen Inorganic materials 0.000 description 41
- 150000002367 halogens Chemical class 0.000 description 41
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 38
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 37
- 125000004366 heterocycloalkenyl group Chemical group 0.000 description 36
- 238000004587 chromatography analysis Methods 0.000 description 34
- 206010028980 Neoplasm Diseases 0.000 description 30
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 30
- 125000004432 carbon atom Chemical group C* 0.000 description 28
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 23
- 210000004027 cell Anatomy 0.000 description 23
- 229910052938 sodium sulfate Inorganic materials 0.000 description 23
- 235000011152 sodium sulphate Nutrition 0.000 description 23
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 22
- 238000001914 filtration Methods 0.000 description 22
- SVALSHAHFMBAEX-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide Chemical compound CC1=CC(B2OC(C)(C)C(C)(C)O2)=CC=C1C(=O)NC1CC1 SVALSHAHFMBAEX-UHFFFAOYSA-N 0.000 description 21
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 20
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 20
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 19
- CSFRKRKCGOHTJB-UHFFFAOYSA-N 8-bromo-6-chloro-3-iodoimidazo[1,2-b]pyridazine Chemical compound N1=C(Cl)C=C(Br)C2=NC=C(I)N21 CSFRKRKCGOHTJB-UHFFFAOYSA-N 0.000 description 18
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 18
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 18
- 229940126062 Compound A Drugs 0.000 description 16
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 16
- QLULGIRFKAWHOJ-UHFFFAOYSA-N pyridin-4-ylboronic acid Chemical compound OB(O)C1=CC=NC=C1 QLULGIRFKAWHOJ-UHFFFAOYSA-N 0.000 description 16
- 108091000080 Phosphotransferase Proteins 0.000 description 15
- 102000020233 phosphotransferase Human genes 0.000 description 15
- 150000002430 hydrocarbons Chemical group 0.000 description 14
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 14
- 239000012074 organic phase Substances 0.000 description 14
- FHHJXOHKRXQGOB-UHFFFAOYSA-N 4-[6-bromo-8-(thian-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(Br)C=C(NCC4CCSCC4)C3=NC=2)=CC=C1C(=O)NC1CC1 FHHJXOHKRXQGOB-UHFFFAOYSA-N 0.000 description 13
- 208000035475 disorder Diseases 0.000 description 13
- 235000019439 ethyl acetate Nutrition 0.000 description 13
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 13
- 238000001946 ultra-performance liquid chromatography-mass spectrometry Methods 0.000 description 13
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 239000012267 brine Substances 0.000 description 12
- 238000005859 coupling reaction Methods 0.000 description 12
- 150000002148 esters Chemical class 0.000 description 12
- 239000012044 organic layer Substances 0.000 description 12
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 12
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 11
- 230000004663 cell proliferation Effects 0.000 description 11
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 11
- 239000002244 precipitate Substances 0.000 description 11
- 230000002062 proliferating effect Effects 0.000 description 11
- ZDEUGINAVLMAET-UHFFFAOYSA-N 3-fluorobenzenethiol Chemical compound FC1=CC=CC(S)=C1 ZDEUGINAVLMAET-UHFFFAOYSA-N 0.000 description 10
- HULPYSWCOQYXBS-UHFFFAOYSA-N 4-[6-chloro-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(Cl)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 HULPYSWCOQYXBS-UHFFFAOYSA-N 0.000 description 10
- LBUNNMJLXWQQBY-UHFFFAOYSA-N 4-fluorophenylboronic acid Chemical compound OB(O)C1=CC=C(F)C=C1 LBUNNMJLXWQQBY-UHFFFAOYSA-N 0.000 description 10
- LQZMLBORDGWNPD-UHFFFAOYSA-N N-iodosuccinimide Chemical compound IN1C(=O)CCC1=O LQZMLBORDGWNPD-UHFFFAOYSA-N 0.000 description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- 125000001424 substituent group Chemical group 0.000 description 10
- HLXOVAMYQUFLPE-UHFFFAOYSA-N 1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole Chemical compound CN1N=CC=C1B1OC(C)(C)C(C)(C)O1 HLXOVAMYQUFLPE-UHFFFAOYSA-N 0.000 description 9
- CNLOFJKPLANCFV-UHFFFAOYSA-N 4-[6-chloro-8-(2-methylpropylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound C=1N=C2C(NCC(C)C)=CC(Cl)=NN2C=1C(C=C1C)=CC=C1C(=O)NC1CC1 CNLOFJKPLANCFV-UHFFFAOYSA-N 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 230000024932 T cell mediated immunity Effects 0.000 description 9
- 239000002585 base Substances 0.000 description 9
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 9
- 230000010261 cell growth Effects 0.000 description 9
- 230000001413 cellular effect Effects 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 230000004083 survival effect Effects 0.000 description 9
- ITQAGWRCXRRJLY-UHFFFAOYSA-N 6-chloro-3-iodo-n-(2-methylpropyl)imidazo[1,2-b]pyridazin-8-amine Chemical compound CC(C)CNC1=CC(Cl)=NN2C(I)=CN=C12 ITQAGWRCXRRJLY-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 8
- 125000002619 bicyclic group Chemical group 0.000 description 8
- 230000028709 inflammatory response Effects 0.000 description 8
- 239000003112 inhibitor Substances 0.000 description 8
- 230000017205 mitotic cell cycle checkpoint Effects 0.000 description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 8
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 8
- 229920006395 saturated elastomer Polymers 0.000 description 8
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 8
- 235000017557 sodium bicarbonate Nutrition 0.000 description 8
- CRQHLWUGEZWMFF-UHFFFAOYSA-N 1-[[6-chloro-3-[4-(1,3-dioxolan-2-yl)phenyl]imidazo[1,2-b]pyridazin-8-yl]amino]-2-methylpropan-2-ol Chemical compound C=1N=C2C(NCC(C)(O)C)=CC(Cl)=NN2C=1C(C=C1)=CC=C1C1OCCO1 CRQHLWUGEZWMFF-UHFFFAOYSA-N 0.000 description 7
- BVXSGNHDNBVQNJ-UHFFFAOYSA-N 6,8-dibromo-3-iodoimidazo[1,2-b]pyridazine Chemical compound N1=C(Br)C=C(Br)C2=NC=C(I)N21 BVXSGNHDNBVQNJ-UHFFFAOYSA-N 0.000 description 7
- 241000282414 Homo sapiens Species 0.000 description 7
- WCRPDYXXIVYAAJ-UHFFFAOYSA-N [4-(cyclopropylcarbamoyl)phenyl]boronic acid Chemical compound C1=CC(B(O)O)=CC=C1C(=O)NC1CC1 WCRPDYXXIVYAAJ-UHFFFAOYSA-N 0.000 description 7
- 150000001412 amines Chemical class 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 230000014759 maintenance of location Effects 0.000 description 7
- 229910052757 nitrogen Inorganic materials 0.000 description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 7
- 229940124597 therapeutic agent Drugs 0.000 description 7
- OJUAZAZYZJBJBT-UHFFFAOYSA-N 1-[(6-chloro-3-iodoimidazo[1,2-b]pyridazin-8-yl)amino]-2-methylpropan-2-ol Chemical compound CC(C)(O)CNC1=CC(Cl)=NN2C(I)=CN=C12 OJUAZAZYZJBJBT-UHFFFAOYSA-N 0.000 description 6
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 6
- DPGSPRJLAZGUBQ-UHFFFAOYSA-N 2-ethenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Chemical compound CC1(C)OB(C=C)OC1(C)C DPGSPRJLAZGUBQ-UHFFFAOYSA-N 0.000 description 6
- KDSNLYIMUZNERS-UHFFFAOYSA-N 2-methylpropanamine Chemical compound CC(C)CN KDSNLYIMUZNERS-UHFFFAOYSA-N 0.000 description 6
- SJTBRFHBXDZMPS-UHFFFAOYSA-N 3-fluorophenol Chemical compound OC1=CC=CC(F)=C1 SJTBRFHBXDZMPS-UHFFFAOYSA-N 0.000 description 6
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 208000003174 Brain Neoplasms Diseases 0.000 description 6
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 206010027476 Metastases Diseases 0.000 description 6
- 150000001204 N-oxides Chemical class 0.000 description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
- AFHOBSCDNXGFMO-UHFFFAOYSA-N [2-(hydroxymethyl)phenyl]boronic acid Chemical compound OCC1=CC=CC=C1B(O)O AFHOBSCDNXGFMO-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 229940095076 benzaldehyde Drugs 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 125000005842 heteroatom Chemical group 0.000 description 6
- 150000002431 hydrogen Chemical class 0.000 description 6
- 150000004942 imidazo[1,2-b]pyridazines Chemical class 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 125000002950 monocyclic group Chemical group 0.000 description 6
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 6
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- GVZLAPQNXUIOMF-UHFFFAOYSA-N 1-[[6-chloro-3-[4-(2-cyclopropyl-1h-imidazol-5-yl)phenyl]imidazo[1,2-b]pyridazin-8-yl]amino]-2-methylpropan-2-ol Chemical compound C=1N=C2C(NCC(C)(O)C)=CC(Cl)=NN2C=1C(C=C1)=CC=C1C(N1)=CN=C1C1CC1 GVZLAPQNXUIOMF-UHFFFAOYSA-N 0.000 description 5
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 5
- KRNCURCYWRLGSM-UHFFFAOYSA-N 4-[6-chloro-8-[(3,3,3-trifluoro-2-hydroxypropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(Cl)C=C(NCC(O)C(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 KRNCURCYWRLGSM-UHFFFAOYSA-N 0.000 description 5
- TUYVCQAAPPGTTR-UHFFFAOYSA-N 6-chloro-3-[4-(2-cyclopropyl-1h-imidazol-5-yl)phenyl]-n-(3,3,3-trifluoropropyl)imidazo[1,2-b]pyridazin-8-amine Chemical compound C=1N=C2C(NCCC(F)(F)F)=CC(Cl)=NN2C=1C(C=C1)=CC=C1C(N1)=CN=C1C1CC1 TUYVCQAAPPGTTR-UHFFFAOYSA-N 0.000 description 5
- VEBNDJHAGGCIIB-UHFFFAOYSA-N 6-chloro-3-iodo-n-(3,3,3-trifluoropropyl)imidazo[1,2-b]pyridazin-8-amine Chemical compound FC(F)(F)CCNC1=CC(Cl)=NN2C(I)=CN=C12 VEBNDJHAGGCIIB-UHFFFAOYSA-N 0.000 description 5
- 238000007792 addition Methods 0.000 description 5
- 125000004429 atom Chemical group 0.000 description 5
- 125000005605 benzo group Chemical group 0.000 description 5
- 229910052794 bromium Inorganic materials 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 125000004122 cyclic group Chemical group 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 150000002391 heterocyclic compounds Chemical class 0.000 description 5
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 5
- 230000002503 metabolic effect Effects 0.000 description 5
- 125000004433 nitrogen atom Chemical group N* 0.000 description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 description 5
- 229960001407 sodium bicarbonate Drugs 0.000 description 5
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- RPEPGIOVXBBUMJ-UHFFFAOYSA-N 2,3-difluorophenol Chemical compound OC1=CC=CC(F)=C1F RPEPGIOVXBBUMJ-UHFFFAOYSA-N 0.000 description 4
- DSCJETUEDFKYGN-UHFFFAOYSA-N 2-Methoxybenzenethiol Chemical compound COC1=CC=CC=C1S DSCJETUEDFKYGN-UHFFFAOYSA-N 0.000 description 4
- FCJHBXCQIOVMEM-UHFFFAOYSA-N 2-fluoro-4-methoxyphenol Chemical compound COC1=CC=C(O)C(F)=C1 FCJHBXCQIOVMEM-UHFFFAOYSA-N 0.000 description 4
- VRRSYCJFFOUSFM-UHFFFAOYSA-N 3-fluoro-5-methylbenzenethiol Chemical compound CC1=CC(F)=CC(S)=C1 VRRSYCJFFOUSFM-UHFFFAOYSA-N 0.000 description 4
- AYMBVFCWNCCREA-UHFFFAOYSA-N 3-fluoro-5-methylphenol Chemical compound CC1=CC(O)=CC(F)=C1 AYMBVFCWNCCREA-UHFFFAOYSA-N 0.000 description 4
- JJYPMNFTHPTTDI-UHFFFAOYSA-N 3-methylaniline Chemical compound CC1=CC=CC(N)=C1 JJYPMNFTHPTTDI-UHFFFAOYSA-N 0.000 description 4
- XDRQLDYLYNLLGS-UHFFFAOYSA-N 4-[6-(3-fluorophenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzoic acid Chemical compound C1=C(C(O)=O)C(C)=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCCC(F)(F)F)C3=NC=2)=C1 XDRQLDYLYNLLGS-UHFFFAOYSA-N 0.000 description 4
- FDOWIRFKAHKIDS-UHFFFAOYSA-N 4-[6-bromo-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(Br)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 FDOWIRFKAHKIDS-UHFFFAOYSA-N 0.000 description 4
- JMPJBIFBYDKELV-UHFFFAOYSA-N 4-[8-[(2-amino-2-methylpropyl)amino]-6-chloroimidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(Cl)C=C(NCC(C)(C)N)C3=NC=2)=CC=C1C(=O)NC1CC1 JMPJBIFBYDKELV-UHFFFAOYSA-N 0.000 description 4
- VDBQQFUSXNTPKU-UHFFFAOYSA-N 6,8-dibromoimidazo[1,2-b]pyridazine Chemical compound N1=C(Br)C=C(Br)C2=NC=CN21 VDBQQFUSXNTPKU-UHFFFAOYSA-N 0.000 description 4
- ASNCWFZNEXNXJP-UHFFFAOYSA-N 6-chloro-3-[4-(1,3-dioxolan-2-yl)phenyl]-n-(3,3,3-trifluoropropyl)imidazo[1,2-b]pyridazin-8-amine Chemical compound C=1N=C2C(NCCC(F)(F)F)=CC(Cl)=NN2C=1C(C=C1)=CC=C1C1OCCO1 ASNCWFZNEXNXJP-UHFFFAOYSA-N 0.000 description 4
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 4
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 229910052801 chlorine Inorganic materials 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 125000000753 cycloalkyl group Chemical group 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 125000000524 functional group Chemical group 0.000 description 4
- 150000004677 hydrates Chemical class 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 208000032839 leukemia Diseases 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 230000011278 mitosis Effects 0.000 description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 235000015424 sodium Nutrition 0.000 description 4
- 229940083542 sodium Drugs 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000012312 sodium hydride Substances 0.000 description 4
- 229910000104 sodium hydride Inorganic materials 0.000 description 4
- RMBAVIFYHOYIFM-UHFFFAOYSA-M sodium methanethiolate Chemical compound [Na+].[S-]C RMBAVIFYHOYIFM-UHFFFAOYSA-M 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 description 3
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- YCCQGFYAVUTQFK-UHFFFAOYSA-N 2,3-difluoroaniline Chemical compound NC1=CC=CC(F)=C1F YCCQGFYAVUTQFK-UHFFFAOYSA-N 0.000 description 3
- DVDXVDUMSBCCTP-UHFFFAOYSA-N 2-[4-(1,3-dioxolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Chemical compound O1C(C)(C)C(C)(C)OB1C1=CC=C(C2OCCO2)C=C1 DVDXVDUMSBCCTP-UHFFFAOYSA-N 0.000 description 3
- NGZVNONVXYLYQW-UHFFFAOYSA-N 3,3,3-trifluoropropan-1-amine Chemical compound NCCC(F)(F)F NGZVNONVXYLYQW-UHFFFAOYSA-N 0.000 description 3
- AXNUZKSSQHTNPZ-UHFFFAOYSA-N 3,4-difluoroaniline Chemical compound NC1=CC=C(F)C(F)=C1 AXNUZKSSQHTNPZ-UHFFFAOYSA-N 0.000 description 3
- KQLUXUHTWARHJO-UHFFFAOYSA-N 3-[4-(2-cyclopropyl-1h-imidazol-5-yl)phenyl]-6-ethenyl-n-(3,3,3-trifluoropropyl)imidazo[1,2-b]pyridazin-8-amine Chemical compound C=1N=C2C(NCCC(F)(F)F)=CC(C=C)=NN2C=1C(C=C1)=CC=C1C(N1)=CN=C1C1CC1 KQLUXUHTWARHJO-UHFFFAOYSA-N 0.000 description 3
- QMVAZEHZOPDGHA-UHFFFAOYSA-N 3-methoxybenzenethiol Chemical compound COC1=CC=CC(S)=C1 QMVAZEHZOPDGHA-UHFFFAOYSA-N 0.000 description 3
- MMLKBHQSNNDPHO-UHFFFAOYSA-N 4-[6-bromo-8-(2-hydroxyethylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(Br)C=C(NCCO)C3=NC=2)=CC=C1C(=O)NC1CC1 MMLKBHQSNNDPHO-UHFFFAOYSA-N 0.000 description 3
- YYZHAOJXENHDLL-UHFFFAOYSA-N 4-[6-chloro-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(Cl)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 YYZHAOJXENHDLL-UHFFFAOYSA-N 0.000 description 3
- VSYQNFCJQTUXOD-MRXNPFEDSA-N 4-[6-chloro-8-[[(2r)-oxolan-2-yl]methylamino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(Cl)C=C(NC[C@@H]4OCCC4)C3=NC=2)=CC=C1C(=O)NC1CC1 VSYQNFCJQTUXOD-MRXNPFEDSA-N 0.000 description 3
- VSYQNFCJQTUXOD-INIZCTEOSA-N 4-[6-chloro-8-[[(2s)-oxolan-2-yl]methylamino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(Cl)C=C(NC[C@H]4OCCC4)C3=NC=2)=CC=C1C(=O)NC1CC1 VSYQNFCJQTUXOD-INIZCTEOSA-N 0.000 description 3
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 description 3
- WRZOMWDJOLIVQP-UHFFFAOYSA-N 5-Chloro-ortho-toluidine Chemical compound CC1=CC=C(Cl)C=C1N WRZOMWDJOLIVQP-UHFFFAOYSA-N 0.000 description 3
- JLCDTNNLXUMYFQ-UHFFFAOYSA-N 5-fluoro-2-methylaniline Chemical compound CC1=CC=C(F)C=C1N JLCDTNNLXUMYFQ-UHFFFAOYSA-N 0.000 description 3
- PCIQHGSRMDFYLI-UHFFFAOYSA-N 6-bromo-3-iodo-n-(3,3,3-trifluoropropyl)imidazo[1,2-b]pyridazin-8-amine Chemical compound FC(F)(F)CCNC1=CC(Br)=NN2C(I)=CN=C12 PCIQHGSRMDFYLI-UHFFFAOYSA-N 0.000 description 3
- VXYXPKMZGLRVPC-UHFFFAOYSA-N 6-bromo-3-iodo-n-(oxan-4-ylmethyl)imidazo[1,2-b]pyridazin-8-amine Chemical compound C12=NC=C(I)N2N=C(Br)C=C1NCC1CCOCC1 VXYXPKMZGLRVPC-UHFFFAOYSA-N 0.000 description 3
- LFFGBZDTWUFIDR-UHFFFAOYSA-N 6-chloro-3-iodo-n-(oxan-2-ylmethyl)imidazo[1,2-b]pyridazin-8-amine Chemical compound C12=NC=C(I)N2N=C(Cl)C=C1NCC1CCCCO1 LFFGBZDTWUFIDR-UHFFFAOYSA-N 0.000 description 3
- VFTJLVYMSQLYIY-SSDOTTSWSA-N 6-chloro-3-iodo-n-[[(2r)-oxolan-2-yl]methyl]imidazo[1,2-b]pyridazin-8-amine Chemical compound C12=NC=C(I)N2N=C(Cl)C=C1NC[C@H]1CCCO1 VFTJLVYMSQLYIY-SSDOTTSWSA-N 0.000 description 3
- VFTJLVYMSQLYIY-ZETCQYMHSA-N 6-chloro-3-iodo-n-[[(2s)-oxolan-2-yl]methyl]imidazo[1,2-b]pyridazin-8-amine Chemical compound C12=NC=C(I)N2N=C(Cl)C=C1NC[C@@H]1CCCO1 VFTJLVYMSQLYIY-ZETCQYMHSA-N 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 3
- 102100021752 Corticoliberin Human genes 0.000 description 3
- HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 206010025323 Lymphomas Diseases 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 206010059282 Metastases to central nervous system Diseases 0.000 description 3
- 241001024304 Mino Species 0.000 description 3
- 201000003793 Myelodysplastic syndrome Diseases 0.000 description 3
- 206010029098 Neoplasm skin Diseases 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- YUROUWWCCSZTIP-UHFFFAOYSA-N [4-(cyclopropylcarbamoyl)-2-methoxyphenyl]boronic acid Chemical compound C1=C(B(O)O)C(OC)=CC(C(=O)NC2CC2)=C1 YUROUWWCCSZTIP-UHFFFAOYSA-N 0.000 description 3
- CRDGQMHVPOLLDL-UHFFFAOYSA-N [4-(cyclopropylcarbamoyl)-3-methylphenyl]boronic acid Chemical compound CC1=CC(B(O)O)=CC=C1C(=O)NC1CC1 CRDGQMHVPOLLDL-UHFFFAOYSA-N 0.000 description 3
- WDCNOFNVHZOFOW-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]boronic acid Chemical compound OCC1=CC(F)=CC=C1B(O)O WDCNOFNVHZOFOW-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 3
- 125000003342 alkenyl group Chemical group 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 230000033077 cellular process Effects 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052804 chromium Inorganic materials 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 125000000392 cycloalkenyl group Chemical group 0.000 description 3
- 230000002124 endocrine Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 201000010536 head and neck cancer Diseases 0.000 description 3
- NAUOUPATZLZONR-UHFFFAOYSA-N imidazo[1,2-b]pyridazin-8-amine Chemical compound NC1=CC=NN2C=CN=C12 NAUOUPATZLZONR-UHFFFAOYSA-N 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 210000002415 kinetochore Anatomy 0.000 description 3
- 208000037841 lung tumor Diseases 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 150000007522 mineralic acids Chemical class 0.000 description 3
- 230000000394 mitotic effect Effects 0.000 description 3
- UMOCWIBXOUGVNT-UHFFFAOYSA-N n-cyclopropyl-4-[6-(5-methoxy-2-methylanilino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound COC1=CC=C(C)C(NC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCCC(F)(F)F)=C2)=C1 UMOCWIBXOUGVNT-UHFFFAOYSA-N 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- BHAAPTBBJKJZER-UHFFFAOYSA-N p-anisidine Chemical compound COC1=CC=C(N)C=C1 BHAAPTBBJKJZER-UHFFFAOYSA-N 0.000 description 3
- 229910052763 palladium Inorganic materials 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 229960003742 phenol Drugs 0.000 description 3
- 238000002953 preparative HPLC Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 210000002307 prostate Anatomy 0.000 description 3
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 3
- 150000003335 secondary amines Chemical class 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 201000004477 skin sarcoma Diseases 0.000 description 3
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 3
- 235000019345 sodium thiosulphate Nutrition 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- KAKIJVTZFSELRI-UHFFFAOYSA-N tert-butyl n-(6-bromoimidazo[1,2-b]pyridazin-8-yl)-n-(3,3,3-trifluoropropyl)carbamate Chemical compound CC(C)(C)OC(=O)N(CCC(F)(F)F)C1=CC(Br)=NN2C=CN=C12 KAKIJVTZFSELRI-UHFFFAOYSA-N 0.000 description 3
- 150000003568 thioethers Chemical class 0.000 description 3
- 239000003643 water by type Substances 0.000 description 3
- KZFZIALCFGIPRE-DTWKUNHWSA-N (1s)-2-[(6-chloro-3-iodoimidazo[1,2-b]pyridazin-8-yl)amino]-1-[(4r)-2,2-dimethyl-1,3-dioxolan-4-yl]ethanol Chemical compound O1C(C)(C)OC[C@@H]1[C@@H](O)CNC1=CC(Cl)=NN2C1=NC=C2I KZFZIALCFGIPRE-DTWKUNHWSA-N 0.000 description 2
- PTUMVGFMLYYJDW-UHFFFAOYSA-N (2-bromo-5-fluorophenyl)methoxy-tri(propan-2-yl)silane Chemical compound CC(C)[Si](C(C)C)(C(C)C)OCC1=CC(F)=CC=C1Br PTUMVGFMLYYJDW-UHFFFAOYSA-N 0.000 description 2
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 2
- DECWLXUOZUMPBF-UHFFFAOYSA-N (4-cyano-3-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(C#N)C(F)=C1 DECWLXUOZUMPBF-UHFFFAOYSA-N 0.000 description 2
- VJTBYIVDTPQLIE-UHFFFAOYSA-N (5-chloro-2-sulfanylphenyl)methanol Chemical compound OCC1=CC(Cl)=CC=C1S VJTBYIVDTPQLIE-UHFFFAOYSA-N 0.000 description 2
- CYEXXDYQJPRMIQ-UHFFFAOYSA-N (5-cyanopyridin-3-yl)boronic acid Chemical compound OB(O)C1=CN=CC(C#N)=C1 CYEXXDYQJPRMIQ-UHFFFAOYSA-N 0.000 description 2
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 2
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 2
- AUHZEENZYGFFBQ-UHFFFAOYSA-N 1,3,5-trimethylbenzene Chemical compound CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 2
- IUBHUSKSWSCXTM-UHFFFAOYSA-N 1-[(6-bromo-3-iodoimidazo[1,2-b]pyridazin-8-yl)amino]-2-methylpropan-2-ol Chemical compound CC(C)(O)CNC1=CC(Br)=NN2C(I)=CN=C12 IUBHUSKSWSCXTM-UHFFFAOYSA-N 0.000 description 2
- AFTNBHGUHBQZGR-UHFFFAOYSA-N 1-[[3-[4-(1,3-dioxolan-2-yl)phenyl]-6-(3-fluorophenoxy)imidazo[1,2-b]pyridazin-8-yl]amino]-2-methylpropan-2-ol Chemical compound N=1N2C(C=3C=CC(=CC=3)C3OCCO3)=CN=C2C(NCC(C)(O)C)=CC=1OC1=CC=CC(F)=C1 AFTNBHGUHBQZGR-UHFFFAOYSA-N 0.000 description 2
- DIWBPYQBESPNAG-UHFFFAOYSA-N 1-[[3-[4-(1,3-dioxolan-2-yl)phenyl]-6-(3-fluorophenyl)sulfanylimidazo[1,2-b]pyridazin-8-yl]amino]-2-methylpropan-2-ol Chemical compound N=1N2C(C=3C=CC(=CC=3)C3OCCO3)=CN=C2C(NCC(C)(O)C)=CC=1SC1=CC=CC(F)=C1 DIWBPYQBESPNAG-UHFFFAOYSA-N 0.000 description 2
- QXLVWPSRZHYLLA-UHFFFAOYSA-N 1-[[3-[4-(1,3-dioxolan-2-yl)phenyl]-6-(4-fluorophenyl)imidazo[1,2-b]pyridazin-8-yl]amino]-2-methylpropan-2-ol Chemical compound C=1N=C2C(NCC(C)(O)C)=CC(C=3C=CC(F)=CC=3)=NN2C=1C(C=C1)=CC=C1C1OCCO1 QXLVWPSRZHYLLA-UHFFFAOYSA-N 0.000 description 2
- XJYLHPSZFBVKOD-UHFFFAOYSA-N 1-[[3-[4-(1,3-dioxolan-2-yl)phenyl]-6-phenoxyimidazo[1,2-b]pyridazin-8-yl]amino]-2-methylpropan-2-ol Chemical compound N=1N2C(C=3C=CC(=CC=3)C3OCCO3)=CN=C2C(NCC(C)(O)C)=CC=1OC1=CC=CC=C1 XJYLHPSZFBVKOD-UHFFFAOYSA-N 0.000 description 2
- MEKQMAMOSRPOIY-UHFFFAOYSA-N 1-[[6-(cyclohexen-1-yl)-3-[4-(1,3-dioxolan-2-yl)phenyl]imidazo[1,2-b]pyridazin-8-yl]amino]-2-methylpropan-2-ol Chemical compound C=1N=C2C(NCC(C)(O)C)=CC(C=3CCCCC=3)=NN2C=1C(C=C1)=CC=C1C1OCCO1 MEKQMAMOSRPOIY-UHFFFAOYSA-N 0.000 description 2
- LXQMHOKEXZETKB-UHFFFAOYSA-N 1-amino-2-methylpropan-2-ol Chemical compound CC(C)(O)CN LXQMHOKEXZETKB-UHFFFAOYSA-N 0.000 description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
- HKAVADYDPYUPRD-UHFFFAOYSA-N 1h-pyrazine-2-thione Chemical compound SC1=CN=CC=N1 HKAVADYDPYUPRD-UHFFFAOYSA-N 0.000 description 2
- CDZXJJOGDCLNKX-UHFFFAOYSA-N 2,2,3,3-tetrafluorobutane-1,4-diol Chemical compound OCC(F)(F)C(F)(F)CO CDZXJJOGDCLNKX-UHFFFAOYSA-N 0.000 description 2
- PQRVQUXEBQKVEQ-UHFFFAOYSA-N 2,5-difluorobenzenethiol Chemical compound FC1=CC=C(F)C(S)=C1 PQRVQUXEBQKVEQ-UHFFFAOYSA-N 0.000 description 2
- QXHDYMUPPXAMPQ-UHFFFAOYSA-N 2-(4-aminophenyl)ethanol Chemical compound NC1=CC=C(CCO)C=C1 QXHDYMUPPXAMPQ-UHFFFAOYSA-N 0.000 description 2
- SXVRARBIVGEMRF-UHFFFAOYSA-N 2-[(6-bromo-3-iodoimidazo[1,2-b]pyridazin-8-yl)amino]ethanol Chemical compound OCCNC1=CC(Br)=NN2C(I)=CN=C12 SXVRARBIVGEMRF-UHFFFAOYSA-N 0.000 description 2
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 2
- ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 description 2
- JHEKZGQIHWVRFW-UHFFFAOYSA-N 2-fluoro-4-[8-(2-methylpropylamino)-6-phenylimidazo[1,2-b]pyridazin-3-yl]benzonitrile Chemical compound C=1N=C2C(NCC(C)C)=CC(C=3C=CC=CC=3)=NN2C=1C1=CC=C(C#N)C(F)=C1 JHEKZGQIHWVRFW-UHFFFAOYSA-N 0.000 description 2
- VLXWEUASWRQBAY-UHFFFAOYSA-N 2-fluoro-4-methylbenzenethiol Chemical compound CC1=CC=C(S)C(F)=C1 VLXWEUASWRQBAY-UHFFFAOYSA-N 0.000 description 2
- QZUXMXZNVAJNSE-UHFFFAOYSA-N 2-fluoro-5-methylaniline Chemical compound CC1=CC=C(F)C(N)=C1 QZUXMXZNVAJNSE-UHFFFAOYSA-N 0.000 description 2
- XEHPMVZYZDQLDN-UHFFFAOYSA-N 2-fluoro-5-methylphenol Chemical compound CC1=CC=C(F)C(O)=C1 XEHPMVZYZDQLDN-UHFFFAOYSA-N 0.000 description 2
- FTZQXOJYPFINKJ-UHFFFAOYSA-N 2-fluoroaniline Chemical compound NC1=CC=CC=C1F FTZQXOJYPFINKJ-UHFFFAOYSA-N 0.000 description 2
- WJTZZPVVTSDNJJ-UHFFFAOYSA-N 2-fluorobenzenethiol Chemical compound FC1=CC=CC=C1S WJTZZPVVTSDNJJ-UHFFFAOYSA-N 0.000 description 2
- HFHFGHLXUCOHLN-UHFFFAOYSA-N 2-fluorophenol Chemical compound OC1=CC=CC=C1F HFHFGHLXUCOHLN-UHFFFAOYSA-N 0.000 description 2
- YZVWMFBVTTUSAW-UHFFFAOYSA-N 2-morpholin-4-ylethanethiol Chemical compound SCCN1CCOCC1 YZVWMFBVTTUSAW-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- YNNQPLHRDOMWNW-UHFFFAOYSA-N 3,3-dimethylbutane-1-thiol Chemical compound CC(C)(C)CCS YNNQPLHRDOMWNW-UHFFFAOYSA-N 0.000 description 2
- BGVRHDQMTMPAEZ-UHFFFAOYSA-N 3,4-difluorobenzenethiol Chemical compound FC1=CC=C(S)C=C1F BGVRHDQMTMPAEZ-UHFFFAOYSA-N 0.000 description 2
- BNPWVUJOPCGHIK-UHFFFAOYSA-N 3,4-difluorophenol Chemical compound OC1=CC=C(F)C(F)=C1 BNPWVUJOPCGHIK-UHFFFAOYSA-N 0.000 description 2
- KQOIBXZRCYFZSO-UHFFFAOYSA-N 3,5-difluoroaniline Chemical compound NC1=CC(F)=CC(F)=C1 KQOIBXZRCYFZSO-UHFFFAOYSA-N 0.000 description 2
- LFYVNHDFVIPZHV-UHFFFAOYSA-N 3,5-difluorobenzenethiol Chemical compound FC1=CC(F)=CC(S)=C1 LFYVNHDFVIPZHV-UHFFFAOYSA-N 0.000 description 2
- TUAMRELNJMMDMT-UHFFFAOYSA-N 3,5-xylenol Chemical compound CC1=CC(C)=CC(O)=C1 TUAMRELNJMMDMT-UHFFFAOYSA-N 0.000 description 2
- HKFNSPCPXRHIGW-UHFFFAOYSA-N 3,6,8-tribromoimidazo[1,2-b]pyridazine Chemical compound BrC1=CC(Br)=NN2C(Br)=CN=C21 HKFNSPCPXRHIGW-UHFFFAOYSA-N 0.000 description 2
- IGIHESAFEHKUSR-UHFFFAOYSA-N 3-[4-(1,3-dioxolan-2-yl)phenyl]-6-(2-methylpyrazol-3-yl)-n-(3,3,3-trifluoropropyl)imidazo[1,2-b]pyridazin-8-amine Chemical compound CN1N=CC=C1C1=NN2C(C=3C=CC(=CC=3)C3OCCO3)=CN=C2C(NCCC(F)(F)F)=C1 IGIHESAFEHKUSR-UHFFFAOYSA-N 0.000 description 2
- FJXBVCUNMIPAPD-UHFFFAOYSA-N 3-[4-(1,3-dioxolan-2-yl)phenyl]-n-(2-methylpropyl)-6-pyridin-4-ylimidazo[1,2-b]pyridazin-8-amine Chemical compound C=1N=C2C(NCC(C)C)=CC(C=3C=CN=CC=3)=NN2C=1C(C=C1)=CC=C1C1OCCO1 FJXBVCUNMIPAPD-UHFFFAOYSA-N 0.000 description 2
- PNPCRKVUWYDDST-UHFFFAOYSA-N 3-chloroaniline Chemical compound NC1=CC=CC(Cl)=C1 PNPCRKVUWYDDST-UHFFFAOYSA-N 0.000 description 2
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 2
- HORNXRXVQWOLPJ-UHFFFAOYSA-N 3-chlorophenol Chemical compound OC1=CC=CC(Cl)=C1 HORNXRXVQWOLPJ-UHFFFAOYSA-N 0.000 description 2
- LJWAPDSCYTZUJU-UHFFFAOYSA-N 3-fluoro-4-methoxyaniline Chemical compound COC1=CC=C(N)C=C1F LJWAPDSCYTZUJU-UHFFFAOYSA-N 0.000 description 2
- DPHBKGYVIHTBDG-UHFFFAOYSA-N 3-fluoro-5-methylaniline Chemical compound CC1=CC(N)=CC(F)=C1 DPHBKGYVIHTBDG-UHFFFAOYSA-N 0.000 description 2
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 2
- OPXLVWLFDKRYRB-UHFFFAOYSA-N 3-methoxy-2-methylaniline Chemical compound COC1=CC=CC(N)=C1C OPXLVWLFDKRYRB-UHFFFAOYSA-N 0.000 description 2
- ASHGTJPOSUFTGB-UHFFFAOYSA-N 3-methoxyphenol Chemical compound COC1=CC=CC(O)=C1 ASHGTJPOSUFTGB-UHFFFAOYSA-N 0.000 description 2
- XCCNRBCNYGWTQX-UHFFFAOYSA-N 3-propan-2-ylaniline Chemical compound CC(C)C1=CC=CC(N)=C1 XCCNRBCNYGWTQX-UHFFFAOYSA-N 0.000 description 2
- VLJSLTNSFSOYQR-UHFFFAOYSA-N 3-propan-2-ylphenol Chemical compound CC(C)C1=CC=CC(O)=C1 VLJSLTNSFSOYQR-UHFFFAOYSA-N 0.000 description 2
- GRFNBEZIAWKNCO-UHFFFAOYSA-N 3-pyridinol Chemical compound OC1=CC=CN=C1 GRFNBEZIAWKNCO-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- WCMLRSZJUIKVCW-UHFFFAOYSA-N 4-(trifluoromethyl)benzenethiol Chemical compound FC(F)(F)C1=CC=C(S)C=C1 WCMLRSZJUIKVCW-UHFFFAOYSA-N 0.000 description 2
- OKIHXNKYYGUVTE-UHFFFAOYSA-N 4-Fluorothiophenol Chemical compound FC1=CC=C(S)C=C1 OKIHXNKYYGUVTE-UHFFFAOYSA-N 0.000 description 2
- VJPPLCNBDLZIFG-ZDUSSCGKSA-N 4-[(3S)-3-(but-2-ynoylamino)piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide Chemical compound C(C#CC)(=O)N[C@@H]1CN(CCC1)C1=C2C(=C(NC2=C(C=C1F)C(=O)N)C)C VJPPLCNBDLZIFG-ZDUSSCGKSA-N 0.000 description 2
- BJQVCXRFJBMXMJ-UHFFFAOYSA-N 4-[6-(3-fluorophenoxy)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]benzaldehyde Chemical compound N=1N2C(C=3C=CC(C=O)=CC=3)=CN=C2C(NCC(C)(O)C)=CC=1OC1=CC=CC(F)=C1 BJQVCXRFJBMXMJ-UHFFFAOYSA-N 0.000 description 2
- HSYXFEXCFMCNAO-UHFFFAOYSA-N 4-[6-(3-fluorophenyl)sulfanyl-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]benzaldehyde Chemical compound N=1N2C(C=3C=CC(C=O)=CC=3)=CN=C2C(NCC(C)(O)C)=CC=1SC1=CC=CC(F)=C1 HSYXFEXCFMCNAO-UHFFFAOYSA-N 0.000 description 2
- ZBDWQZKQCDFUBA-UHFFFAOYSA-N 4-[6-(4-fluorophenyl)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]benzaldehyde Chemical compound C=1N=C2C(NCC(C)(O)C)=CC(C=3C=CC(F)=CC=3)=NN2C=1C1=CC=C(C=O)C=C1 ZBDWQZKQCDFUBA-UHFFFAOYSA-N 0.000 description 2
- LCHBTPBTVLSBTP-UHFFFAOYSA-N 4-[6-bromo-8-(oxan-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropylbenzamide Chemical compound C12=NC=C(C=3C=CC(=CC=3)C(=O)NC3CC3)N2N=C(Br)C=C1NCC1CCOCC1 LCHBTPBTVLSBTP-UHFFFAOYSA-N 0.000 description 2
- BXSUZZBUBWWDAT-UHFFFAOYSA-N 4-[6-bromo-8-[(1,1-dioxothian-4-yl)methylamino]imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(Br)C=C(NCC4CCS(=O)(=O)CC4)C3=NC=2)=CC=C1C(=O)NC1CC1 BXSUZZBUBWWDAT-UHFFFAOYSA-N 0.000 description 2
- QYCYXTNXWTYUKA-UHFFFAOYSA-N 4-[6-chloro-8-(2-methylpropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-fluorobenzonitrile Chemical compound C=1N=C2C(NCC(C)C)=CC(Cl)=NN2C=1C1=CC=C(C#N)C(F)=C1 QYCYXTNXWTYUKA-UHFFFAOYSA-N 0.000 description 2
- FZPXZSHVQSHOQD-UHFFFAOYSA-N 4-[6-chloro-8-(2-methylpropylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropylbenzamide Chemical compound C=1N=C2C(NCC(C)C)=CC(Cl)=NN2C=1C(C=C1)=CC=C1C(=O)NC1CC1 FZPXZSHVQSHOQD-UHFFFAOYSA-N 0.000 description 2
- OUVQJGKKVIUVAD-UHFFFAOYSA-N 4-[6-chloro-8-(2-morpholin-4-ylsulfonylethylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(Cl)C=C(NCCS(=O)(=O)N4CCOCC4)C3=NC=2)=CC=C1C(=O)NC1CC1 OUVQJGKKVIUVAD-UHFFFAOYSA-N 0.000 description 2
- CETMLJPSTRDABR-UHFFFAOYSA-N 4-[6-chloro-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzenecarbothioamide Chemical compound CC1=CC(C=2N3N=C(Cl)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=S)NC1CC1 CETMLJPSTRDABR-UHFFFAOYSA-N 0.000 description 2
- YCSWBHPCCAPTKF-UHFFFAOYSA-N 4-[6-chloro-8-(oxan-2-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(Cl)C=C(NCC4OCCCC4)C3=NC=2)=CC=C1C(=O)NC1CC1 YCSWBHPCCAPTKF-UHFFFAOYSA-N 0.000 description 2
- UQFBMLWKZCMDJH-UHFFFAOYSA-N 4-[6-chloro-8-[(2-methyloxolan-2-yl)methylamino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(Cl)C=C(NCC4(C)OCCC4)C3=NC=2)=CC=C1C(=O)NC1CC1 UQFBMLWKZCMDJH-UHFFFAOYSA-N 0.000 description 2
- QQVIINCRQLPUHL-UHFFFAOYSA-N 4-[6-chloro-8-[(2-methylpyrazol-3-yl)methylamino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(Cl)C=C(NCC=4N(N=CC=4)C)C3=NC=2)=CC=C1C(=O)NC1CC1 QQVIINCRQLPUHL-UHFFFAOYSA-N 0.000 description 2
- NFVWOGCOBMFKNQ-UHFFFAOYSA-N 4-[6-chloro-8-[(4-methylmorpholin-2-yl)methylamino]imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropyl-2-methylbenzamide Chemical compound C1N(C)CCOC1CNC1=CC(Cl)=NN2C1=NC=C2C(C=C1C)=CC=C1C(=O)NC1CC1 NFVWOGCOBMFKNQ-UHFFFAOYSA-N 0.000 description 2
- KKKFBPVKGJCKBM-UHFFFAOYSA-N 4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-phenoxyimidazo[1,2-b]pyridazin-3-yl]benzaldehyde Chemical compound N=1N2C(C=3C=CC(C=O)=CC=3)=CN=C2C(NCC(C)(O)C)=CC=1OC1=CC=CC=C1 KKKFBPVKGJCKBM-UHFFFAOYSA-N 0.000 description 2
- KFPAYYHBMPHYHR-UHFFFAOYSA-N 4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-phenylsulfanylimidazo[1,2-b]pyridazin-3-yl]benzaldehyde Chemical compound N=1N2C(C=3C=CC(C=O)=CC=3)=CN=C2C(NCC(C)(O)C)=CC=1SC1=CC=CC=C1 KFPAYYHBMPHYHR-UHFFFAOYSA-N 0.000 description 2
- OJCAKOFFLWVGEA-UHFFFAOYSA-N 4-bromo-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(Br)=CC=C1C(=O)NC1CC1 OJCAKOFFLWVGEA-UHFFFAOYSA-N 0.000 description 2
- CSFDTBRRIBJILD-UHFFFAOYSA-N 4-chloro-2-fluoroaniline Chemical compound NC1=CC=C(Cl)C=C1F CSFDTBRRIBJILD-UHFFFAOYSA-N 0.000 description 2
- ACMJJQYSPUPMPN-UHFFFAOYSA-N 4-chloro-3-fluoroaniline Chemical compound NC1=CC=C(Cl)C(F)=C1 ACMJJQYSPUPMPN-UHFFFAOYSA-N 0.000 description 2
- XLHYAEBESNFTCA-UHFFFAOYSA-N 4-chloro-3-fluorophenol Chemical compound OC1=CC=C(Cl)C(F)=C1 XLHYAEBESNFTCA-UHFFFAOYSA-N 0.000 description 2
- QSNSCYSYFYORTR-UHFFFAOYSA-N 4-chloroaniline Chemical compound NC1=CC=C(Cl)C=C1 QSNSCYSYFYORTR-UHFFFAOYSA-N 0.000 description 2
- BNRRMRUVYDETQC-UHFFFAOYSA-N 4-fluoro-2-methoxyaniline Chemical compound COC1=CC(F)=CC=C1N BNRRMRUVYDETQC-UHFFFAOYSA-N 0.000 description 2
- XAACOEWSHBIFGJ-UHFFFAOYSA-N 4-fluoro-3-methoxyaniline Chemical compound COC1=CC(N)=CC=C1F XAACOEWSHBIFGJ-UHFFFAOYSA-N 0.000 description 2
- NYMDPDNETOLVBS-UHFFFAOYSA-N 4-fluoro-3-methylaniline Chemical compound CC1=CC(N)=CC=C1F NYMDPDNETOLVBS-UHFFFAOYSA-N 0.000 description 2
- WIYZIRGRLJSWNS-UHFFFAOYSA-N 4-fluoro-3-methylbenzenethiol Chemical compound CC1=CC(S)=CC=C1F WIYZIRGRLJSWNS-UHFFFAOYSA-N 0.000 description 2
- RHMPLDJJXGPMEX-UHFFFAOYSA-N 4-fluorophenol Chemical compound OC1=CC=C(F)C=C1 RHMPLDJJXGPMEX-UHFFFAOYSA-N 0.000 description 2
- NIFAOMSJMGEFTQ-UHFFFAOYSA-N 4-methoxybenzenethiol Chemical compound COC1=CC=C(S)C=C1 NIFAOMSJMGEFTQ-UHFFFAOYSA-N 0.000 description 2
- AGWWTUWTOBEQFE-UHFFFAOYSA-N 4-methyl-1h-1,2,4-triazole-5-thione Chemical compound CN1C=NN=C1S AGWWTUWTOBEQFE-UHFFFAOYSA-N 0.000 description 2
- QEYQMWSESURNPP-UHFFFAOYSA-N 4-propan-2-yloxyphenol Chemical compound CC(C)OC1=CC=C(O)C=C1 QEYQMWSESURNPP-UHFFFAOYSA-N 0.000 description 2
- SECLKVXODNUVIB-UHFFFAOYSA-N 5-(4-bromophenyl)-2-cyclopropyl-1h-imidazole Chemical compound C1=CC(Br)=CC=C1C1=CNC(C2CC2)=N1 SECLKVXODNUVIB-UHFFFAOYSA-N 0.000 description 2
- AVPBPARCKGVYMH-UHFFFAOYSA-N 5-fluoro-2-methylbenzenethiol Chemical compound CC1=CC=C(F)C=C1S AVPBPARCKGVYMH-UHFFFAOYSA-N 0.000 description 2
- CKJOSIHYVLHIER-UHFFFAOYSA-N 5-fluoro-2-methylphenol Chemical compound CC1=CC=C(F)C=C1O CKJOSIHYVLHIER-UHFFFAOYSA-N 0.000 description 2
- RPJXLEZOFUNGNZ-UHFFFAOYSA-N 5-methoxy-2-methylaniline Chemical compound COC1=CC=C(C)C(N)=C1 RPJXLEZOFUNGNZ-UHFFFAOYSA-N 0.000 description 2
- CRVNSRICWIACSB-UHFFFAOYSA-N 6-bromo-3-iodo-n-(4,4,4-trifluorobutyl)imidazo[1,2-b]pyridazin-8-amine Chemical compound FC(F)(F)CCCNC1=CC(Br)=NN2C(I)=CN=C12 CRVNSRICWIACSB-UHFFFAOYSA-N 0.000 description 2
- REGPMKCAOMWXJM-UHFFFAOYSA-N 6-bromo-n-(3,3,3-trifluoropropyl)imidazo[1,2-b]pyridazin-8-amine Chemical compound FC(F)(F)CCNC1=CC(Br)=NN2C=CN=C12 REGPMKCAOMWXJM-UHFFFAOYSA-N 0.000 description 2
- HYFDBKBCUYTXJR-UHFFFAOYSA-N 6-chloro-3-[4-(1,3-dioxolan-2-yl)phenyl]-n-(2-methylpropyl)imidazo[1,2-b]pyridazin-8-amine Chemical compound C=1N=C2C(NCC(C)C)=CC(Cl)=NN2C=1C(C=C1)=CC=C1C1OCCO1 HYFDBKBCUYTXJR-UHFFFAOYSA-N 0.000 description 2
- DTUNMTZEFCSWLC-QGZVFWFLSA-N 6-chloro-3-[4-(2-cyclopropyl-1H-imidazol-5-yl)phenyl]-N-[[(2R)-oxolan-2-yl]methyl]imidazo[1,2-b]pyridazin-8-amine Chemical compound C12=NC=C(C=3C=CC(=CC=3)C=3NC(=NC=3)C3CC3)N2N=C(Cl)C=C1NC[C@H]1CCCO1 DTUNMTZEFCSWLC-QGZVFWFLSA-N 0.000 description 2
- WYLHWOVONMTEND-UHFFFAOYSA-N 6-chloro-3-[4-(2-cyclopropyl-1h-imidazol-5-yl)phenyl]-n-(oxan-2-ylmethyl)imidazo[1,2-b]pyridazin-8-amine Chemical compound C12=NC=C(C=3C=CC(=CC=3)C=3N=C(NC=3)C3CC3)N2N=C(Cl)C=C1NCC1CCCCO1 WYLHWOVONMTEND-UHFFFAOYSA-N 0.000 description 2
- DTUNMTZEFCSWLC-KRWDZBQOSA-N 6-chloro-3-[4-(2-cyclopropyl-1h-imidazol-5-yl)phenyl]-n-[[(2s)-oxolan-2-yl]methyl]imidazo[1,2-b]pyridazin-8-amine Chemical compound C12=NC=C(C=3C=CC(=CC=3)C=3NC(=NC=3)C3CC3)N2N=C(Cl)C=C1NC[C@@H]1CCCO1 DTUNMTZEFCSWLC-KRWDZBQOSA-N 0.000 description 2
- JUFWDTQQQULFFA-UHFFFAOYSA-N 6-chloro-3-iodo-n-(2-methoxy-2-methylpropyl)imidazo[1,2-b]pyridazin-8-amine Chemical compound COC(C)(C)CNC1=CC(Cl)=NN2C(I)=CN=C12 JUFWDTQQQULFFA-UHFFFAOYSA-N 0.000 description 2
- GMOFZDDFUITZFW-UHFFFAOYSA-N 6-chloro-3-iodo-n-(2-morpholin-4-ylsulfonylethyl)imidazo[1,2-b]pyridazin-8-amine Chemical compound C12=NC=C(I)N2N=C(Cl)C=C1NCCS(=O)(=O)N1CCOCC1 GMOFZDDFUITZFW-UHFFFAOYSA-N 0.000 description 2
- QGFDTPZYDXOOMZ-UHFFFAOYSA-N 6-chloro-3-iodo-n-[(2-methylpyrazol-3-yl)methyl]imidazo[1,2-b]pyridazin-8-amine Chemical compound CN1N=CC=C1CNC1=CC(Cl)=NN2C1=NC=C2I QGFDTPZYDXOOMZ-UHFFFAOYSA-N 0.000 description 2
- UYVWOESWUGYANU-UHFFFAOYSA-N 6-chloro-3-iodo-n-[(4-methylmorpholin-2-yl)methyl]imidazo[1,2-b]pyridazin-8-amine Chemical compound C1N(C)CCOC1CNC1=CC(Cl)=NN2C1=NC=C2I UYVWOESWUGYANU-UHFFFAOYSA-N 0.000 description 2
- DXFQGADLXCAIRO-UHFFFAOYSA-N 6-chloro-n-(1,4-dioxan-2-ylmethyl)-3-iodoimidazo[1,2-b]pyridazin-8-amine Chemical compound C12=NC=C(I)N2N=C(Cl)C=C1NCC1COCCO1 DXFQGADLXCAIRO-UHFFFAOYSA-N 0.000 description 2
- NQKLZQUYDPBVPZ-UHFFFAOYSA-N 6-cyclopentyloxy-3-iodo-n-(3,3,3-trifluoropropyl)imidazo[1,2-b]pyridazin-8-amine Chemical compound N=1N2C(I)=CN=C2C(NCCC(F)(F)F)=CC=1OC1CCCC1 NQKLZQUYDPBVPZ-UHFFFAOYSA-N 0.000 description 2
- YTHMOBMZVVFNBE-UHFFFAOYSA-N 6-fluoropyridin-3-amine Chemical compound NC1=CC=C(F)N=C1 YTHMOBMZVVFNBE-UHFFFAOYSA-N 0.000 description 2
- HTRLNWYWOKWCLV-UHFFFAOYSA-N 6-fluoropyridin-3-ol Chemical compound OC1=CC=C(F)N=C1 HTRLNWYWOKWCLV-UHFFFAOYSA-N 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 2
- UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 description 2
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- 239000012425 OXONE® Substances 0.000 description 2
- 229930012538 Paclitaxel Natural products 0.000 description 2
- 102000001253 Protein Kinase Human genes 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 229940123237 Taxane Drugs 0.000 description 2
- CBMCZKMIOZYAHS-NSCUHMNNSA-N [(e)-prop-1-enyl]boronic acid Chemical compound C\C=C\B(O)O CBMCZKMIOZYAHS-NSCUHMNNSA-N 0.000 description 2
- CCXHEPSOPWJNJB-ONEGZZNKSA-N [(z)-but-2-en-2-yl]boronic acid Chemical compound C\C=C(/C)B(O)O CCXHEPSOPWJNJB-ONEGZZNKSA-N 0.000 description 2
- KPKXGHISVNPSIV-UHFFFAOYSA-N [2-[3-[4-(1,3-dioxolan-2-yl)phenyl]-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-6-yl]phenyl]methanol Chemical compound OCC1=CC=CC=C1C1=NN2C(C=3C=CC(=CC=3)C3OCCO3)=CN=C2C(NCCC(F)(F)F)=C1 KPKXGHISVNPSIV-UHFFFAOYSA-N 0.000 description 2
- AEOJDQJSNRBDKQ-UHFFFAOYSA-N [3-[3-[4-(1,3-dioxolan-2-yl)phenyl]-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-6-yl]phenyl]methanol Chemical compound OCC1=CC=CC(C2=NN3C(C=4C=CC(=CC=4)C4OCCO4)=CN=C3C(NCCC(F)(F)F)=C2)=C1 AEOJDQJSNRBDKQ-UHFFFAOYSA-N 0.000 description 2
- SPGPJDKIBHDACA-UHFFFAOYSA-N [4-chloro-2-(hydroxymethyl)phenyl]boronic acid Chemical compound OCC1=CC(Cl)=CC=C1B(O)O SPGPJDKIBHDACA-UHFFFAOYSA-N 0.000 description 2
- UTCXJLROIZMSEK-UHFFFAOYSA-N [4-fluoro-2-[tri(propan-2-yl)silyloxymethyl]phenyl]boronic acid Chemical compound CC(C)[Si](C(C)C)(C(C)C)OCC1=CC(F)=CC=C1B(O)O UTCXJLROIZMSEK-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 150000001345 alkine derivatives Chemical class 0.000 description 2
- 125000000304 alkynyl group Chemical group 0.000 description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 2
- 230000031016 anaphase Effects 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 2
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 2
- 150000001649 bromium compounds Chemical class 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 238000004296 chiral HPLC Methods 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 229960001701 chloroform Drugs 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- XZWQKJXJNKYMAP-UHFFFAOYSA-N cyclohexen-1-ylboronic acid Chemical compound OB(O)C1=CCCCC1 XZWQKJXJNKYMAP-UHFFFAOYSA-N 0.000 description 2
- NISGSNTVMOOSJQ-UHFFFAOYSA-N cyclopentanamine Chemical compound NC1CCCC1 NISGSNTVMOOSJQ-UHFFFAOYSA-N 0.000 description 2
- 238000001212 derivatisation Methods 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 238000003821 enantio-separation Methods 0.000 description 2
- 229930013356 epothilone Natural products 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 150000004694 iodide salts Chemical class 0.000 description 2
- VYFOAVADNIHPTR-UHFFFAOYSA-N isatoic anhydride Chemical compound NC1=CC=CC=C1CO VYFOAVADNIHPTR-UHFFFAOYSA-N 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- YSVZADAAWQNYCF-UHFFFAOYSA-N methylsulfanylmethane;sodium Chemical compound [Na].CSC YSVZADAAWQNYCF-UHFFFAOYSA-N 0.000 description 2
- 230000036456 mitotic arrest Effects 0.000 description 2
- IPVAUQOZKBKERC-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[6-pyridin-3-yloxy-8-(thian-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=NC=CC=4)C=C(NCC4CCSCC4)C3=NC=2)=CC=C1C(=O)NC1CC1 IPVAUQOZKBKERC-UHFFFAOYSA-N 0.000 description 2
- KBHVRRMYZYKJBP-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[8-(2-methylpropylamino)-6-phenylsulfanylimidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound N=1N2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCC(C)C)=CC=1SC1=CC=CC=C1 KBHVRRMYZYKJBP-UHFFFAOYSA-N 0.000 description 2
- FHKHYJKWGYVFOU-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluorophenyl)sulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C=C(F)C=CC=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 FHKHYJKWGYVFOU-UHFFFAOYSA-N 0.000 description 2
- FMXLUSCLYSPAIF-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-methoxy-2-methylanilino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound COC1=CC=CC(NC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCCC(F)(F)F)=C2)=C1C FMXLUSCLYSPAIF-UHFFFAOYSA-N 0.000 description 2
- KHGZZVISNCZHGN-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-fluoro-3-methoxyanilino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C1=C(F)C(OC)=CC(NC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCCC(F)(F)F)=C2)=C1 KHGZZVISNCZHGN-UHFFFAOYSA-N 0.000 description 2
- KQGQNDIARMXUQS-UHFFFAOYSA-N n-cyclopropyl-4-[6-(5-hydroxy-2-methylanilino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC=C(O)C=C1NC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCC(F)(F)F)=C1 KQGQNDIARMXUQS-UHFFFAOYSA-N 0.000 description 2
- NWSHNGZGICYCIZ-UHFFFAOYSA-N n-cyclopropyl-4-[6-[2-(hydroxymethyl)phenyl]-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCC(C)(C)O)C3=NC=2)C=2C(=CC=CC=2)CO)=CC=C1C(=O)NC1CC1 NWSHNGZGICYCIZ-UHFFFAOYSA-N 0.000 description 2
- NVKUYFKNPDWEEG-UHFFFAOYSA-N n-cyclopropyl-4-[8-(2-methylpropylamino)-6-methylsulfanylimidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound N12N=C(SC)C=C(NCC(C)C)C2=NC=C1C(C=C1)=CC=C1C(=O)NC1CC1 NVKUYFKNPDWEEG-UHFFFAOYSA-N 0.000 description 2
- JHSXHOLAPBGKLO-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(2-methoxyanilino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound COC1=CC=CC=C1NC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCC(C)(C)O)=C1 JHSXHOLAPBGKLO-UHFFFAOYSA-N 0.000 description 2
- QEPYPYRXRQZZMU-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(3-methoxyanilino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound COC1=CC=CC(NC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCC(C)(C)O)=C2)=C1 QEPYPYRXRQZZMU-UHFFFAOYSA-N 0.000 description 2
- GXZASSUQCVVOFI-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(3-methoxyphenyl)sulfanylimidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound COC1=CC=CC(SC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCC(C)(C)O)=C2)=C1 GXZASSUQCVVOFI-UHFFFAOYSA-N 0.000 description 2
- MLSONLILJQGSCW-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-methylsulfanylimidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound N12N=C(SC)C=C(NCC(C)(C)O)C2=NC=C1C(C=C1C)=CC=C1C(=O)NC1CC1 MLSONLILJQGSCW-UHFFFAOYSA-N 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- VMPITZXILSNTON-UHFFFAOYSA-N o-anisidine Chemical compound COC1=CC=CC=C1N VMPITZXILSNTON-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 2
- 229960001592 paclitaxel Drugs 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 235000011056 potassium acetate Nutrition 0.000 description 2
- OKBMCNHOEMXPTM-UHFFFAOYSA-M potassium peroxymonosulfate Chemical compound [K+].OOS([O-])(=O)=O OKBMCNHOEMXPTM-UHFFFAOYSA-M 0.000 description 2
- 150000003141 primary amines Chemical class 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 108060006633 protein kinase Proteins 0.000 description 2
- 125000003226 pyrazolyl group Chemical group 0.000 description 2
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical compound OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 2
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 2
- MTEQAOQIRDWEES-UHFFFAOYSA-N tert-butyl N-(6-cyclopentyloxyimidazo[1,2-b]pyridazin-8-yl)-N-(3,3,3-trifluoropropyl)carbamate Chemical compound N=1N2C=CN=C2C(N(CCC(F)(F)F)C(=O)OC(C)(C)C)=CC=1OC1CCCC1 MTEQAOQIRDWEES-UHFFFAOYSA-N 0.000 description 2
- VCRKOUPXSMOIQU-UHFFFAOYSA-N tert-butyl N-[6-(cyclopentylamino)imidazo[1,2-b]pyridazin-8-yl]-N-(3,3,3-trifluoropropyl)carbamate Chemical compound N=1N2C=CN=C2C(N(CCC(F)(F)F)C(=O)OC(C)(C)C)=CC=1NC1CCCC1 VCRKOUPXSMOIQU-UHFFFAOYSA-N 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N thiocyanic acid Chemical compound SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- 229940062627 tribasic potassium phosphate Drugs 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- UGOMMVLRQDMAQQ-UHFFFAOYSA-N xphos Chemical compound CC(C)C1=CC(C(C)C)=CC(C(C)C)=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 UGOMMVLRQDMAQQ-UHFFFAOYSA-N 0.000 description 2
- PCEIEQLJYDMRFZ-UHFFFAOYSA-N (1-cyanocyclopropyl)azanium;chloride Chemical compound Cl.N#CC1(N)CC1 PCEIEQLJYDMRFZ-UHFFFAOYSA-N 0.000 description 1
- GHILZUOTUJGCDH-UHFFFAOYSA-N (1-methylcyclopropyl)azanium;chloride Chemical compound Cl.CC1(N)CC1 GHILZUOTUJGCDH-UHFFFAOYSA-N 0.000 description 1
- SOCAXRLFGRNEPK-IFZYUDKTSA-N (1r,3s,5r)-2-n-[1-carbamoyl-5-(cyanomethoxy)indol-3-yl]-3-n-[(3-chloro-2-fluorophenyl)methyl]-2-azabicyclo[3.1.0]hexane-2,3-dicarboxamide Chemical compound O=C([C@@H]1C[C@H]2C[C@H]2N1C(=O)NC1=CN(C2=CC=C(OCC#N)C=C21)C(=O)N)NCC1=CC=CC(Cl)=C1F SOCAXRLFGRNEPK-IFZYUDKTSA-N 0.000 description 1
- MKDRHMDHWIBVRH-NTSWFWBYSA-N (1s)-2-amino-1-[(4r)-2,2-dimethyl-1,3-dioxolan-4-yl]ethanol Chemical compound CC1(C)OC[C@H]([C@@H](O)CN)O1 MKDRHMDHWIBVRH-NTSWFWBYSA-N 0.000 description 1
- XOLSMTBBIZDHSG-UHFFFAOYSA-N (2,2-difluorocyclopropyl)methanol Chemical compound OCC1CC1(F)F XOLSMTBBIZDHSG-UHFFFAOYSA-N 0.000 description 1
- HXGZPMHPSBJMKB-UHFFFAOYSA-N (2-bromo-5-fluorophenyl)methanol Chemical compound OCC1=CC(F)=CC=C1Br HXGZPMHPSBJMKB-UHFFFAOYSA-N 0.000 description 1
- QCSLIRFWJPOENV-UHFFFAOYSA-N (2-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC=C1F QCSLIRFWJPOENV-UHFFFAOYSA-N 0.000 description 1
- DLKKHCBCEHVVFW-UHFFFAOYSA-N (2-methyloxolan-2-yl)methanamine Chemical compound NCC1(C)CCCO1 DLKKHCBCEHVVFW-UHFFFAOYSA-N 0.000 description 1
- XNTFQMKXUFFUQO-UHFFFAOYSA-N (2-methylpyrazol-3-yl)methanamine Chemical compound CN1N=CC=C1CN XNTFQMKXUFFUQO-UHFFFAOYSA-N 0.000 description 1
- FYWFCRHZXORPFH-UHFFFAOYSA-N (2-sulfanylphenyl)methanol Chemical compound OCC1=CC=CC=C1S FYWFCRHZXORPFH-UHFFFAOYSA-N 0.000 description 1
- DOMQFIFVDIAOOT-ROUUACIJSA-N (2S,3R)-N-[4-(2,6-dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-1,2,4-triazol-3-yl]-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide Chemical compound COC1=C(C(=CC=C1)OC)N1C(=NN=C1C=1C=NC=C(C=1)C)NS(=O)(=O)[C@@H](C)[C@H](C)C1=NC=C(C=N1)C DOMQFIFVDIAOOT-ROUUACIJSA-N 0.000 description 1
- CUGDYSSBTWBKII-LXGUWJNJSA-N (2r,3r,4r,5s)-6-(dimethylamino)hexane-1,2,3,4,5-pentol Chemical compound CN(C)C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO CUGDYSSBTWBKII-LXGUWJNJSA-N 0.000 description 1
- IKXCHOUDIPZROZ-LXGUWJNJSA-N (2r,3r,4r,5s)-6-(ethylamino)hexane-1,2,3,4,5-pentol Chemical compound CCNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO IKXCHOUDIPZROZ-LXGUWJNJSA-N 0.000 description 1
- FRKGSNOMLIYPSH-VKHMYHEASA-N (3s)-3-hydroxypyrrolidin-2-one Chemical compound O[C@H]1CCNC1=O FRKGSNOMLIYPSH-VKHMYHEASA-N 0.000 description 1
- OYUDJHNYSVXVNK-UHFFFAOYSA-N (4-fluoro-2-methoxycarbonylphenyl)boronic acid Chemical compound COC(=O)C1=CC(F)=CC=C1B(O)O OYUDJHNYSVXVNK-UHFFFAOYSA-N 0.000 description 1
- IQMLIVUHMSIOQP-UHFFFAOYSA-N (4-fluoro-2-methylphenyl)boronic acid Chemical compound CC1=CC(F)=CC=C1B(O)O IQMLIVUHMSIOQP-UHFFFAOYSA-N 0.000 description 1
- SOBFKNVNVLNAJQ-UHFFFAOYSA-N (4-methylmorpholin-2-yl)methanamine Chemical compound CN1CCOC(CN)C1 SOBFKNVNVLNAJQ-UHFFFAOYSA-N 0.000 description 1
- HGRWHBQLRXWSLV-DEOSSOPVSA-N (4s)-3'-(3,6-dihydro-2h-pyran-5-yl)-1'-fluoro-7'-(3-fluoropyridin-2-yl)spiro[5h-1,3-oxazole-4,5'-chromeno[2,3-c]pyridine]-2-amine Chemical compound C1OC(N)=N[C@]21C1=CC(C=3COCCC=3)=NC(F)=C1OC1=CC=C(C=3C(=CC=CN=3)F)C=C12 HGRWHBQLRXWSLV-DEOSSOPVSA-N 0.000 description 1
- 125000006582 (C5-C6) heterocycloalkyl group Chemical group 0.000 description 1
- LKJPYSCBVHEWIU-KRWDZBQOSA-N (R)-bicalutamide Chemical compound C([C@@](O)(C)C(=O)NC=1C=C(C(C#N)=CC=1)C(F)(F)F)S(=O)(=O)C1=CC=C(F)C=C1 LKJPYSCBVHEWIU-KRWDZBQOSA-N 0.000 description 1
- UKGJZDSUJSPAJL-YPUOHESYSA-N (e)-n-[(1r)-1-[3,5-difluoro-4-(methanesulfonamido)phenyl]ethyl]-3-[2-propyl-6-(trifluoromethyl)pyridin-3-yl]prop-2-enamide Chemical compound CCCC1=NC(C(F)(F)F)=CC=C1\C=C\C(=O)N[C@H](C)C1=CC(F)=C(NS(C)(=O)=O)C(F)=C1 UKGJZDSUJSPAJL-YPUOHESYSA-N 0.000 description 1
- OPCJOXGBLDJWRM-UHFFFAOYSA-N 1,2-diamino-2-methylpropane Chemical compound CC(C)(N)CN OPCJOXGBLDJWRM-UHFFFAOYSA-N 0.000 description 1
- XBYRMPXUBGMOJC-UHFFFAOYSA-N 1,2-dihydropyrazol-3-one Chemical compound OC=1C=CNN=1 XBYRMPXUBGMOJC-UHFFFAOYSA-N 0.000 description 1
- 125000005918 1,2-dimethylbutyl group Chemical group 0.000 description 1
- VUMCUSHVMYIRMB-UHFFFAOYSA-N 1,3,5-tri(propan-2-yl)benzene Chemical compound CC(C)C1=CC(C(C)C)=CC(C(C)C)=C1 VUMCUSHVMYIRMB-UHFFFAOYSA-N 0.000 description 1
- PREOONMJIVUPMI-UHFFFAOYSA-N 1,4-dioxan-2-ylmethanamine Chemical compound NCC1COCCO1 PREOONMJIVUPMI-UHFFFAOYSA-N 0.000 description 1
- CYPYTURSJDMMMP-UHFFFAOYSA-N 1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1C=CC(=O)C=CC1=CC=CC=C1.C=1C=CC=CC=1C=CC(=O)C=CC1=CC=CC=C1.C=1C=CC=CC=1C=CC(=O)C=CC1=CC=CC=C1 CYPYTURSJDMMMP-UHFFFAOYSA-N 0.000 description 1
- CGMLIPSMGVCIIT-UHFFFAOYSA-N 1-[[3-[4-(1,3-dioxolan-2-yl)phenyl]-6-pyridin-4-ylimidazo[1,2-b]pyridazin-8-yl]amino]-2-methylpropan-2-ol Chemical compound C=1N=C2C(NCC(C)(O)C)=CC(C=3C=CN=CC=3)=NN2C=1C(C=C1)=CC=C1C1OCCO1 CGMLIPSMGVCIIT-UHFFFAOYSA-N 0.000 description 1
- WPASTZVOBADJHL-UHFFFAOYSA-N 1-[[3-[4-(2-cyclopropyl-1h-imidazol-5-yl)phenyl]-6-(4-fluorophenyl)imidazo[1,2-b]pyridazin-8-yl]amino]-2-methylpropan-2-ol Chemical compound C=1N=C2C(NCC(C)(O)C)=CC(C=3C=CC(F)=CC=3)=NN2C=1C(C=C1)=CC=C1C(N1)=CN=C1C1CC1 WPASTZVOBADJHL-UHFFFAOYSA-N 0.000 description 1
- RTTHXECCTVSYTD-UHFFFAOYSA-N 1-[[3-[4-(2-cyclopropyl-1h-imidazol-5-yl)phenyl]-6-pyridin-4-ylimidazo[1,2-b]pyridazin-8-yl]amino]-2-methylpropan-2-ol Chemical compound C=1N=C2C(NCC(C)(O)C)=CC(C=3C=CN=CC=3)=NN2C=1C(C=C1)=CC=C1C(N1)=CN=C1C1CC1 RTTHXECCTVSYTD-UHFFFAOYSA-N 0.000 description 1
- ZGCHLAJIRWDGFE-UHFFFAOYSA-N 1-aminopropane-1,1-diol Chemical compound CCC(N)(O)O ZGCHLAJIRWDGFE-UHFFFAOYSA-N 0.000 description 1
- 125000004972 1-butynyl group Chemical group [H]C([H])([H])C([H])([H])C#C* 0.000 description 1
- VFWCMGCRMGJXDK-UHFFFAOYSA-N 1-chlorobutane Chemical class CCCCCl VFWCMGCRMGJXDK-UHFFFAOYSA-N 0.000 description 1
- 125000006218 1-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- IEPAHAXVBXNSKS-UHFFFAOYSA-N 1-methoxycyclopropan-1-amine;hydrochloride Chemical compound [Cl-].COC1([NH3+])CC1 IEPAHAXVBXNSKS-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- NEUWPDLMDVINSN-UHFFFAOYSA-N 1h-pyrazol-5-ylboronic acid Chemical compound OB(O)C=1C=CNN=1 NEUWPDLMDVINSN-UHFFFAOYSA-N 0.000 description 1
- QYTSIBBNZWTHMZ-UHFFFAOYSA-N 2,3-difluorobenzenethiol Chemical compound FC1=CC=CC(S)=C1F QYTSIBBNZWTHMZ-UHFFFAOYSA-N 0.000 description 1
- SQDUGGGBJXULJR-UHFFFAOYSA-N 2,3-dihydro-1,4-benzodioxin-6-ylboronic acid Chemical compound O1CCOC2=CC(B(O)O)=CC=C21 SQDUGGGBJXULJR-UHFFFAOYSA-N 0.000 description 1
- CEPCPXLLFXPZGW-UHFFFAOYSA-N 2,4-difluoroaniline Chemical compound NC1=CC=C(F)C=C1F CEPCPXLLFXPZGW-UHFFFAOYSA-N 0.000 description 1
- PALORHWWZVBSLZ-UHFFFAOYSA-N 2,6-difluorobenzenethiol Chemical compound FC1=CC=CC(F)=C1S PALORHWWZVBSLZ-UHFFFAOYSA-N 0.000 description 1
- JHKKTXXMAQLGJB-UHFFFAOYSA-N 2-(methylamino)phenol Chemical compound CNC1=CC=CC=C1O JHKKTXXMAQLGJB-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- MAOTUJPKBAIACF-UHFFFAOYSA-N 2-amino-4-fluorobenzenethiol Chemical compound NC1=CC(F)=CC=C1S MAOTUJPKBAIACF-UHFFFAOYSA-N 0.000 description 1
- IIDUNAVOCYMUFB-UHFFFAOYSA-N 2-amino-5-fluorophenol Chemical compound NC1=CC=C(F)C=C1O IIDUNAVOCYMUFB-UHFFFAOYSA-N 0.000 description 1
- DGUVEYAZTOUCEJ-UHFFFAOYSA-N 2-aminoethanesulfonamide;hydron;chloride Chemical compound Cl.NCCS(N)(=O)=O DGUVEYAZTOUCEJ-UHFFFAOYSA-N 0.000 description 1
- KJJPLEZQSCZCKE-UHFFFAOYSA-N 2-aminopropane-1,3-diol Chemical compound OCC(N)CO KJJPLEZQSCZCKE-UHFFFAOYSA-N 0.000 description 1
- FKJSFKCZZIXQIP-UHFFFAOYSA-N 2-bromo-1-(4-bromophenyl)ethanone Chemical compound BrCC(=O)C1=CC=C(Br)C=C1 FKJSFKCZZIXQIP-UHFFFAOYSA-N 0.000 description 1
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 1
- FJKIADFDXOCBRV-UHFFFAOYSA-N 2-chloro-3-fluoroaniline Chemical compound NC1=CC=CC(F)=C1Cl FJKIADFDXOCBRV-UHFFFAOYSA-N 0.000 description 1
- XRAKCYJTJGTSMM-UHFFFAOYSA-N 2-chloro-4-fluoroaniline Chemical compound NC1=CC=C(F)C=C1Cl XRAKCYJTJGTSMM-UHFFFAOYSA-N 0.000 description 1
- OXXHRLOTYJWMIW-UHFFFAOYSA-N 2-cyclopropyl-5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1h-imidazole Chemical compound O1C(C)(C)C(C)(C)OB1C1=CC=C(C=2NC(=NC=2)C2CC2)C=C1 OXXHRLOTYJWMIW-UHFFFAOYSA-N 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- XFAWPESFTAFNGT-UHFFFAOYSA-N 2-fluoro-4-[6-(3-fluorophenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzonitrile Chemical compound FC1=CC=CC(OC2=NN3C(C=4C=C(F)C(C#N)=CC=4)=CN=C3C(NCCC(F)(F)F)=C2)=C1 XFAWPESFTAFNGT-UHFFFAOYSA-N 0.000 description 1
- ZSTYQALWKOGXOV-UHFFFAOYSA-N 2-methoxy-2-methylpropan-1-amine Chemical compound COC(C)(C)CN ZSTYQALWKOGXOV-UHFFFAOYSA-N 0.000 description 1
- JMYJYCLCOQMNOY-UHFFFAOYSA-N 2-methoxy-3-propan-2-ylphenol Chemical compound COC1=C(O)C=CC=C1C(C)C JMYJYCLCOQMNOY-UHFFFAOYSA-N 0.000 description 1
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 1
- UMJGOCMSBZWCNY-UHFFFAOYSA-N 2-methyl-4-sulfanylphenol Chemical compound CC1=CC(S)=CC=C1O UMJGOCMSBZWCNY-UHFFFAOYSA-N 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- OINANNBISYKCNE-UHFFFAOYSA-N 2-morpholin-4-ylsulfonylethanamine Chemical compound NCCS(=O)(=O)N1CCOCC1 OINANNBISYKCNE-UHFFFAOYSA-N 0.000 description 1
- WMPPDTMATNBGJN-UHFFFAOYSA-N 2-phenylethylbromide Chemical class BrCCC1=CC=CC=C1 WMPPDTMATNBGJN-UHFFFAOYSA-N 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000001698 2H-pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- IGOPOYHPIKTQSS-UHFFFAOYSA-N 3,3,3-trifluoropropan-1-amine;hydrochloride Chemical compound [Cl-].[NH3+]CCC(F)(F)F IGOPOYHPIKTQSS-UHFFFAOYSA-N 0.000 description 1
- HJSSBIMVTMYKPD-UHFFFAOYSA-N 3,5-difluorophenol Chemical compound OC1=CC(F)=CC(F)=C1 HJSSBIMVTMYKPD-UHFFFAOYSA-N 0.000 description 1
- ZFSXZJFCSFCJOX-UHFFFAOYSA-N 3,6-dibromo-n-(3,3,3-trifluoropropyl)imidazo[1,2-b]pyridazin-8-amine Chemical compound FC(F)(F)CCNC1=CC(Br)=NN2C(Br)=CN=C12 ZFSXZJFCSFCJOX-UHFFFAOYSA-N 0.000 description 1
- FUAKUDUYSVHHPU-UHFFFAOYSA-N 3-(3-amino-1h-indazol-6-yl)-6-(3-fluorophenoxy)-n-(3,3,3-trifluoropropyl)imidazo[1,2-b]pyridazin-8-amine Chemical compound C=1C=C2C(N)=NNC2=CC=1C(N1N=2)=CN=C1C(NCCC(F)(F)F)=CC=2OC1=CC=CC(F)=C1 FUAKUDUYSVHHPU-UHFFFAOYSA-N 0.000 description 1
- NQIISOASJVNVFU-UHFFFAOYSA-N 3-(3-amino-1h-indazol-6-yl)-n-(2-methylpropyl)-6-phenylimidazo[1,2-b]pyridazin-8-amine Chemical compound N=1N2C(C=3C=C4NN=C(N)C4=CC=3)=CN=C2C(NCC(C)C)=CC=1C1=CC=CC=C1 NQIISOASJVNVFU-UHFFFAOYSA-N 0.000 description 1
- YGYGASJNJTYNOL-CQSZACIVSA-N 3-[(4r)-2,2-dimethyl-1,1-dioxothian-4-yl]-5-(4-fluorophenyl)-1h-indole-7-carboxamide Chemical compound C1CS(=O)(=O)C(C)(C)C[C@@H]1C1=CNC2=C(C(N)=O)C=C(C=3C=CC(F)=CC=3)C=C12 YGYGASJNJTYNOL-CQSZACIVSA-N 0.000 description 1
- LKWDARKUZCSXNI-UHFFFAOYSA-N 3-[(6-chloro-3-iodoimidazo[1,2-b]pyridazin-8-yl)amino]-1,1,1-trifluoropropan-2-ol Chemical compound FC(F)(F)C(O)CNC1=CC(Cl)=NN2C(I)=CN=C12 LKWDARKUZCSXNI-UHFFFAOYSA-N 0.000 description 1
- JJVMLZPKTIXMRQ-UHFFFAOYSA-N 3-[2-methyl-2-tri(propan-2-yl)silyloxypropoxy]phenol Chemical compound CC(C)[Si](C(C)C)(C(C)C)OC(C)(C)COC1=CC=CC(O)=C1 JJVMLZPKTIXMRQ-UHFFFAOYSA-N 0.000 description 1
- PPKCUWDRZUVJKX-UHFFFAOYSA-N 3-[4-(2-cyclopropyl-1h-imidazol-5-yl)phenyl]-6-(4-fluorophenyl)-n-(3,3,3-trifluoropropyl)imidazo[1,2-b]pyridazin-8-amine Chemical compound C1=CC(F)=CC=C1C1=NN2C(C=3C=CC(=CC=3)C=3NC(=NC=3)C3CC3)=CN=C2C(NCCC(F)(F)F)=C1 PPKCUWDRZUVJKX-UHFFFAOYSA-N 0.000 description 1
- XBKHBIIZZMLSLD-UHFFFAOYSA-N 3-[4-(2-cyclopropyl-1h-imidazol-5-yl)phenyl]-6-pyridin-4-yl-n-(3,3,3-trifluoropropyl)imidazo[1,2-b]pyridazin-8-amine Chemical compound C=1N=C2C(NCCC(F)(F)F)=CC(C=3C=CN=CC=3)=NN2C=1C(C=C1)=CC=C1C(N1)=CN=C1C1CC1 XBKHBIIZZMLSLD-UHFFFAOYSA-N 0.000 description 1
- FWHPLDJOTXITEK-UHFFFAOYSA-N 3-[4-(2-cyclopropyl-1h-imidazol-5-yl)phenyl]-n-(2-methylpropyl)-6-pyridin-4-ylimidazo[1,2-b]pyridazin-8-amine Chemical compound C=1N=C2C(NCC(C)C)=CC(C=3C=CN=CC=3)=NN2C=1C(C=C1)=CC=C1C(N1)=CN=C1C1CC1 FWHPLDJOTXITEK-UHFFFAOYSA-N 0.000 description 1
- PTDBVVVCFFYSNM-UHFFFAOYSA-N 3-[4-(2-cyclopropyl-1h-imidazol-5-yl)phenyl]-n-(oxan-2-ylmethyl)-6-pyridin-4-ylimidazo[1,2-b]pyridazin-8-amine Chemical compound C1CCCOC1CNC(C1=NC=2)=CC(C=3C=CN=CC=3)=NN1C=2C(C=C1)=CC=C1C(N1)=CN=C1C1CC1 PTDBVVVCFFYSNM-UHFFFAOYSA-N 0.000 description 1
- RRUGOLVLCMESIY-JOCHJYFZSA-N 3-[4-(2-cyclopropyl-1h-imidazol-5-yl)phenyl]-n-[[(2r)-oxolan-2-yl]methyl]-6-pyridin-4-ylimidazo[1,2-b]pyridazin-8-amine Chemical compound C([C@@H]1OCCC1)NC(C1=NC=2)=CC(C=3C=CN=CC=3)=NN1C=2C(C=C1)=CC=C1C(N1)=CN=C1C1CC1 RRUGOLVLCMESIY-JOCHJYFZSA-N 0.000 description 1
- RRUGOLVLCMESIY-QFIPXVFZSA-N 3-[4-(2-cyclopropyl-1h-imidazol-5-yl)phenyl]-n-[[(2s)-oxolan-2-yl]methyl]-6-pyridin-4-ylimidazo[1,2-b]pyridazin-8-amine Chemical compound C([C@H]1OCCC1)NC(C1=NC=2)=CC(C=3C=CN=CC=3)=NN1C=2C(C=C1)=CC=C1C(N1)=CN=C1C1CC1 RRUGOLVLCMESIY-QFIPXVFZSA-N 0.000 description 1
- NBRDIIGPFDBUFZ-UHFFFAOYSA-N 3-[4-(cyclopropylcarbamoyl)-3-methylphenyl]-n-(2-hydroxyethyl)-8-(2-methylpropylamino)imidazo[1,2-b]pyridazine-6-carboxamide Chemical compound C=1N=C2C(NCC(C)C)=CC(C(=O)NCCO)=NN2C=1C(C=C1C)=CC=C1C(=O)NC1CC1 NBRDIIGPFDBUFZ-UHFFFAOYSA-N 0.000 description 1
- RISHBQWFBUTROQ-UHFFFAOYSA-N 3-amino-1,1,1-trifluoropropan-2-ol Chemical compound NCC(O)C(F)(F)F RISHBQWFBUTROQ-UHFFFAOYSA-N 0.000 description 1
- CUYKNJBYIJFRCU-UHFFFAOYSA-N 3-aminopyridine Chemical compound NC1=CC=CN=C1 CUYKNJBYIJFRCU-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 1
- ZQXLIXHVJVAPLW-UHFFFAOYSA-N 3-chloro-4-fluorophenol Chemical compound OC1=CC=C(F)C(Cl)=C1 ZQXLIXHVJVAPLW-UHFFFAOYSA-N 0.000 description 1
- IFSSSYDVRQSDSG-UHFFFAOYSA-N 3-ethenylaniline Chemical compound NC1=CC=CC(C=C)=C1 IFSSSYDVRQSDSG-UHFFFAOYSA-N 0.000 description 1
- SWXOGIWNHWXDBS-UHFFFAOYSA-N 3-fluoro-2-methylbenzenethiol Chemical compound CC1=C(F)C=CC=C1S SWXOGIWNHWXDBS-UHFFFAOYSA-N 0.000 description 1
- NLIOVTBTQHQXHO-UHFFFAOYSA-N 3-fluoro-4-methylbenzenethiol Chemical compound CC1=CC=C(S)C=C1F NLIOVTBTQHQXHO-UHFFFAOYSA-N 0.000 description 1
- SGHBRHKBCLLVCI-UHFFFAOYSA-N 3-hydroxybenzonitrile Chemical compound OC1=CC=CC(C#N)=C1 SGHBRHKBCLLVCI-UHFFFAOYSA-N 0.000 description 1
- 125000004208 3-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C([H])C(*)=C1[H] 0.000 description 1
- 125000003542 3-methylbutan-2-yl group Chemical group [H]C([H])([H])C([H])(*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005917 3-methylpentyl group Chemical group 0.000 description 1
- AELUMDDQRLJQRX-UHFFFAOYSA-N 3-propan-2-ylbenzenethiol Chemical compound CC(C)C1=CC=CC(S)=C1 AELUMDDQRLJQRX-UHFFFAOYSA-N 0.000 description 1
- QMGBIPKOKCSUCL-UHFFFAOYSA-N 3-propan-2-yloxyaniline Chemical compound CC(C)OC1=CC=CC(N)=C1 QMGBIPKOKCSUCL-UHFFFAOYSA-N 0.000 description 1
- CBGJTIYHMKYCMR-UHFFFAOYSA-N 3-propan-2-yloxybenzenethiol Chemical compound CC(C)OC1=CC=CC(S)=C1 CBGJTIYHMKYCMR-UHFFFAOYSA-N 0.000 description 1
- GZMVGNWHSXIDKT-UHFFFAOYSA-N 3-propan-2-yloxyphenol Chemical compound CC(C)OC1=CC=CC(O)=C1 GZMVGNWHSXIDKT-UHFFFAOYSA-N 0.000 description 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- YELMWJNXDALKFE-UHFFFAOYSA-N 3h-imidazo[4,5-f]quinoxaline Chemical class N1=CC=NC2=C(NC=N3)C3=CC=C21 YELMWJNXDALKFE-UHFFFAOYSA-N 0.000 description 1
- LAXWLCVPJLBABV-UHFFFAOYSA-N 4,4,4-trifluorobutan-1-amine Chemical compound NCCCC(F)(F)F LAXWLCVPJLBABV-UHFFFAOYSA-N 0.000 description 1
- LZPWAYBEOJRFAX-UHFFFAOYSA-N 4,4,5,5-tetramethyl-1,3,2$l^{2}-dioxaborolane Chemical compound CC1(C)O[B]OC1(C)C LZPWAYBEOJRFAX-UHFFFAOYSA-N 0.000 description 1
- LNPMZQXEPNWCMG-UHFFFAOYSA-N 4-(2-aminoethyl)aniline Chemical compound NCCC1=CC=C(N)C=C1 LNPMZQXEPNWCMG-UHFFFAOYSA-N 0.000 description 1
- AIPUNCFCQBDNDJ-UHFFFAOYSA-N 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine Chemical compound O1C(C)(C)C(C)(C)OB1C1=CCNCC1 AIPUNCFCQBDNDJ-UHFFFAOYSA-N 0.000 description 1
- CLGGPCCAPPVNKG-UHFFFAOYSA-N 4-[6-(2-amino-4-fluorophenyl)sulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C(=CC(F)=CC=4)N)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 CLGGPCCAPPVNKG-UHFFFAOYSA-N 0.000 description 1
- SWQCDUBHQPDGQE-UHFFFAOYSA-N 4-[6-(2-chloro-3-fluorophenoxy)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C(=C(F)C=CC=4)Cl)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 SWQCDUBHQPDGQE-UHFFFAOYSA-N 0.000 description 1
- ZJUKQNUXHMFWIO-UHFFFAOYSA-N 4-[6-(2-chloro-4-fluoroanilino)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C(=CC(F)=CC=4)Cl)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 ZJUKQNUXHMFWIO-UHFFFAOYSA-N 0.000 description 1
- GUVPBROLELMWAW-UHFFFAOYSA-N 4-[6-(2-methylpyrazol-3-yl)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzaldehyde Chemical compound CN1N=CC=C1C1=NN2C(C=3C=CC(C=O)=CC=3)=CN=C2C(NCCC(F)(F)F)=C1 GUVPBROLELMWAW-UHFFFAOYSA-N 0.000 description 1
- CGXAAERYILCNDB-UHFFFAOYSA-N 4-[6-(3-chloroanilino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C=C(Cl)C=CC=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 CGXAAERYILCNDB-UHFFFAOYSA-N 0.000 description 1
- OROBSHOBYGKVLJ-UHFFFAOYSA-N 4-[6-(3-chloroanilino)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C=C(Cl)C=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 OROBSHOBYGKVLJ-UHFFFAOYSA-N 0.000 description 1
- PXRGQELQOMRONE-UHFFFAOYSA-N 4-[6-(3-fluorophenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C1=C(C(N)=O)C(C)=CC(C=2N3N=C(OC=4C=C(F)C=CC=4)C=C(NCCC(F)(F)F)C3=NC=2)=C1 PXRGQELQOMRONE-UHFFFAOYSA-N 0.000 description 1
- ONKGLTSWGJXKRG-UHFFFAOYSA-N 4-[6-(4-chloro-2-fluoroanilino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C(=CC(Cl)=CC=4)F)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 ONKGLTSWGJXKRG-UHFFFAOYSA-N 0.000 description 1
- MGYMYBLKQDGOBJ-UHFFFAOYSA-N 4-[6-(4-chloro-2-fluoroanilino)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C(=CC(Cl)=CC=4)F)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 MGYMYBLKQDGOBJ-UHFFFAOYSA-N 0.000 description 1
- JMSKOZNZXNTWNR-UHFFFAOYSA-N 4-[6-(4-chloro-3-fluoroanilino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C=C(F)C(Cl)=CC=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 JMSKOZNZXNTWNR-UHFFFAOYSA-N 0.000 description 1
- BVLXSTWFIOSTRF-UHFFFAOYSA-N 4-[6-(4-chloro-3-fluoroanilino)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C=C(F)C(Cl)=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 BVLXSTWFIOSTRF-UHFFFAOYSA-N 0.000 description 1
- PUJNZOKOQINFFP-UHFFFAOYSA-N 4-[6-(4-chloro-3-fluorophenoxy)-8-(thian-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C(Cl)=CC=4)C=C(NCC4CCSCC4)C3=NC=2)=CC=C1C(=O)NC1CC1 PUJNZOKOQINFFP-UHFFFAOYSA-N 0.000 description 1
- NHNWFZAOZMEVPI-UHFFFAOYSA-N 4-[6-(4-chloroanilino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C=CC(Cl)=CC=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 NHNWFZAOZMEVPI-UHFFFAOYSA-N 0.000 description 1
- KZMSAXMFRLBOPW-UHFFFAOYSA-N 4-[6-(4-chloroanilino)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C=CC(Cl)=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 KZMSAXMFRLBOPW-UHFFFAOYSA-N 0.000 description 1
- PNQZGZZHULYUDT-UHFFFAOYSA-N 4-[6-(4-chlorophenoxy)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=CC(Cl)=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 PNQZGZZHULYUDT-UHFFFAOYSA-N 0.000 description 1
- JGAZYWLFBRAOLX-UHFFFAOYSA-N 4-[6-(5-chloro-2-methylanilino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC=C(Cl)C=C1NC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCC(F)(F)F)=C1 JGAZYWLFBRAOLX-UHFFFAOYSA-N 0.000 description 1
- IIVFWJRRSYUWFU-UHFFFAOYSA-N 4-[6-(5-chloro-2-methylanilino)-8-(4,4,4-trifluorobutylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC=C(Cl)C=C1NC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCCC(F)(F)F)=C1 IIVFWJRRSYUWFU-UHFFFAOYSA-N 0.000 description 1
- XANWKJZOPPBDHJ-UHFFFAOYSA-N 4-[6-(5-chloro-2-methylanilino)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC=C(Cl)C=C1NC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCC(C)(C)O)=C1 XANWKJZOPPBDHJ-UHFFFAOYSA-N 0.000 description 1
- HERBRAOUQDOUQV-UHFFFAOYSA-N 4-[6-(5-cyanopyridin-3-yl)-8-(2-methylpropylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound C=1N=C2C(NCC(C)C)=CC(C=3C=C(C=NC=3)C#N)=NN2C=1C(C=C1C)=CC=C1C(=O)NC1CC1 HERBRAOUQDOUQV-UHFFFAOYSA-N 0.000 description 1
- ITUJASTWHLGGGT-UHFFFAOYSA-N 4-[6-(5-cyanopyridin-3-yl)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCC(C)(C)O)C3=NC=2)C=2C=C(C=NC=2)C#N)=CC=C1C(=O)NC1CC1 ITUJASTWHLGGGT-UHFFFAOYSA-N 0.000 description 1
- OSOBOKHEPJHWGU-UHFFFAOYSA-N 4-[6-(benzenesulfonyl)-8-(2-methylpropylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound C=1N=C2C(NCC(C)C)=CC(S(=O)(=O)C=3C=CC=CC=3)=NN2C=1C(C=C1C)=CC=C1C(=O)NC1CC1 OSOBOKHEPJHWGU-UHFFFAOYSA-N 0.000 description 1
- RLPHFEWJEGFJPV-UHFFFAOYSA-N 4-[6-(benzenesulfonyl)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCCC(F)(F)F)C3=NC=2)S(=O)(=O)C=2C=CC=CC=2)=CC=C1C(=O)NC1CC1 RLPHFEWJEGFJPV-UHFFFAOYSA-N 0.000 description 1
- ZMFQZOCBCIXENP-UHFFFAOYSA-N 4-[6-(cyclohexen-1-yl)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropylbenzenecarbothioamide Chemical compound C=1N=C2C(NCC(C)(O)C)=CC(C=3CCCCC=3)=NN2C=1C(C=C1)=CC=C1C(=S)NC1CC1 ZMFQZOCBCIXENP-UHFFFAOYSA-N 0.000 description 1
- XPJJQNLAYCUBPC-UHFFFAOYSA-N 4-[6-(cyclohexen-1-yl)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]benzaldehyde Chemical compound C=1N=C2C(NCC(C)(O)C)=CC(C=3CCCCC=3)=NN2C=1C1=CC=C(C=O)C=C1 XPJJQNLAYCUBPC-UHFFFAOYSA-N 0.000 description 1
- UUVYDXASDGPQAS-UHFFFAOYSA-N 4-[6-(cyclohexen-1-yl)-8-[(3,3,3-trifluoro-2-hydroxypropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCC(O)C(F)(F)F)C3=NC=2)C=2CCCCC=2)=CC=C1C(=O)NC1CC1 UUVYDXASDGPQAS-UHFFFAOYSA-N 0.000 description 1
- JGCRHEBBVXXMGE-UHFFFAOYSA-N 4-[6-(cyclohexylamino)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC4CCCCC4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 JGCRHEBBVXXMGE-UHFFFAOYSA-N 0.000 description 1
- LIYWCGOAMJIFMR-UHFFFAOYSA-N 4-[6-(cyclopent-3-en-1-ylamino)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC4CC=CC4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 LIYWCGOAMJIFMR-UHFFFAOYSA-N 0.000 description 1
- JVBSBKLIAFERKK-UHFFFAOYSA-N 4-[6-(cyclopentylamino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC4CCCC4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 JVBSBKLIAFERKK-UHFFFAOYSA-N 0.000 description 1
- MRDAFIXGKSEGCZ-UHFFFAOYSA-N 4-[6-(cyclopentylamino)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC4CCCC4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 MRDAFIXGKSEGCZ-UHFFFAOYSA-N 0.000 description 1
- VJJQBYKRTQFOOB-LNKIKWGQSA-N 4-[6-[(e)-but-2-en-2-yl]-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound N12N=C(C(/C)=C/C)C=C(NCCC(F)(F)F)C2=NC=C1C(C=C1C)=CC=C1C(=O)NC1CC1 VJJQBYKRTQFOOB-LNKIKWGQSA-N 0.000 description 1
- KOWPNYTWPZHHNA-GIDUJCDVSA-N 4-[6-[(e)-but-2-en-2-yl]-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound N12N=C(C(/C)=C/C)C=C(NCC(C)(C)O)C2=NC=C1C(C=C1C)=CC=C1C(=O)NC1CC1 KOWPNYTWPZHHNA-GIDUJCDVSA-N 0.000 description 1
- VDUPTHPKUCCAED-GIDUJCDVSA-N 4-[6-[(e)-but-2-en-2-yl]-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-3-methoxybenzamide Chemical compound C=1C=C(C=2N3N=C(C=C(NCC(C)(C)O)C3=NC=2)C(\C)=C\C)C(OC)=CC=1C(=O)NC1CC1 VDUPTHPKUCCAED-GIDUJCDVSA-N 0.000 description 1
- UFZFQYHYDQOVJZ-UHFFFAOYSA-N 4-[6-[2-(hydroxymethyl)phenyl]-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzaldehyde Chemical compound OCC1=CC=CC=C1C1=NN2C(C=3C=CC(C=O)=CC=3)=CN=C2C(NCCC(F)(F)F)=C1 UFZFQYHYDQOVJZ-UHFFFAOYSA-N 0.000 description 1
- HYQQHKSETLNNJA-UHFFFAOYSA-N 4-[6-[3-(hydroxymethyl)phenyl]-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzaldehyde Chemical compound OCC1=CC=CC(C2=NN3C(C=4C=CC(C=O)=CC=4)=CN=C3C(NCCC(F)(F)F)=C2)=C1 HYQQHKSETLNNJA-UHFFFAOYSA-N 0.000 description 1
- GREPGBWHHDFNOJ-UHFFFAOYSA-N 4-[6-[4-(2-aminoethyl)anilino]-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C=CC(CCN)=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 GREPGBWHHDFNOJ-UHFFFAOYSA-N 0.000 description 1
- QAVKSGTYTPHWQZ-UHFFFAOYSA-N 4-[6-[4-chloro-2-(hydroxymethyl)phenyl]-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCCC(F)(F)F)C3=NC=2)C=2C(=CC(Cl)=CC=2)CO)=CC=C1C(=O)NC1CC1 QAVKSGTYTPHWQZ-UHFFFAOYSA-N 0.000 description 1
- NLZVXWXKGSYDHT-UHFFFAOYSA-N 4-[6-[4-chloro-2-(hydroxymethyl)phenyl]-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCC(C)(C)O)C3=NC=2)C=2C(=CC(Cl)=CC=2)CO)=CC=C1C(=O)NC1CC1 NLZVXWXKGSYDHT-UHFFFAOYSA-N 0.000 description 1
- QFZGOHPWUKWRPB-UHFFFAOYSA-N 4-[6-[4-chloro-2-(hydroxymethyl)phenyl]sulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C(=CC(Cl)=CC=4)CO)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 QFZGOHPWUKWRPB-UHFFFAOYSA-N 0.000 description 1
- XVTSJKAGQGVAQR-UHFFFAOYSA-N 4-[6-[4-chloro-2-(hydroxymethyl)phenyl]sulfanyl-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C(=CC(Cl)=CC=4)CO)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 XVTSJKAGQGVAQR-UHFFFAOYSA-N 0.000 description 1
- XTWSCTSZPHXZLC-UHFFFAOYSA-N 4-[6-anilino-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C=CC=CC=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 XTWSCTSZPHXZLC-UHFFFAOYSA-N 0.000 description 1
- AIGUAKJNKXPQIV-UHFFFAOYSA-N 4-[6-bromo-8-(4,4,4-trifluorobutylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(Br)C=C(NCCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 AIGUAKJNKXPQIV-UHFFFAOYSA-N 0.000 description 1
- OFFVATUZVCGJEC-UHFFFAOYSA-N 4-[6-chloro-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-3-methoxybenzamide Chemical compound C=1C=C(C=2N3N=C(Cl)C=C(NCCC(F)(F)F)C3=NC=2)C(OC)=CC=1C(=O)NC1CC1 OFFVATUZVCGJEC-UHFFFAOYSA-N 0.000 description 1
- IPXASTQCKWAPIP-UHFFFAOYSA-N 4-[6-chloro-8-(3-hydroxypropylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(Cl)C=C(NCCCO)C3=NC=2)=CC=C1C(=O)NC1CC1 IPXASTQCKWAPIP-UHFFFAOYSA-N 0.000 description 1
- KARORNTYIKTRNK-UHFFFAOYSA-N 4-[6-chloro-8-(thiophen-2-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-n,n-dimethylbenzamide Chemical compound C1=CC(C(=O)N(C)C)=CC=C1C1=CN=C2N1N=C(Cl)C=C2NCC1=CC=CS1 KARORNTYIKTRNK-UHFFFAOYSA-N 0.000 description 1
- ZRXRHFSTXSPLDM-UHFFFAOYSA-N 4-[6-chloro-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-3-methoxybenzamide Chemical compound C=1C=C(C=2N3N=C(Cl)C=C(NCC(C)(C)O)C3=NC=2)C(OC)=CC=1C(=O)NC1CC1 ZRXRHFSTXSPLDM-UHFFFAOYSA-N 0.000 description 1
- FLJPRGOWKMZTFI-RBUKOAKNSA-N 4-[6-chloro-8-[[(2s)-2-[(4r)-2,2-dimethyl-1,3-dioxolan-4-yl]-2-hydroxyethyl]amino]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropylbenzamide Chemical compound O1C(C)(C)OC[C@@H]1[C@@H](O)CNC1=CC(Cl)=NN2C1=NC=C2C1=CC=C(C(=O)NC2CC2)C=C1 FLJPRGOWKMZTFI-RBUKOAKNSA-N 0.000 description 1
- YLRGUGFJMHIPKK-UHFFFAOYSA-N 4-[6-cyclopentyloxy-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC4CCCC4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 YLRGUGFJMHIPKK-UHFFFAOYSA-N 0.000 description 1
- JXNABYABIAVWPE-UHFFFAOYSA-N 4-[8-(2-methylpropylamino)-6-pyridin-4-ylimidazo[1,2-b]pyridazin-3-yl]benzaldehyde Chemical compound C=1N=C2C(NCC(C)C)=CC(C=3C=CN=CC=3)=NN2C=1C1=CC=C(C=O)C=C1 JXNABYABIAVWPE-UHFFFAOYSA-N 0.000 description 1
- IZEVTBSFBDBQRD-UHFFFAOYSA-N 4-[8-[(2-amino-2-methylpropyl)amino]-6-(2-methylpyrazol-3-yl)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCC(C)(C)N)C3=NC=2)C=2N(N=CC=2)C)=CC=C1C(=O)NC1CC1 IZEVTBSFBDBQRD-UHFFFAOYSA-N 0.000 description 1
- ZIOBVRJYQOMREI-UHFFFAOYSA-N 4-[8-[(2-amino-2-methylpropyl)amino]-6-(3-fluorophenyl)sulfanylimidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C=C(F)C=CC=4)C=C(NCC(C)(C)N)C3=NC=2)=CC=C1C(=O)NC1CC1 ZIOBVRJYQOMREI-UHFFFAOYSA-N 0.000 description 1
- OONLZOGPSBJRMX-UHFFFAOYSA-N 4-[8-[(2-amino-2-methylpropyl)amino]-6-(4-fluorophenyl)imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCC(C)(C)N)C3=NC=2)C=2C=CC(F)=CC=2)=CC=C1C(=O)NC1CC1 OONLZOGPSBJRMX-UHFFFAOYSA-N 0.000 description 1
- VOSIPRDUNIJFKX-UHFFFAOYSA-N 4-[8-[(2-amino-2-methylpropyl)amino]-6-[2-(hydroxymethyl)phenyl]imidazo[1,2-b]pyridazin-3-yl]-n-cyclopropyl-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCC(C)(C)N)C3=NC=2)C=2C(=CC=CC=2)CO)=CC=C1C(=O)NC1CC1 VOSIPRDUNIJFKX-UHFFFAOYSA-N 0.000 description 1
- QONYKJTZAAGKSS-UHFFFAOYSA-N 4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-pyridin-4-ylimidazo[1,2-b]pyridazin-3-yl]benzaldehyde Chemical compound C=1N=C2C(NCC(C)(O)C)=CC(C=3C=CN=CC=3)=NN2C=1C1=CC=C(C=O)C=C1 QONYKJTZAAGKSS-UHFFFAOYSA-N 0.000 description 1
- XYWIPYBIIRTJMM-IBGZPJMESA-N 4-[[(2S)-2-[4-[5-chloro-2-[4-(trifluoromethyl)triazol-1-yl]phenyl]-5-methoxy-2-oxopyridin-1-yl]butanoyl]amino]-2-fluorobenzamide Chemical compound CC[C@H](N1C=C(OC)C(=CC1=O)C1=C(C=CC(Cl)=C1)N1C=C(N=N1)C(F)(F)F)C(=O)NC1=CC(F)=C(C=C1)C(N)=O XYWIPYBIIRTJMM-IBGZPJMESA-N 0.000 description 1
- WIFPJDJJFUSIFP-UHFFFAOYSA-N 4-aminobutane-1,2,3-triol Chemical compound NCC(O)C(O)CO WIFPJDJJFUSIFP-UHFFFAOYSA-N 0.000 description 1
- NUKYPUAOHBNCPY-UHFFFAOYSA-N 4-aminopyridine Chemical compound NC1=CC=NC=C1 NUKYPUAOHBNCPY-UHFFFAOYSA-N 0.000 description 1
- ITWXOEQLYFYTJX-UHFFFAOYSA-N 4-borono-3-methoxybenzoic acid Chemical compound COC1=CC(C(O)=O)=CC=C1B(O)O ITWXOEQLYFYTJX-UHFFFAOYSA-N 0.000 description 1
- RVCJOGNLYVNRDN-UHFFFAOYSA-N 4-bromo-2-methylbenzoic acid Chemical compound CC1=CC(Br)=CC=C1C(O)=O RVCJOGNLYVNRDN-UHFFFAOYSA-N 0.000 description 1
- KRZCOLNOCZKSDF-UHFFFAOYSA-N 4-fluoroaniline Chemical compound NC1=CC=C(F)C=C1 KRZCOLNOCZKSDF-UHFFFAOYSA-N 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 125000001826 4H-pyranyl group Chemical group O1C(=CCC=C1)* 0.000 description 1
- ZKOFMMGFJURGCI-UHFFFAOYSA-N 5-[3-[4-(cyclopropylcarbamoyl)-3-methylphenyl]-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-6-yl]oxypyridine-3-carboxamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(C=NC=4)C(N)=O)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 ZKOFMMGFJURGCI-UHFFFAOYSA-N 0.000 description 1
- IUFLFKASIHPKNZ-UHFFFAOYSA-N 5-fluoropyridin-3-ol Chemical compound OC1=CN=CC(F)=C1 IUFLFKASIHPKNZ-UHFFFAOYSA-N 0.000 description 1
- UIJCDEKRKCCYIF-UHFFFAOYSA-N 5-hydroxypyridine-3-carboxamide Chemical compound NC(=O)C1=CN=CC(O)=C1 UIJCDEKRKCCYIF-UHFFFAOYSA-N 0.000 description 1
- WGVHNCAJPFIFCR-UHFFFAOYSA-N 5-methyl-1,2-dihydropyrazol-3-one Chemical compound CC1=CC(O)=NN1 WGVHNCAJPFIFCR-UHFFFAOYSA-N 0.000 description 1
- YCPXWRQRBFJBPZ-UHFFFAOYSA-N 5-sulfosalicylic acid Chemical compound OC(=O)C1=CC(S(O)(=O)=O)=CC=C1O YCPXWRQRBFJBPZ-UHFFFAOYSA-N 0.000 description 1
- MJQSRSOTRPMVKB-UHFFFAOYSA-N 5h-imidazo[4,5-c]pyridazine Chemical compound C1=NNC2=NC=NC2=C1 MJQSRSOTRPMVKB-UHFFFAOYSA-N 0.000 description 1
- OGWKCGZFUXNPDA-CFWMRBGOSA-N 5j49q6b70f Chemical compound C([C@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C=O)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 OGWKCGZFUXNPDA-CFWMRBGOSA-N 0.000 description 1
- WYWHKKSPHMUBEB-UHFFFAOYSA-N 6-Mercaptoguanine Natural products N1C(N)=NC(=S)C2=C1N=CN2 WYWHKKSPHMUBEB-UHFFFAOYSA-N 0.000 description 1
- IOEAZSDEWKPTII-CRKCGEKBSA-N 6-[(e)-but-2-en-2-yl]-3-[4-(2-cyclopropyl-1h-imidazol-5-yl)phenyl]-n-(3,3,3-trifluoropropyl)imidazo[1,2-b]pyridazin-8-amine Chemical compound N12N=C(C(/C)=C/C)C=C(NCCC(F)(F)F)C2=NC=C1C(C=C1)=CC=C1C(N1)=CN=C1C1CC1 IOEAZSDEWKPTII-CRKCGEKBSA-N 0.000 description 1
- USLMQUUBJVRUGX-UHFFFAOYSA-N 6-chloro-3-iodo-n-(thiophen-2-ylmethyl)imidazo[1,2-b]pyridazin-8-amine Chemical compound C12=NC=C(I)N2N=C(Cl)C=C1NCC1=CC=CS1 USLMQUUBJVRUGX-UHFFFAOYSA-N 0.000 description 1
- OTRFLZUSZAVLKP-UHFFFAOYSA-N 6-chloro-3-iodo-n-[(2-methyloxolan-2-yl)methyl]imidazo[1,2-b]pyridazin-8-amine Chemical compound C=1C(Cl)=NN2C(I)=CN=C2C=1NCC1(C)CCCO1 OTRFLZUSZAVLKP-UHFFFAOYSA-N 0.000 description 1
- XXFLFPDHUCPEPP-UHFFFAOYSA-N 6-cyclopentyloxy-n-(3,3,3-trifluoropropyl)imidazo[1,2-b]pyridazin-8-amine Chemical compound N=1N2C=CN=C2C(NCCC(F)(F)F)=CC=1OC1CCCC1 XXFLFPDHUCPEPP-UHFFFAOYSA-N 0.000 description 1
- UUVDJIWRSIJEBS-UHFFFAOYSA-N 6-methoxypyridin-3-amine Chemical compound COC1=CC=C(N)C=N1 UUVDJIWRSIJEBS-UHFFFAOYSA-N 0.000 description 1
- DHLUJPLHLZJUBW-UHFFFAOYSA-N 6-methylpyridin-3-ol Chemical compound CC1=CC=C(O)C=N1 DHLUJPLHLZJUBW-UHFFFAOYSA-N 0.000 description 1
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 1
- LZEJQXOCRMRVNP-UHFFFAOYSA-N 8-bromo-6-chloroimidazo[1,2-b]pyridazine Chemical compound N1=C(Cl)C=C(Br)C2=NC=CN21 LZEJQXOCRMRVNP-UHFFFAOYSA-N 0.000 description 1
- ZRPZPNYZFSJUPA-UHFFFAOYSA-N ARS-1620 Chemical compound Oc1cccc(F)c1-c1c(Cl)cc2c(ncnc2c1F)N1CCN(CC1)C(=O)C=C ZRPZPNYZFSJUPA-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 101100439662 Arabidopsis thaliana CHR5 gene Proteins 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 238000006443 Buchwald-Hartwig cross coupling reaction Methods 0.000 description 1
- 229910014585 C2-Ce Inorganic materials 0.000 description 1
- 101100326430 Caenorhabditis elegans bub-1 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- GAGWJHPBXLXJQN-UORFTKCHSA-N Capecitabine Chemical compound C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](C)O1 GAGWJHPBXLXJQN-UORFTKCHSA-N 0.000 description 1
- GAGWJHPBXLXJQN-UHFFFAOYSA-N Capecitabine Natural products C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1C1C(O)C(O)C(C)O1 GAGWJHPBXLXJQN-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102100025832 Centromere-associated protein E Human genes 0.000 description 1
- 108091060290 Chromatid Proteins 0.000 description 1
- PTOAARAWEBMLNO-KVQBGUIXSA-N Cladribine Chemical compound C1=NC=2C(N)=NC(Cl)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 PTOAARAWEBMLNO-KVQBGUIXSA-N 0.000 description 1
- 108010022152 Corticotropin-Releasing Hormone Proteins 0.000 description 1
- 241000938605 Crocodylia Species 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- XDXDZDZNSLXDNA-TZNDIEGXSA-N Idarubicin Chemical compound C1[C@H](N)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2C[C@@](O)(C(C)=O)C1 XDXDZDZNSLXDNA-TZNDIEGXSA-N 0.000 description 1
- XDXDZDZNSLXDNA-UHFFFAOYSA-N Idarubicin Natural products C1C(N)C(O)C(C)OC1OC1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2CC(O)(C(C)=O)C1 XDXDZDZNSLXDNA-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- 125000002842 L-seryl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])O[H] 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 102000001291 MAP Kinase Kinase Kinase Human genes 0.000 description 1
- 102000043136 MAP kinase family Human genes 0.000 description 1
- 108091054455 MAP kinase family Proteins 0.000 description 1
- 108060006687 MAP kinase kinase kinase Proteins 0.000 description 1
- 102000029749 Microtubule Human genes 0.000 description 1
- 108091022875 Microtubule Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- FEYNFHSRETUBEM-UHFFFAOYSA-N N-[3-(1,1-difluoroethyl)phenyl]-1-(4-methoxyphenyl)-3-methyl-5-oxo-4H-pyrazole-4-carboxamide Chemical compound COc1ccc(cc1)N1N=C(C)C(C(=O)Nc2cccc(c2)C(C)(F)F)C1=O FEYNFHSRETUBEM-UHFFFAOYSA-N 0.000 description 1
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 1
- UALORLCYRCEIME-IBGZPJMESA-N N-cyclopropyl-2-methyl-4-[6-(2-methylpyrazol-3-yl)-8-[[(2S)-oxolan-2-yl]methylamino]imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NC[C@H]4OCCC4)C3=NC=2)C=2N(N=CC=2)C)=CC=C1C(=O)NC1CC1 UALORLCYRCEIME-IBGZPJMESA-N 0.000 description 1
- JNNBAAUFKRFXHP-UHFFFAOYSA-N N-cyclopropyl-2-methyl-4-[8-[(2-methyloxolan-2-yl)methylamino]-6-pyridin-4-ylimidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCC4(C)OCCC4)C3=NC=2)C=2C=CN=CC=2)=CC=C1C(=O)NC1CC1 JNNBAAUFKRFXHP-UHFFFAOYSA-N 0.000 description 1
- GMOFUGLLPMZVFN-UHFFFAOYSA-N N-cyclopropyl-3-hydroxy-4-[6-phenylsulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound OC1=CC(C(=O)NC2CC2)=CC=C1C(N1N=2)=CN=C1C(NCCC(F)(F)F)=CC=2SC1=CC=CC=C1 GMOFUGLLPMZVFN-UHFFFAOYSA-N 0.000 description 1
- CNSUPAYXOZACOU-UHFFFAOYSA-N N-cyclopropyl-3-hydroxy-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-phenylsulfanylimidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound N=1N2C(C=3C(=CC(=CC=3)C(=O)NC3CC3)O)=CN=C2C(NCC(C)(O)C)=CC=1SC1=CC=CC=C1 CNSUPAYXOZACOU-UHFFFAOYSA-N 0.000 description 1
- QISDGGVOHVSRNQ-UHFFFAOYSA-N N-cyclopropyl-4-[6-(2-hydroxyanilino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C(=CC=CC=4)O)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 QISDGGVOHVSRNQ-UHFFFAOYSA-N 0.000 description 1
- YCVDQRSIDGEBNR-UHFFFAOYSA-N N-cyclopropyl-4-[6-(2-hydroxyanilino)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C(=CC=CC=4)O)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 YCVDQRSIDGEBNR-UHFFFAOYSA-N 0.000 description 1
- ZGMSTIQIVPFMGN-UHFFFAOYSA-N N-cyclopropyl-4-[6-(3-fluorophenyl)sulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-3-hydroxybenzamide Chemical compound OC1=CC(C(=O)NC2CC2)=CC=C1C(N1N=2)=CN=C1C(NCCC(F)(F)F)=CC=2SC1=CC=CC(F)=C1 ZGMSTIQIVPFMGN-UHFFFAOYSA-N 0.000 description 1
- UQJUYVTZNOCGMF-UHFFFAOYSA-N N-cyclopropyl-4-[6-(3-fluorophenyl)sulfanyl-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-3-hydroxybenzamide Chemical compound N=1N2C(C=3C(=CC(=CC=3)C(=O)NC3CC3)O)=CN=C2C(NCC(C)(O)C)=CC=1SC1=CC=CC(F)=C1 UQJUYVTZNOCGMF-UHFFFAOYSA-N 0.000 description 1
- DMLIQHNMBZCNTR-UHFFFAOYSA-N N-cyclopropyl-4-[6-(4-fluoro-2-hydroxyanilino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C(=CC(F)=CC=4)O)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 DMLIQHNMBZCNTR-UHFFFAOYSA-N 0.000 description 1
- YRIFVGQSZKENTE-UHFFFAOYSA-N N-cyclopropyl-4-[8-[(1,1-dioxothian-4-yl)methylamino]-6-(3-fluorophenyl)sulfanylimidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C=C(F)C=CC=4)C=C(NCC4CCS(=O)(=O)CC4)C3=NC=2)=CC=C1C(=O)NC1CC1 YRIFVGQSZKENTE-UHFFFAOYSA-N 0.000 description 1
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- 101100258328 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) crc-2 gene Proteins 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- WUGQZFFCHPXWKQ-UHFFFAOYSA-N Propanolamine Chemical compound NCCCO WUGQZFFCHPXWKQ-UHFFFAOYSA-N 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- BFZKMNSQCNVFGM-UCEYFQQTSA-N Sagopilone Chemical compound O1C(=O)C[C@H](O)C(C)(C)C(=O)[C@H](CC=C)[C@@H](O)[C@@H](C)CCC[C@@]2(C)O[C@H]2C[C@H]1C1=CC=C(SC(C)=N2)C2=C1 BFZKMNSQCNVFGM-UCEYFQQTSA-N 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 238000003477 Sonogashira cross-coupling reaction Methods 0.000 description 1
- SWEDAZLCYJDAGW-UHFFFAOYSA-N Thiophene-2-thiol Chemical compound SC1=CC=CS1 SWEDAZLCYJDAGW-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 229940122803 Vinca alkaloid Drugs 0.000 description 1
- YNOGYQAEJGADFJ-RXMQYKEDSA-N [(2r)-oxolan-2-yl]methanamine Chemical compound NC[C@H]1CCCO1 YNOGYQAEJGADFJ-RXMQYKEDSA-N 0.000 description 1
- YNOGYQAEJGADFJ-YFKPBYRVSA-N [(2s)-oxolan-2-yl]methanamine Chemical compound NC[C@@H]1CCCO1 YNOGYQAEJGADFJ-YFKPBYRVSA-N 0.000 description 1
- XPUNXPPXMANQGF-UHFFFAOYSA-N [2-methyl-5-(trifluoromethyl)pyrazol-3-yl]boronic acid Chemical compound CN1N=C(C(F)(F)F)C=C1B(O)O XPUNXPPXMANQGF-UHFFFAOYSA-N 0.000 description 1
- HGTDLKXUWVKLQX-UHFFFAOYSA-N [3-(hydroxymethyl)phenyl]boronic acid Chemical compound OCC1=CC=CC(B(O)O)=C1 HGTDLKXUWVKLQX-UHFFFAOYSA-N 0.000 description 1
- QHMZFIHGASQDNZ-UHFFFAOYSA-N [4-(2-cyclopropyl-1h-imidazol-5-yl)phenyl]boronic acid Chemical compound C1=CC(B(O)O)=CC=C1C1=CN=C(C2CC2)N1 QHMZFIHGASQDNZ-UHFFFAOYSA-N 0.000 description 1
- QJYYVSIRDJVQJW-UHFFFAOYSA-N [4-(dimethylcarbamoyl)phenyl]boronic acid Chemical compound CN(C)C(=O)C1=CC=C(B(O)O)C=C1 QJYYVSIRDJVQJW-UHFFFAOYSA-N 0.000 description 1
- ZVQOOHYFBIDMTQ-UHFFFAOYSA-N [methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulfanylidene]cyanamide Chemical compound N#CN=S(C)(=O)C(C)C1=CC=C(C(F)(F)F)N=C1 ZVQOOHYFBIDMTQ-UHFFFAOYSA-N 0.000 description 1
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 125000005042 acyloxymethyl group Chemical group 0.000 description 1
- 229940009456 adriamycin Drugs 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000004849 alkoxymethyl group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 208000036878 aneuploidy Diseases 0.000 description 1
- 231100001075 aneuploidy Toxicity 0.000 description 1
- 150000001448 anilines Chemical class 0.000 description 1
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 125000005427 anthranyl group Chemical group 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 239000003080 antimitotic agent Substances 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- VSRXQHXAPYXROS-UHFFFAOYSA-N azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) Chemical compound [NH2-].[NH2-].[Pt+2].OC(=O)C1(C(O)=O)CCC1 VSRXQHXAPYXROS-UHFFFAOYSA-N 0.000 description 1
- 125000002393 azetidinyl group Chemical group 0.000 description 1
- 125000004931 azocinyl group Chemical group N1=C(C=CC=CC=C1)* 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000004603 benzisoxazolyl group Chemical group O1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 229960000997 bicalutamide Drugs 0.000 description 1
- MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical compound C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- GXJABQQUPOEUTA-RDJZCZTQSA-N bortezomib Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)B(O)O)NC(=O)C=1N=CC=NC=1)C1=CC=CC=C1 GXJABQQUPOEUTA-RDJZCZTQSA-N 0.000 description 1
- 229960001467 bortezomib Drugs 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- QARVLSVVCXYDNA-UHFFFAOYSA-N bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960004117 capecitabine Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- VZSXFJPZOCRDPW-UHFFFAOYSA-N carbanide;trioxorhenium Chemical compound [CH3-].O=[Re](=O)=O VZSXFJPZOCRDPW-UHFFFAOYSA-N 0.000 description 1
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
- 125000001589 carboacyl group Chemical group 0.000 description 1
- 125000002837 carbocyclic group Chemical group 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 229960004562 carboplatin Drugs 0.000 description 1
- 125000001721 carboxyacetyl group Chemical group 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000034303 cell budding Effects 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000023359 cell cycle switching, meiotic to mitotic cell cycle Effects 0.000 description 1
- 108010031379 centromere protein E Proteins 0.000 description 1
- DGLFSNZWRYADFC-UHFFFAOYSA-N chembl2334586 Chemical compound C1CCC2=CN=C(N)N=C2C2=C1NC1=CC=C(C#CC(C)(O)C)C=C12 DGLFSNZWRYADFC-UHFFFAOYSA-N 0.000 description 1
- 239000013000 chemical inhibitor Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 229960004630 chlorambucil Drugs 0.000 description 1
- JCKYGMPEJWAADB-UHFFFAOYSA-N chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- KQIADDMXRMTWHZ-UHFFFAOYSA-N chloro-tri(propan-2-yl)silane Chemical compound CC(C)[Si](Cl)(C(C)C)C(C)C KQIADDMXRMTWHZ-UHFFFAOYSA-N 0.000 description 1
- 210000004756 chromatid Anatomy 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 230000024321 chromosome segregation Effects 0.000 description 1
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000006880 cross-coupling reaction Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- RWGFKTVRMDUZSP-UHFFFAOYSA-N cumene Chemical compound CC(C)C1=CC=CC=C1 RWGFKTVRMDUZSP-UHFFFAOYSA-N 0.000 description 1
- WZHCOOQXZCIUNC-UHFFFAOYSA-N cyclandelate Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C(O)C1=CC=CC=C1 WZHCOOQXZCIUNC-UHFFFAOYSA-N 0.000 description 1
- 125000001047 cyclobutenyl group Chemical group C1(=CCC1)* 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- PFURGBBHAOXLIO-UHFFFAOYSA-N cyclohexane-1,2-diol Chemical compound OC1CCCCC1O PFURGBBHAOXLIO-UHFFFAOYSA-N 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 1
- LJSBEPFUQWPNBZ-UHFFFAOYSA-N cyclopent-3-en-1-amine Chemical compound NC1CC=CC1 LJSBEPFUQWPNBZ-UHFFFAOYSA-N 0.000 description 1
- XCIXKGXIYUWCLL-UHFFFAOYSA-N cyclopentanol Chemical compound OC1CCCC1 XCIXKGXIYUWCLL-UHFFFAOYSA-N 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- JRYOZJIRAVZGMV-UHFFFAOYSA-N cyclopropanecarboximidamide;hydron;chloride Chemical compound Cl.NC(=N)C1CC1 JRYOZJIRAVZGMV-UHFFFAOYSA-N 0.000 description 1
- UWFYSQMTEOIJJG-FDTZYFLXSA-N cyproterone acetate Chemical compound C1=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 UWFYSQMTEOIJJG-FDTZYFLXSA-N 0.000 description 1
- 229960000978 cyproterone acetate Drugs 0.000 description 1
- 229960000684 cytarabine Drugs 0.000 description 1
- 230000021953 cytokinesis Effects 0.000 description 1
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
- 229960000975 daunorubicin Drugs 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 150000008050 dialkyl sulfates Chemical class 0.000 description 1
- 125000005117 dialkylcarbamoyl group Chemical group 0.000 description 1
- 125000005959 diazepanyl group Chemical group 0.000 description 1
- LMEDOLJKVASKTP-UHFFFAOYSA-N dibutyl sulfate Chemical compound CCCCOS(=O)(=O)OCCCC LMEDOLJKVASKTP-UHFFFAOYSA-N 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Chemical compound CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 description 1
- 125000005045 dihydroisoquinolinyl group Chemical group C1(NC=CC2=CC=CC=C12)* 0.000 description 1
- 125000005046 dihydronaphthyl group Chemical group 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- FFHWGQQFANVOHV-UHFFFAOYSA-N dimethyldioxirane Chemical compound CC1(C)OO1 FFHWGQQFANVOHV-UHFFFAOYSA-N 0.000 description 1
- 108700003601 dimethylglycine Proteins 0.000 description 1
- GAFRWLVTHPVQGK-UHFFFAOYSA-N dipentyl sulfate Chemical class CCCCCOS(=O)(=O)OCCCCC GAFRWLVTHPVQGK-UHFFFAOYSA-N 0.000 description 1
- GPAYUJZHTULNBE-UHFFFAOYSA-N diphenylphosphine Chemical compound C=1C=CC=CC=1PC1=CC=CC=C1 GPAYUJZHTULNBE-UHFFFAOYSA-N 0.000 description 1
- 125000005883 dithianyl group Chemical group 0.000 description 1
- 229960003668 docetaxel Drugs 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229960004679 doxorubicin Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000000132 electrospray ionisation Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- HESCAJZNRMSMJG-KKQRBIROSA-N epothilone A Chemical class C/C([C@@H]1C[C@@H]2O[C@@H]2CCC[C@@H]([C@@H]([C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1)O)C)=C\C1=CSC(C)=N1 HESCAJZNRMSMJG-KKQRBIROSA-N 0.000 description 1
- HESCAJZNRMSMJG-HGYUPSKWSA-N epothilone A Natural products O=C1[C@H](C)[C@H](O)[C@H](C)CCC[C@H]2O[C@H]2C[C@@H](/C(=C\c2nc(C)sc2)/C)OC(=O)C[C@H](O)C1(C)C HESCAJZNRMSMJG-HGYUPSKWSA-N 0.000 description 1
- QXRSDHAAWVKZLJ-PVYNADRNSA-N epothilone B Chemical compound C/C([C@@H]1C[C@@H]2O[C@]2(C)CCC[C@@H]([C@@H]([C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1)O)C)=C\C1=CSC(C)=N1 QXRSDHAAWVKZLJ-PVYNADRNSA-N 0.000 description 1
- 150000003883 epothilone derivatives Chemical class 0.000 description 1
- FRPJXPJMRWBBIH-RBRWEJTLSA-N estramustine Chemical compound ClCCN(CCCl)C(=O)OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 FRPJXPJMRWBBIH-RBRWEJTLSA-N 0.000 description 1
- 229940031098 ethanolamine Drugs 0.000 description 1
- VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 description 1
- 229960005420 etoposide Drugs 0.000 description 1
- 229960004979 fampridine Drugs 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 229960000390 fludarabine Drugs 0.000 description 1
- GIUYCYHIANZCFB-FJFJXFQQSA-N fludarabine phosphate Chemical compound C1=NC=2C(N)=NC(F)=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O GIUYCYHIANZCFB-FJFJXFQQSA-N 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- MKXKFYHWDHIYRV-UHFFFAOYSA-N flutamide Chemical compound CC(C)C(=O)NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 MKXKFYHWDHIYRV-UHFFFAOYSA-N 0.000 description 1
- 229960002074 flutamide Drugs 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 229960001867 guaiacol Drugs 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid group Chemical group C(CCCCCC)(=O)O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid group Chemical group C(CCCCC)(=O)O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 125000001145 hydrido group Chemical group *[H] 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 229960000908 idarubicin Drugs 0.000 description 1
- HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 description 1
- 229960001101 ifosfamide Drugs 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 230000006882 induction of apoptosis Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 150000002485 inorganic esters Chemical class 0.000 description 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- FABUFPQFXZVHFB-CFWQTKTJSA-N ixabepilone Chemical compound C/C([C@@H]1C[C@@H]2O[C@]2(C)CCC[C@@H]([C@@H]([C@H](C)C(=O)C(C)(C)[C@H](O)CC(=O)N1)O)C)=C\C1=CSC(C)=N1 FABUFPQFXZVHFB-CFWQTKTJSA-N 0.000 description 1
- 229960002014 ixabepilone Drugs 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- NCBZRJODKRCREW-UHFFFAOYSA-N m-anisidine Chemical compound COC1=CC=CC(N)=C1 NCBZRJODKRCREW-UHFFFAOYSA-N 0.000 description 1
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- BPHQBQAJVFDYRF-UHFFFAOYSA-M magnesium;ethenylbenzene;bromide Chemical compound [Mg+2].[Br-].C=[C-]C1=CC=CC=C1 BPHQBQAJVFDYRF-UHFFFAOYSA-M 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- SGDBTWWWUNNDEQ-LBPRGKRZSA-N melphalan Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N(CCCl)CCCl)C=C1 SGDBTWWWUNNDEQ-LBPRGKRZSA-N 0.000 description 1
- 229960001924 melphalan Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- ATVCAUUSVKIWJW-UHFFFAOYSA-N methyl 2-[3-[4-(cyclopropylcarbamoyl)-3-methylphenyl]-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-6-yl]-5-fluorobenzoate Chemical compound COC(=O)C1=CC(F)=CC=C1C1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCC(C)(C)O)=C1 ATVCAUUSVKIWJW-UHFFFAOYSA-N 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 210000004688 microtubule Anatomy 0.000 description 1
- 230000008880 microtubule cytoskeleton organization Effects 0.000 description 1
- 230000006618 mitotic catastrophe Effects 0.000 description 1
- 229960001156 mitoxantrone Drugs 0.000 description 1
- KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940078490 n,n-dimethylglycine Drugs 0.000 description 1
- FMASTMURQSHELY-UHFFFAOYSA-N n-(4-fluoro-2-methylphenyl)-3-methyl-n-[(2-methyl-1h-indol-4-yl)methyl]pyridine-4-carboxamide Chemical compound C1=CC=C2NC(C)=CC2=C1CN(C=1C(=CC(F)=CC=1)C)C(=O)C1=CC=NC=C1C FMASTMURQSHELY-UHFFFAOYSA-N 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- VFBILHPIHUPBPZ-UHFFFAOYSA-N n-[[2-[4-(difluoromethoxy)-3-propan-2-yloxyphenyl]-1,3-oxazol-4-yl]methyl]-2-ethoxybenzamide Chemical compound CCOC1=CC=CC=C1C(=O)NCC1=COC(C=2C=C(OC(C)C)C(OC(F)F)=CC=2)=N1 VFBILHPIHUPBPZ-UHFFFAOYSA-N 0.000 description 1
- DOWVMJFBDGWVML-UHFFFAOYSA-N n-cyclohexyl-n-methyl-4-(1-oxidopyridin-1-ium-3-yl)imidazole-1-carboxamide Chemical compound C1=NC(C=2C=[N+]([O-])C=CC=2)=CN1C(=O)N(C)C1CCCCC1 DOWVMJFBDGWVML-UHFFFAOYSA-N 0.000 description 1
- OFPVNGDNAMSUHG-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[6-(1-phenylethenyl)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCCC(F)(F)F)C3=NC=2)C(=C)C=2C=CC=CC=2)=CC=C1C(=O)NC1CC1 OFPVNGDNAMSUHG-UHFFFAOYSA-N 0.000 description 1
- WNMZUFQOWFIXGW-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[6-(2,2,3,3-tetrafluoro-4-hydroxybutoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CC1=CC(C=2N3N=C(OCC(F)(F)C(F)(F)CO)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 WNMZUFQOWFIXGW-UHFFFAOYSA-N 0.000 description 1
- DKTIRGIKIDKSAJ-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[6-(2-methylpyrazol-3-yl)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCCC(F)(F)F)C3=NC=2)C=2N(N=CC=2)C)=CC=C1C(=O)NC1CC1 DKTIRGIKIDKSAJ-UHFFFAOYSA-N 0.000 description 1
- CANYVRITYBPCSP-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[6-(2-methylpyrazol-3-yl)-8-[(3,3,3-trifluoro-2-hydroxypropyl)amino]imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCC(O)C(F)(F)F)C3=NC=2)C=2N(N=CC=2)C)=CC=C1C(=O)NC1CC1 CANYVRITYBPCSP-UHFFFAOYSA-N 0.000 description 1
- UALORLCYRCEIME-LJQANCHMSA-N n-cyclopropyl-2-methyl-4-[6-(2-methylpyrazol-3-yl)-8-[[(2r)-oxolan-2-yl]methylamino]imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NC[C@@H]4OCCC4)C3=NC=2)C=2N(N=CC=2)C)=CC=C1C(=O)NC1CC1 UALORLCYRCEIME-LJQANCHMSA-N 0.000 description 1
- LGDIKVFBMZOYMI-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[6-(2-morpholin-4-ylethylsulfanyl)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CC1=CC(C=2N3N=C(SCCN4CCOCC4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 LGDIKVFBMZOYMI-UHFFFAOYSA-N 0.000 description 1
- YXCQVWFWOHCQKN-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[6-(3-methylanilino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CC1=CC=CC(NC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCCC(F)(F)F)=C2)=C1 YXCQVWFWOHCQKN-UHFFFAOYSA-N 0.000 description 1
- FCZFRWCOTVFGBS-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[6-(3-propan-2-ylanilino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CC(C)C1=CC=CC(NC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCCC(F)(F)F)=C2)=C1 FCZFRWCOTVFGBS-UHFFFAOYSA-N 0.000 description 1
- GXKSEQCLUVRCIW-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[6-(pyridin-3-ylamino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C=NC=CC=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 GXKSEQCLUVRCIW-UHFFFAOYSA-N 0.000 description 1
- GFNLLXMSXDIRMB-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[6-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CC1=CC(C=2N3N=C(SC=4N(C=NN=4)C)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 GFNLLXMSXDIRMB-UHFFFAOYSA-N 0.000 description 1
- JBMMAOWLEIVNJM-YBFXNURJSA-N n-cyclopropyl-2-methyl-4-[6-[(e)-2,3,3-trifluoro-4-hydroxybut-1-enoxy]-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CC1=CC(C=2N3N=C(O\C=C(\F)C(F)(F)CO)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 JBMMAOWLEIVNJM-YBFXNURJSA-N 0.000 description 1
- NCYCTKIJPPGLBI-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[6-[4-(trifluoromethyl)phenyl]sulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C=CC(=CC=4)C(F)(F)F)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 NCYCTKIJPPGLBI-UHFFFAOYSA-N 0.000 description 1
- IDNQTCZTYUNJGY-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[6-methylsulfanyl-8-(2-morpholin-4-ylsulfonylethylamino)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound C12=NC=C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)N2N=C(SC)C=C1NCCS(=O)(=O)N1CCOCC1 IDNQTCZTYUNJGY-UHFFFAOYSA-N 0.000 description 1
- ASGTXDHKYSHFRS-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[6-methylsulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound N12N=C(SC)C=C(NCCC(F)(F)F)C2=NC=C1C(C=C1C)=CC=C1C(=O)NC1CC1 ASGTXDHKYSHFRS-UHFFFAOYSA-N 0.000 description 1
- NLFTZWAMPZBBDC-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[6-methylsulfanyl-8-[(3,3,3-trifluoro-2-hydroxypropyl)amino]imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound N12N=C(SC)C=C(NCC(O)C(F)(F)F)C2=NC=C1C(C=C1C)=CC=C1C(=O)NC1CC1 NLFTZWAMPZBBDC-UHFFFAOYSA-N 0.000 description 1
- RLBSJCXVCVKAOX-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[6-phenylsulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C=CC=CC=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 RLBSJCXVCVKAOX-UHFFFAOYSA-N 0.000 description 1
- CEWRUGYCGXGDCJ-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[6-phenylsulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzenecarbothioamide Chemical compound CC1=CC(C=2N3N=C(SC=4C=CC=CC=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=S)NC1CC1 CEWRUGYCGXGDCJ-UHFFFAOYSA-N 0.000 description 1
- URWCQYRJNVWADI-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[6-phenylsulfanyl-8-(thian-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C=CC=CC=4)C=C(NCC4CCSCC4)C3=NC=2)=CC=C1C(=O)NC1CC1 URWCQYRJNVWADI-UHFFFAOYSA-N 0.000 description 1
- FDFTYSCILBZFPU-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[6-pyrazin-2-ylsulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CC1=CC(C=2N3N=C(SC=4N=CC=NC=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 FDFTYSCILBZFPU-UHFFFAOYSA-N 0.000 description 1
- UHEMBCPSXXTMKO-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[6-pyridin-4-yl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCCC(F)(F)F)C3=NC=2)C=2C=CN=CC=2)=CC=C1C(=O)NC1CC1 UHEMBCPSXXTMKO-UHFFFAOYSA-N 0.000 description 1
- KNSCNGSTNBUZGW-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[8-(2-methylpropylamino)-6-(1h-pyrazol-5-yl)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound C=1N=C2C(NCC(C)C)=CC(C=3NN=CC=3)=NN2C=1C(C=C1C)=CC=C1C(=O)NC1CC1 KNSCNGSTNBUZGW-UHFFFAOYSA-N 0.000 description 1
- XUEUCRPTCHXOQI-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[8-(2-methylpropylamino)-6-(2-methylpyrazol-3-yl)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound C=1N=C2C(NCC(C)C)=CC(C=3N(N=CC=3)C)=NN2C=1C(C=C1C)=CC=C1C(=O)NC1CC1 XUEUCRPTCHXOQI-UHFFFAOYSA-N 0.000 description 1
- SSYGPINEHJALJE-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[8-(2-methylpropylamino)-6-(oxolan-2-ylmethylsulfanyl)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound N=1N2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCC(C)C)=CC=1SCC1CCCO1 SSYGPINEHJALJE-UHFFFAOYSA-N 0.000 description 1
- UCSDECHVQRMBBV-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[8-(2-methylpropylamino)-6-methylsulfanylimidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound N12N=C(SC)C=C(NCC(C)C)C2=NC=C1C(C=C1C)=CC=C1C(=O)NC1CC1 UCSDECHVQRMBBV-UHFFFAOYSA-N 0.000 description 1
- SYXGHDYWQDFZJZ-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[8-(2-methylpropylamino)-6-propylsulfanylimidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound N12N=C(SCCC)C=C(NCC(C)C)C2=NC=C1C(C=C1C)=CC=C1C(=O)NC1CC1 SYXGHDYWQDFZJZ-UHFFFAOYSA-N 0.000 description 1
- ZUEDKJFQTDYJRO-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[8-(oxan-2-ylmethylamino)-6-pyridin-4-ylimidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCC4OCCCC4)C3=NC=2)C=2C=CN=CC=2)=CC=C1C(=O)NC1CC1 ZUEDKJFQTDYJRO-UHFFFAOYSA-N 0.000 description 1
- ZCAUJYZBKNIOET-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[8-[(2-methylpyrazol-3-yl)methylamino]-6-methylsulfanylimidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound C12=NC=C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)N2N=C(SC)C=C1NCC1=CC=NN1C ZCAUJYZBKNIOET-UHFFFAOYSA-N 0.000 description 1
- HKWKVEHNGKQPGI-UHFFFAOYSA-N n-cyclopropyl-2-methyl-4-[8-[(4-methylmorpholin-2-yl)methylamino]-6-phenylsulfanylimidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound C1N(C)CCOC1CNC1=CC(SC=2C=CC=CC=2)=NN2C1=NC=C2C(C=C1C)=CC=C1C(=O)NC1CC1 HKWKVEHNGKQPGI-UHFFFAOYSA-N 0.000 description 1
- DTJLIMGDXVTLJY-OAQYLSRUSA-N n-cyclopropyl-2-methyl-4-[8-[[(2r)-oxolan-2-yl]methylamino]-6-pyridin-4-ylimidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NC[C@@H]4OCCC4)C3=NC=2)C=2C=CN=CC=2)=CC=C1C(=O)NC1CC1 DTJLIMGDXVTLJY-OAQYLSRUSA-N 0.000 description 1
- DTJLIMGDXVTLJY-NRFANRHFSA-N n-cyclopropyl-2-methyl-4-[8-[[(2s)-oxolan-2-yl]methylamino]-6-pyridin-4-ylimidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NC[C@H]4OCCC4)C3=NC=2)C=2C=CN=CC=2)=CC=C1C(=O)NC1CC1 DTJLIMGDXVTLJY-NRFANRHFSA-N 0.000 description 1
- NNKPHNTWNILINE-UHFFFAOYSA-N n-cyclopropyl-3-fluoro-4-methyl-5-[3-[[1-[2-[2-(methylamino)ethoxy]phenyl]cyclopropyl]amino]-2-oxopyrazin-1-yl]benzamide Chemical compound CNCCOC1=CC=CC=C1C1(NC=2C(N(C=3C(=C(F)C=C(C=3)C(=O)NC3CC3)C)C=CN=2)=O)CC1 NNKPHNTWNILINE-UHFFFAOYSA-N 0.000 description 1
- VTSMZDCBCYFERV-UHFFFAOYSA-N n-cyclopropyl-3-methoxy-4-[6-(2-methylpyrazol-3-yl)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound COC1=CC(C(=O)NC2CC2)=CC=C1C(N1N=2)=CN=C1C(NCCC(F)(F)F)=CC=2C1=CC=NN1C VTSMZDCBCYFERV-UHFFFAOYSA-N 0.000 description 1
- HYIISDRAVCTNTL-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2,3-difluoroanilino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C(=C(F)C=CC=4)F)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 HYIISDRAVCTNTL-UHFFFAOYSA-N 0.000 description 1
- ZEXPCJVXYGXKFV-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2,3-difluoroanilino)-8-(4,4,4-trifluorobutylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C(=C(F)C=CC=4)F)C=C(NCCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 ZEXPCJVXYGXKFV-UHFFFAOYSA-N 0.000 description 1
- AEYNNGACQVWQPP-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2,3-difluoroanilino)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C(=C(F)C=CC=4)F)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 AEYNNGACQVWQPP-UHFFFAOYSA-N 0.000 description 1
- ZTOKZZGJCXDBRP-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2,3-difluorophenyl)sulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C(=C(F)C=CC=4)F)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 ZTOKZZGJCXDBRP-UHFFFAOYSA-N 0.000 description 1
- XLTKKASCMCFYHB-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2,4-difluoroanilino)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C(=CC(F)=CC=4)F)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 XLTKKASCMCFYHB-UHFFFAOYSA-N 0.000 description 1
- ZYHHNLOMNTWFLX-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2,5-difluorophenyl)sulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C(=CC=C(F)C=4)F)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 ZYHHNLOMNTWFLX-UHFFFAOYSA-N 0.000 description 1
- SYDRQFDYCUHGII-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2,5-difluorophenyl)sulfanyl-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C(=CC=C(F)C=4)F)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 SYDRQFDYCUHGII-UHFFFAOYSA-N 0.000 description 1
- KBVIPCSBPGOWBL-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2,6-difluorophenyl)sulfanyl-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C(=CC=CC=4F)F)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 KBVIPCSBPGOWBL-UHFFFAOYSA-N 0.000 description 1
- SQMYSSVJDUSMPP-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-fluoro-4-methoxyphenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound FC1=CC(OC)=CC=C1OC1=NN2C(C=3C=CC(=CC=3)C(=O)NC3CC3)=CN=C2C(NCCC(F)(F)F)=C1 SQMYSSVJDUSMPP-UHFFFAOYSA-N 0.000 description 1
- XGGOILXUXRIANY-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-fluoro-4-methoxyphenoxy)-8-(oxan-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound FC1=CC(OC)=CC=C1OC1=NN2C(C=3C=CC(=CC=3)C(=O)NC3CC3)=CN=C2C(NCC2CCOCC2)=C1 XGGOILXUXRIANY-UHFFFAOYSA-N 0.000 description 1
- LRSXQJWVMCJFBA-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-fluoro-4-methylphenyl)sulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound FC1=CC(C)=CC=C1SC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCC(F)(F)F)=C1 LRSXQJWVMCJFBA-UHFFFAOYSA-N 0.000 description 1
- DWADCDQYDRXWRV-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-fluoro-4-methylphenyl)sulfanyl-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound FC1=CC(C)=CC=C1SC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCC(C)(C)O)=C1 DWADCDQYDRXWRV-UHFFFAOYSA-N 0.000 description 1
- JRZOKMQNVMRJMT-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-fluoro-5-methylanilino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC=C(F)C(NC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCCC(F)(F)F)=C2)=C1 JRZOKMQNVMRJMT-UHFFFAOYSA-N 0.000 description 1
- ZLHPFJJGLHTLJA-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-fluoro-5-methylanilino)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC=C(F)C(NC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCC(C)(C)O)=C2)=C1 ZLHPFJJGLHTLJA-UHFFFAOYSA-N 0.000 description 1
- CGAOOKGKZZXMAO-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-fluoro-5-methylphenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC=C(F)C(OC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCCC(F)(F)F)=C2)=C1 CGAOOKGKZZXMAO-UHFFFAOYSA-N 0.000 description 1
- ANLXHYDFMMZICO-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-fluoroanilino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C(=CC=CC=4)F)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 ANLXHYDFMMZICO-UHFFFAOYSA-N 0.000 description 1
- VXJBPMYPAZYZNR-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-fluoroanilino)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C(=CC=CC=4)F)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 VXJBPMYPAZYZNR-UHFFFAOYSA-N 0.000 description 1
- ZEKKQMBCBLERGJ-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-fluorophenyl)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCC(C)(C)O)C3=NC=2)C=2C(=CC=CC=2)F)=CC=C1C(=O)NC1CC1 ZEKKQMBCBLERGJ-UHFFFAOYSA-N 0.000 description 1
- OQFZVJYENWMKEJ-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-fluorophenyl)sulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C(=CC=CC=4)F)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 OQFZVJYENWMKEJ-UHFFFAOYSA-N 0.000 description 1
- LMIPHEDIIOSBCT-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-fluorophenyl)sulfanyl-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C(=CC=CC=4)F)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 LMIPHEDIIOSBCT-UHFFFAOYSA-N 0.000 description 1
- XUGGMPAODGQCLJ-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-hydroxycyclohexyl)oxy-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC4C(CCCC4)O)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 XUGGMPAODGQCLJ-UHFFFAOYSA-N 0.000 description 1
- KVEXUTPEPUOJCU-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-hydroxyethylsulfanyl)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SCCO)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 KVEXUTPEPUOJCU-UHFFFAOYSA-N 0.000 description 1
- JYXLDUXXLRWNEY-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-hydroxyphenyl)sulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C(=CC=CC=4)O)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 JYXLDUXXLRWNEY-UHFFFAOYSA-N 0.000 description 1
- MUNLNCZGBDNFFX-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-hydroxyphenyl)sulfanyl-8-(thian-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C(=CC=CC=4)O)C=C(NCC4CCSCC4)C3=NC=2)=CC=C1C(=O)NC1CC1 MUNLNCZGBDNFFX-UHFFFAOYSA-N 0.000 description 1
- CXUYTPKUGYIPMO-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-methoxyanilino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound COC1=CC=CC=C1NC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCC(F)(F)F)=C1 CXUYTPKUGYIPMO-UHFFFAOYSA-N 0.000 description 1
- YKTOBYGMBTXNFB-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-methoxyphenyl)sulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound COC1=CC=CC=C1SC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCC(F)(F)F)=C1 YKTOBYGMBTXNFB-UHFFFAOYSA-N 0.000 description 1
- ZWOVKZYEDKWKAV-UHFFFAOYSA-N n-cyclopropyl-4-[6-(2-methylpyrazol-3-yl)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzenecarbothioamide Chemical compound CN1N=CC=C1C1=NN2C(C=3C=CC(=CC=3)C(=S)NC3CC3)=CN=C2C(NCCC(F)(F)F)=C1 ZWOVKZYEDKWKAV-UHFFFAOYSA-N 0.000 description 1
- JPKPOUUAUJTTRU-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3,3-dimethylbutylsulfanyl)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SCCC(C)(C)C)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 JPKPOUUAUJTTRU-UHFFFAOYSA-N 0.000 description 1
- GTPQIXUIWBDJEU-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3,3-dimethylbutylsulfanyl)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SCCC(C)(C)C)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 GTPQIXUIWBDJEU-UHFFFAOYSA-N 0.000 description 1
- AMKKYTQGYPLNJO-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3,4-difluoroanilino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C=C(F)C(F)=CC=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 AMKKYTQGYPLNJO-UHFFFAOYSA-N 0.000 description 1
- KFQAPOJIIVUKHL-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3,4-difluoroanilino)-8-(4,4,4-trifluorobutylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C=C(F)C(F)=CC=4)C=C(NCCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 KFQAPOJIIVUKHL-UHFFFAOYSA-N 0.000 description 1
- LBVPUWPUOIELIN-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3,4-difluoroanilino)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C=C(F)C(F)=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 LBVPUWPUOIELIN-UHFFFAOYSA-N 0.000 description 1
- XELNLIDYYQAKDW-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3,4-difluorophenyl)sulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C=C(F)C(F)=CC=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 XELNLIDYYQAKDW-UHFFFAOYSA-N 0.000 description 1
- QGLLUUYSGRORPB-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3,4-difluorophenyl)sulfanyl-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C=C(F)C(F)=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 QGLLUUYSGRORPB-UHFFFAOYSA-N 0.000 description 1
- FIGJQQYJEDVCHZ-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3,5-difluoroanilino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C=C(F)C=C(F)C=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 FIGJQQYJEDVCHZ-UHFFFAOYSA-N 0.000 description 1
- ZMXUCUPYHBVTFY-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3,5-difluoroanilino)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C=C(F)C=C(F)C=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 ZMXUCUPYHBVTFY-UHFFFAOYSA-N 0.000 description 1
- GVSNOJJMQKMUOP-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3,5-difluorophenyl)sulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C=C(F)C=C(F)C=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 GVSNOJJMQKMUOP-UHFFFAOYSA-N 0.000 description 1
- DIGALEXYONTKIS-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3,5-difluorophenyl)sulfanyl-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C=C(F)C=C(F)C=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 DIGALEXYONTKIS-UHFFFAOYSA-N 0.000 description 1
- FRKWCTRCMCHEFT-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-ethenylanilino)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C=C(C=C)C=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 FRKWCTRCMCHEFT-UHFFFAOYSA-N 0.000 description 1
- NREHQOOKBKDNPA-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluoro-2-methylphenyl)sulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C(=C(F)C=CC=4)C)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 NREHQOOKBKDNPA-UHFFFAOYSA-N 0.000 description 1
- LNQUOVAXPUZSOK-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluoro-4-methoxyanilino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C1=C(F)C(OC)=CC=C1NC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCC(F)(F)F)=C1 LNQUOVAXPUZSOK-UHFFFAOYSA-N 0.000 description 1
- UKWDUQDUUUSSPA-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluoro-4-methoxyanilino)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C1=C(F)C(OC)=CC=C1NC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCC(C)(C)O)=C1 UKWDUQDUUUSSPA-UHFFFAOYSA-N 0.000 description 1
- TZCDBTQIJVPYCH-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluoro-4-methylphenyl)sulfanyl-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C1=C(F)C(C)=CC=C1SC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCC(C)(C)O)=C1 TZCDBTQIJVPYCH-UHFFFAOYSA-N 0.000 description 1
- YZKGLZCDHCZPIY-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluoro-5-methylanilino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(F)=CC(NC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCCC(F)(F)F)=C2)=C1 YZKGLZCDHCZPIY-UHFFFAOYSA-N 0.000 description 1
- LAJNBGGUEPHFEZ-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluoro-5-methylanilino)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(F)=CC(NC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCC(C)(C)O)=C2)=C1 LAJNBGGUEPHFEZ-UHFFFAOYSA-N 0.000 description 1
- MRKNAOQMMPSMSK-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluoro-5-methylphenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(F)=CC(OC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCCC(F)(F)F)=C2)=C1 MRKNAOQMMPSMSK-UHFFFAOYSA-N 0.000 description 1
- VTBOLWKVAZOVQY-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluoro-5-methylphenyl)sulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(F)=CC(SC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCCC(F)(F)F)=C2)=C1 VTBOLWKVAZOVQY-UHFFFAOYSA-N 0.000 description 1
- PUCXOWUKDRVJGR-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluoro-5-methylphenyl)sulfanyl-8-(4,4,4-trifluorobutylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(F)=CC(SC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCCCC(F)(F)F)=C2)=C1 PUCXOWUKDRVJGR-UHFFFAOYSA-N 0.000 description 1
- NATSWSNSBBFYKO-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluoro-5-methylphenyl)sulfanyl-8-(thian-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(F)=CC(SC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCC3CCSCC3)=C2)=C1 NATSWSNSBBFYKO-UHFFFAOYSA-N 0.000 description 1
- UVVGMFVFUSCRCT-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluoro-5-methylphenyl)sulfanyl-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(F)=CC(SC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCC(C)(C)O)=C2)=C1 UVVGMFVFUSCRCT-UHFFFAOYSA-N 0.000 description 1
- IVZUAYBIWHAZLH-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluorophenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound FC1=CC=CC(OC2=NN3C(C=4C=CC(=CC=4)C(=O)NC4CC4)=CN=C3C(NCCC(F)(F)F)=C2)=C1 IVZUAYBIWHAZLH-UHFFFAOYSA-N 0.000 description 1
- NKUGPHCEYSJMID-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluorophenoxy)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]benzenecarbothioamide Chemical compound N=1N2C(C=3C=CC(=CC=3)C(=S)NC3CC3)=CN=C2C(NCC(C)(O)C)=CC=1OC1=CC=CC(F)=C1 NKUGPHCEYSJMID-UHFFFAOYSA-N 0.000 description 1
- QUJDHHPFEDLQSQ-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluorophenyl)sulfanyl-8-(2-hydroxyethylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C=C(F)C=CC=4)C=C(NCCO)C3=NC=2)=CC=C1C(=O)NC1CC1 QUJDHHPFEDLQSQ-UHFFFAOYSA-N 0.000 description 1
- HDMWSZZBLIENJN-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluorophenyl)sulfanyl-8-(thian-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C=C(F)C=CC=4)C=C(NCC4CCSCC4)C3=NC=2)=CC=C1C(=O)NC1CC1 HDMWSZZBLIENJN-UHFFFAOYSA-N 0.000 description 1
- HURVTMRCYVCXLS-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluorophenyl)sulfanyl-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C=C(F)C=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 HURVTMRCYVCXLS-UHFFFAOYSA-N 0.000 description 1
- DPTJGSZOGMYGQP-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluorophenyl)sulfanyl-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NC2CC2)=CC=C1C(N1N=2)=CN=C1C(NCC(C)(C)O)=CC=2SC1=CC=CC(F)=C1 DPTJGSZOGMYGQP-UHFFFAOYSA-N 0.000 description 1
- LFIFMUAVMQQIRB-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluorophenyl)sulfanyl-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]benzenecarbothioamide Chemical compound N=1N2C(C=3C=CC(=CC=3)C(=S)NC3CC3)=CN=C2C(NCC(C)(O)C)=CC=1SC1=CC=CC(F)=C1 LFIFMUAVMQQIRB-UHFFFAOYSA-N 0.000 description 1
- YGACCNRMTXHMGU-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluorophenyl)sulfanyl-8-[(3,3,3-trifluoro-2-hydroxypropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C=C(F)C=CC=4)C=C(NCC(O)C(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 YGACCNRMTXHMGU-UHFFFAOYSA-N 0.000 description 1
- KFQSIQTXJFJIDI-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluorophenyl)sulfinyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCCC(F)(F)F)C3=NC=2)S(=O)C=2C=C(F)C=CC=2)=CC=C1C(=O)NC1CC1 KFQSIQTXJFJIDI-UHFFFAOYSA-N 0.000 description 1
- QANSCOIGAZIDDM-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-fluorophenyl)sulfonyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCCC(F)(F)F)C3=NC=2)S(=O)(=O)C=2C=C(F)C=CC=2)=CC=C1C(=O)NC1CC1 QANSCOIGAZIDDM-UHFFFAOYSA-N 0.000 description 1
- FLVPRKNROMCXLQ-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-hydroxy-2-methylanilino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C(=C(O)C=CC=4)C)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 FLVPRKNROMCXLQ-UHFFFAOYSA-N 0.000 description 1
- RRUDAAISSVOPNQ-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-hydroxyphenyl)sulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C=C(O)C=CC=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 RRUDAAISSVOPNQ-UHFFFAOYSA-N 0.000 description 1
- LMIBPOONXQTZJD-UHFFFAOYSA-N n-cyclopropyl-4-[6-(3-hydroxyphenyl)sulfanyl-8-(thian-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C=C(O)C=CC=4)C=C(NCC4CCSCC4)C3=NC=2)=CC=C1C(=O)NC1CC1 LMIBPOONXQTZJD-UHFFFAOYSA-N 0.000 description 1
- AOUYWXVCYVNFEG-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-fluoro-2-methoxyanilino)-8-(4,4,4-trifluorobutylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound COC1=CC(F)=CC=C1NC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCCC(F)(F)F)=C1 AOUYWXVCYVNFEG-UHFFFAOYSA-N 0.000 description 1
- DKIRWSGCDAVRRN-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-fluoro-2-methoxyanilino)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound COC1=CC(F)=CC=C1NC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCC(C)(C)O)=C1 DKIRWSGCDAVRRN-UHFFFAOYSA-N 0.000 description 1
- MOINPJAUCUUOPE-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-fluoro-2-methylphenyl)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCC(C)(C)O)C3=NC=2)C=2C(=CC(F)=CC=2)C)=CC=C1C(=O)NC1CC1 MOINPJAUCUUOPE-UHFFFAOYSA-N 0.000 description 1
- BBBADJUMIOKWCS-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-fluoro-2-methylphenyl)sulfanyl-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(F)=CC=C1SC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCC(C)(C)O)=C1 BBBADJUMIOKWCS-UHFFFAOYSA-N 0.000 description 1
- LSLDLTZNGVYIAB-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-fluoro-3-hydroxyanilino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C=C(O)C(F)=CC=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 LSLDLTZNGVYIAB-UHFFFAOYSA-N 0.000 description 1
- WRJCVTKSIZGUBP-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-fluoro-3-methoxyanilino)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C1=C(F)C(OC)=CC(NC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCC(C)(C)O)=C2)=C1 WRJCVTKSIZGUBP-UHFFFAOYSA-N 0.000 description 1
- KVEJLBMHMUHTIL-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-fluoro-3-methylanilino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C1=C(F)C(C)=CC(NC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCCC(F)(F)F)=C2)=C1 KVEJLBMHMUHTIL-UHFFFAOYSA-N 0.000 description 1
- UXMUTYLLOWVJIQ-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-fluoro-3-methylanilino)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C1=C(F)C(C)=CC(NC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCC(C)(C)O)=C2)=C1 UXMUTYLLOWVJIQ-UHFFFAOYSA-N 0.000 description 1
- ZUVNJWZHGOFNIA-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-fluoro-3-methylphenyl)sulfanyl-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C1=C(F)C(C)=CC(SC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCC(C)(C)O)=C2)=C1 ZUVNJWZHGOFNIA-UHFFFAOYSA-N 0.000 description 1
- RKMKRDFSVDQHTR-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-fluoroanilino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C=CC(F)=CC=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 RKMKRDFSVDQHTR-UHFFFAOYSA-N 0.000 description 1
- DQKUKUSTXITZCI-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-fluoroanilino)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C=CC(F)=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 DQKUKUSTXITZCI-UHFFFAOYSA-N 0.000 description 1
- OCJUNGZNQYXJFL-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-fluorophenyl)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCCC(F)(F)F)C3=NC=2)C=2C=CC(F)=CC=2)=CC=C1C(=O)NC1CC1 OCJUNGZNQYXJFL-UHFFFAOYSA-N 0.000 description 1
- RNNKRNRRFLGZDJ-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-fluorophenyl)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NC2CC2)=CC=C1C(N1N=2)=CN=C1C(NCCC(F)(F)F)=CC=2C1=CC=C(F)C=C1 RNNKRNRRFLGZDJ-UHFFFAOYSA-N 0.000 description 1
- OAXILSCMYSFHIK-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-fluorophenyl)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCC(C)(C)O)C3=NC=2)C=2C=CC(F)=CC=2)=CC=C1C(=O)NC1CC1 OAXILSCMYSFHIK-UHFFFAOYSA-N 0.000 description 1
- JZTXJUABQDUWIL-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-fluorophenyl)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NC2CC2)=CC=C1C(N1N=2)=CN=C1C(NCC(C)(C)O)=CC=2C1=CC=C(F)C=C1 JZTXJUABQDUWIL-UHFFFAOYSA-N 0.000 description 1
- KFXMPTHGQFUILS-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-fluorophenyl)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound C=1N=C2C(NCC(C)(O)C)=CC(C=3C=CC(F)=CC=3)=NN2C=1C(C=C1)=CC=C1C(=O)NC1CC1 KFXMPTHGQFUILS-UHFFFAOYSA-N 0.000 description 1
- UJEXLJPVWMLXCZ-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-fluorophenyl)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]benzenecarbothioamide Chemical compound C=1N=C2C(NCC(C)(O)C)=CC(C=3C=CC(F)=CC=3)=NN2C=1C(C=C1)=CC=C1C(=S)NC1CC1 UJEXLJPVWMLXCZ-UHFFFAOYSA-N 0.000 description 1
- MRJPPIAXYWTEPK-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-fluorophenyl)-8-[(4-methylmorpholin-2-yl)methylamino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C1N(C)CCOC1CNC1=CC(C=2C=CC(F)=CC=2)=NN2C1=NC=C2C(C=C1C)=CC=C1C(=O)NC1CC1 MRJPPIAXYWTEPK-UHFFFAOYSA-N 0.000 description 1
- CYNBBWUTNDUQKI-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-fluorophenyl)sulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C=CC(F)=CC=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 CYNBBWUTNDUQKI-UHFFFAOYSA-N 0.000 description 1
- LVPRNRRLWLGVFX-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-fluorophenyl)sulfanyl-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C=CC(F)=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 LVPRNRRLWLGVFX-UHFFFAOYSA-N 0.000 description 1
- ZIDVSJWMJNADRK-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-hydroxy-3-methylphenyl)sulfanyl-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C1=C(O)C(C)=CC(SC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCC(C)(C)O)=C2)=C1 ZIDVSJWMJNADRK-UHFFFAOYSA-N 0.000 description 1
- DPDANNAASUSFTK-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-methoxyanilino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C1=CC(OC)=CC=C1NC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCC(F)(F)F)=C1 DPDANNAASUSFTK-UHFFFAOYSA-N 0.000 description 1
- CAAUDXWQNSZFGZ-UHFFFAOYSA-N n-cyclopropyl-4-[6-(4-methoxyphenyl)sulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C1=CC(OC)=CC=C1SC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCC(F)(F)F)=C1 CAAUDXWQNSZFGZ-UHFFFAOYSA-N 0.000 description 1
- WUAJVEQSFQIGMI-UHFFFAOYSA-N n-cyclopropyl-4-[6-(5-fluoro-2-methylanilino)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC=C(F)C=C1NC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCC(F)(F)F)=C1 WUAJVEQSFQIGMI-UHFFFAOYSA-N 0.000 description 1
- UTKSLUDVGOKRJY-UHFFFAOYSA-N n-cyclopropyl-4-[6-(5-fluoro-2-methylanilino)-8-(4,4,4-trifluorobutylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC=C(F)C=C1NC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCCC(F)(F)F)=C1 UTKSLUDVGOKRJY-UHFFFAOYSA-N 0.000 description 1
- KHSSWPNWYZYWBF-UHFFFAOYSA-N n-cyclopropyl-4-[6-(5-fluoro-2-methylanilino)-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC=C(F)C=C1NC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCC(C)(C)O)=C1 KHSSWPNWYZYWBF-UHFFFAOYSA-N 0.000 description 1
- FMHHQGZBELCBMG-UHFFFAOYSA-N n-cyclopropyl-4-[6-(5-fluoro-2-methylphenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC=C(F)C=C1OC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCC(F)(F)F)=C1 FMHHQGZBELCBMG-UHFFFAOYSA-N 0.000 description 1
- SJOFAAWGHRDYPL-UHFFFAOYSA-N n-cyclopropyl-4-[6-(5-fluoro-2-methylphenyl)sulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC=C(F)C=C1SC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCC(F)(F)F)=C1 SJOFAAWGHRDYPL-UHFFFAOYSA-N 0.000 description 1
- BSMHGSNIMCTWKT-UHFFFAOYSA-N n-cyclopropyl-4-[6-(5-fluoro-2-methylphenyl)sulfanyl-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC=C(F)C=C1SC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCC(C)(C)O)=C1 BSMHGSNIMCTWKT-UHFFFAOYSA-N 0.000 description 1
- OWSCFNINYYPIBR-UHFFFAOYSA-N n-cyclopropyl-4-[6-(5-fluoropyridin-3-yl)oxy-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(F)C=NC=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 OWSCFNINYYPIBR-UHFFFAOYSA-N 0.000 description 1
- MLJZXKSAVBMCFI-UHFFFAOYSA-N n-cyclopropyl-4-[6-(6-fluoropyridin-3-yl)oxy-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=NC(F)=CC=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 MLJZXKSAVBMCFI-UHFFFAOYSA-N 0.000 description 1
- MDSYXYDJKMNYOH-UHFFFAOYSA-N n-cyclopropyl-4-[6-(6-fluoropyridin-3-yl)oxy-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=NC(F)=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 MDSYXYDJKMNYOH-UHFFFAOYSA-N 0.000 description 1
- JHUAYRUMDIFJCK-UHFFFAOYSA-N n-cyclopropyl-4-[6-[(2,2-difluorocyclopropyl)methoxy]-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OCC4C(C4)(F)F)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 JHUAYRUMDIFJCK-UHFFFAOYSA-N 0.000 description 1
- CFLPLZYHWYKUBT-UHFFFAOYSA-N n-cyclopropyl-4-[6-[(6-fluoropyridin-3-yl)amino]-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C=NC(F)=CC=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 CFLPLZYHWYKUBT-UHFFFAOYSA-N 0.000 description 1
- BNDXPLDMPMSUKN-UHFFFAOYSA-N n-cyclopropyl-4-[6-[(6-fluoropyridin-3-yl)amino]-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C=NC(F)=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 BNDXPLDMPMSUKN-UHFFFAOYSA-N 0.000 description 1
- CBCUZEBMDWZTCF-UHFFFAOYSA-N n-cyclopropyl-4-[6-[(6-methoxypyridin-3-yl)amino]-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C1=NC(OC)=CC=C1NC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCCC(F)(F)F)=C1 CBCUZEBMDWZTCF-UHFFFAOYSA-N 0.000 description 1
- FSJLCXWWRDNWAU-UHFFFAOYSA-N n-cyclopropyl-4-[6-[2-(diethylamino)ethylsulfanyl]-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound N12N=C(SCCN(CC)CC)C=C(NCCC(F)(F)F)C2=NC=C1C(C=C1C)=CC=C1C(=O)NC1CC1 FSJLCXWWRDNWAU-UHFFFAOYSA-N 0.000 description 1
- BQLVEWBZELLHRJ-UHFFFAOYSA-N n-cyclopropyl-4-[6-[2-(fluoromethyl)phenyl]-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCC(C)(C)O)C3=NC=2)C=2C(=CC=CC=2)CF)=CC=C1C(=O)NC1CC1 BQLVEWBZELLHRJ-UHFFFAOYSA-N 0.000 description 1
- WJVSFGBFDBEZJV-UHFFFAOYSA-N n-cyclopropyl-4-[6-[2-(hydroxymethyl)anilino]-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C(=CC=CC=4)CO)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 WJVSFGBFDBEZJV-UHFFFAOYSA-N 0.000 description 1
- BICAUVVHXBHWQM-UHFFFAOYSA-N n-cyclopropyl-4-[6-[2-(hydroxymethyl)anilino]-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C(=CC=CC=4)CO)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 BICAUVVHXBHWQM-UHFFFAOYSA-N 0.000 description 1
- LWMSYEFPCMQVGB-UHFFFAOYSA-N n-cyclopropyl-4-[6-[2-(hydroxymethyl)phenyl]-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCCC(F)(F)F)C3=NC=2)C=2C(=CC=CC=2)CO)=CC=C1C(=O)NC1CC1 LWMSYEFPCMQVGB-UHFFFAOYSA-N 0.000 description 1
- SJVJVSOIXIAFCS-UHFFFAOYSA-N n-cyclopropyl-4-[6-[2-(hydroxymethyl)phenyl]-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NC2CC2)=CC=C1C(N1N=2)=CN=C1C(NCCC(F)(F)F)=CC=2C1=CC=CC=C1CO SJVJVSOIXIAFCS-UHFFFAOYSA-N 0.000 description 1
- MKLXPSBHNPSULS-UHFFFAOYSA-N n-cyclopropyl-4-[6-[2-(hydroxymethyl)phenyl]-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzenecarbothioamide Chemical compound OCC1=CC=CC=C1C1=NN2C(C=3C=CC(=CC=3)C(=S)NC3CC3)=CN=C2C(NCCC(F)(F)F)=C1 MKLXPSBHNPSULS-UHFFFAOYSA-N 0.000 description 1
- SDPJOMZKTQVEMZ-UHFFFAOYSA-N n-cyclopropyl-4-[6-[2-(hydroxymethyl)phenyl]-8-[(2-methoxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C=1N=C2C(NCC(C)(C)OC)=CC(C=3C(=CC=CC=3)CO)=NN2C=1C(C=C1C)=CC=C1C(=O)NC1CC1 SDPJOMZKTQVEMZ-UHFFFAOYSA-N 0.000 description 1
- LPRPCBYATFAECT-UHFFFAOYSA-N n-cyclopropyl-4-[6-[2-(hydroxymethyl)phenyl]sulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C(=CC=CC=4)CO)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 LPRPCBYATFAECT-UHFFFAOYSA-N 0.000 description 1
- NSGJLAHXKOQZNX-UHFFFAOYSA-N n-cyclopropyl-4-[6-[3-(2-hydroxy-2-methylpropoxy)phenoxy]-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=C(OCC(C)(C)O)C=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 NSGJLAHXKOQZNX-UHFFFAOYSA-N 0.000 description 1
- YEKQVCLABMLUOM-UHFFFAOYSA-N n-cyclopropyl-4-[6-[3-(hydroxymethyl)phenyl]-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]benzenecarbothioamide Chemical compound OCC1=CC=CC(C2=NN3C(C=4C=CC(=CC=4)C(=S)NC4CC4)=CN=C3C(NCCC(F)(F)F)=C2)=C1 YEKQVCLABMLUOM-UHFFFAOYSA-N 0.000 description 1
- VQBHFUPNXVSCOT-UHFFFAOYSA-N n-cyclopropyl-4-[6-[4-(2-hydroxyethyl)anilino]-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C=CC(CCO)=CC=4)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 VQBHFUPNXVSCOT-UHFFFAOYSA-N 0.000 description 1
- BRGXCEQWZKVGAK-UHFFFAOYSA-N n-cyclopropyl-4-[6-[4-(2-hydroxyethyl)anilino]-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C=CC(CCO)=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 BRGXCEQWZKVGAK-UHFFFAOYSA-N 0.000 description 1
- RXKAUSYGRJGCFY-UHFFFAOYSA-N n-cyclopropyl-4-[6-[4-fluoro-2-(hydroxymethyl)phenyl]-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCCC(F)(F)F)C3=NC=2)C=2C(=CC(F)=CC=2)CO)=CC=C1C(=O)NC1CC1 RXKAUSYGRJGCFY-UHFFFAOYSA-N 0.000 description 1
- OTSWUFHREJJWMK-UHFFFAOYSA-N n-cyclopropyl-4-[6-[4-fluoro-2-(hydroxymethyl)phenyl]-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCC(C)(C)O)C3=NC=2)C=2C(=CC(F)=CC=2)CO)=CC=C1C(=O)NC1CC1 OTSWUFHREJJWMK-UHFFFAOYSA-N 0.000 description 1
- DNYPVHNKIWEEPT-UHFFFAOYSA-N n-cyclopropyl-4-[6-cyclopropyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCCC(F)(F)F)C3=NC=2)C2CC2)=CC=C1C(=O)NC1CC1 DNYPVHNKIWEEPT-UHFFFAOYSA-N 0.000 description 1
- ORJJXZHQVHHTKU-UHFFFAOYSA-N n-cyclopropyl-4-[6-ethenyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C)C=C(NCCC(F)(F)F)C3=NC=2)=CC=C1C(=O)NC1CC1 ORJJXZHQVHHTKU-UHFFFAOYSA-N 0.000 description 1
- YJMMXWVMQFWKIX-UHFFFAOYSA-N n-cyclopropyl-4-[6-ethenyl-8-[(2-hydroxy-2-methylpropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 YJMMXWVMQFWKIX-UHFFFAOYSA-N 0.000 description 1
- QFLARDWDIRLBHR-UHFFFAOYSA-N n-cyclopropyl-4-[8-(1,4-dioxan-2-ylmethylamino)-6-pyridin-4-ylimidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCC4OCCOC4)C3=NC=2)C=2C=CN=CC=2)=CC=C1C(=O)NC1CC1 QFLARDWDIRLBHR-UHFFFAOYSA-N 0.000 description 1
- NBOSOSLGMGQVTG-UHFFFAOYSA-N n-cyclopropyl-4-[8-(2-methylpropylamino)-6-methylsulfonylimidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound C=1N=C2C(NCC(C)C)=CC(S(C)(=O)=O)=NN2C=1C(C=C1)=CC=C1C(=O)NC1CC1 NBOSOSLGMGQVTG-UHFFFAOYSA-N 0.000 description 1
- PYCWYALYEPASEN-UHFFFAOYSA-N n-cyclopropyl-4-[8-(2-methylpropylamino)-6-pyridin-4-ylimidazo[1,2-b]pyridazin-3-yl]benzenecarbothioamide Chemical compound C=1N=C2C(NCC(C)C)=CC(C=3C=CN=CC=3)=NN2C=1C(C=C1)=CC=C1C(=S)NC1CC1 PYCWYALYEPASEN-UHFFFAOYSA-N 0.000 description 1
- ZPCWWBPPLWBZFP-UHFFFAOYSA-N n-cyclopropyl-4-[8-(3-hydroxypropylamino)-6-(2-methylpyrazol-3-yl)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCCCO)C3=NC=2)C=2N(N=CC=2)C)=CC=C1C(=O)NC1CC1 ZPCWWBPPLWBZFP-UHFFFAOYSA-N 0.000 description 1
- QGGCRIIVXKIVSI-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(1,1-dioxothian-4-yl)methylamino]-6-phenylsulfanylimidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C=CC=CC=4)C=C(NCC4CCS(=O)(=O)CC4)C3=NC=2)=CC=C1C(=O)NC1CC1 QGGCRIIVXKIVSI-UHFFFAOYSA-N 0.000 description 1
- DOCLTOKSZLJTLR-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(1,1-dioxothian-4-yl)methylamino]-6-pyridin-3-yloxyimidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=NC=CC=4)C=C(NCC4CCS(=O)(=O)CC4)C3=NC=2)=CC=C1C(=O)NC1CC1 DOCLTOKSZLJTLR-UHFFFAOYSA-N 0.000 description 1
- ZSFRVDRNQIUTEA-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCC(C)(C)O)C3=NC=2)C=2CCNCC=2)=CC=C1C(=O)NC1CC1 ZSFRVDRNQIUTEA-UHFFFAOYSA-N 0.000 description 1
- SZVGCVSFSAHIFJ-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(1h-pyrazol-5-yloxy)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4NN=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 SZVGCVSFSAHIFJ-UHFFFAOYSA-N 0.000 description 1
- CNZWNDBIJKIZRE-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(2,2,3,3-tetrafluoro-4-hydroxybutoxy)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OCC(F)(F)C(F)(F)CO)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 CNZWNDBIJKIZRE-UHFFFAOYSA-N 0.000 description 1
- MWKWPEHPVDRFEW-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(2-hydroxyphenyl)sulfanylimidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C(=CC=CC=4)O)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 MWKWPEHPVDRFEW-UHFFFAOYSA-N 0.000 description 1
- OQCFRFUEMRMCFB-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(2-methoxyphenyl)sulfanylimidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound COC1=CC=CC=C1SC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCC(C)(C)O)=C1 OQCFRFUEMRMCFB-UHFFFAOYSA-N 0.000 description 1
- RCMILDLFLPBFFU-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(2-methylpyrazol-3-yl)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCC(C)(C)O)C3=NC=2)C=2N(N=CC=2)C)=CC=C1C(=O)NC1CC1 RCMILDLFLPBFFU-UHFFFAOYSA-N 0.000 description 1
- BMMCHRYDRJDICG-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(2-methylpyrazol-3-yl)imidazo[1,2-b]pyridazin-3-yl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NC2CC2)=CC=C1C(N1N=2)=CN=C1C(NCC(C)(C)O)=CC=2C1=CC=NN1C BMMCHRYDRJDICG-UHFFFAOYSA-N 0.000 description 1
- WNEAQYRBGWBJNM-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(2-morpholin-4-ylethylsulfanyl)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SCCN4CCOCC4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 WNEAQYRBGWBJNM-UHFFFAOYSA-N 0.000 description 1
- UYIXJODYWGFFCH-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(3-hydroxyphenyl)sulfanylimidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C=C(O)C=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 UYIXJODYWGFFCH-UHFFFAOYSA-N 0.000 description 1
- VDDGTRJJQIOAQH-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(3-methoxy-2-methylanilino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound COC1=CC=CC(NC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCC(C)(C)O)=C2)=C1C VDDGTRJJQIOAQH-UHFFFAOYSA-N 0.000 description 1
- RATXOGVHPZSQTG-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(3-propan-2-ylanilino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC(C)C1=CC=CC(NC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCC(C)(C)O)=C2)=C1 RATXOGVHPZSQTG-UHFFFAOYSA-N 0.000 description 1
- GHOUXPRZODPDMI-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(3-propan-2-ylphenyl)sulfanylimidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC(C)C1=CC=CC(SC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCC(C)(C)O)=C2)=C1 GHOUXPRZODPDMI-UHFFFAOYSA-N 0.000 description 1
- OVSWTGAJLIXKDB-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(4-hydroxyphenyl)sulfanylimidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C=CC(O)=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 OVSWTGAJLIXKDB-UHFFFAOYSA-N 0.000 description 1
- OQUCKRDYSFYWSC-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(4-methoxyanilino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C1=CC(OC)=CC=C1NC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCC(C)(C)O)=C1 OQUCKRDYSFYWSC-UHFFFAOYSA-N 0.000 description 1
- SBHAMDXFLZCJOE-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(4-methoxyphenyl)sulfanylimidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C1=CC(OC)=CC=C1SC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCC(C)(C)O)=C1 SBHAMDXFLZCJOE-UHFFFAOYSA-N 0.000 description 1
- JZFGCXJPQIGOCH-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(5-methoxy-2-methylanilino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound COC1=CC=C(C)C(NC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCC(C)(C)O)=C2)=C1 JZFGCXJPQIGOCH-UHFFFAOYSA-N 0.000 description 1
- GJVOOBPXFFZMJI-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(6-methylpyridin-3-yl)oxyimidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C1=NC(C)=CC=C1OC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCC(C)(C)O)=C1 GJVOOBPXFFZMJI-UHFFFAOYSA-N 0.000 description 1
- ABKXOSZAQVKKQX-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(pyridin-2-ylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4N=CC=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 ABKXOSZAQVKKQX-UHFFFAOYSA-N 0.000 description 1
- AUICETRGBAFHJS-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(pyridin-3-ylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C=NC=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 AUICETRGBAFHJS-UHFFFAOYSA-N 0.000 description 1
- LNUPYBVDGOJQEV-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(pyridin-4-ylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC=4C=CN=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 LNUPYBVDGOJQEV-UHFFFAOYSA-N 0.000 description 1
- YPWXDFYFUUKRMT-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-(pyrrolidin-3-ylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(NC4CNCC4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 YPWXDFYFUUKRMT-UHFFFAOYSA-N 0.000 description 1
- VGERDUUGNCVKST-FQEVSTJZSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-[(3s)-2-oxopyrrolidin-3-yl]oxyimidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(O[C@@H]4C(NCC4)=O)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 VGERDUUGNCVKST-FQEVSTJZSA-N 0.000 description 1
- LIHORSKXSFKVNK-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4N(C=NN=4)C)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 LIHORSKXSFKVNK-UHFFFAOYSA-N 0.000 description 1
- MSAAWZOJOVCQSK-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-[(5-methyl-1h-pyrazol-3-yl)oxy]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound N1C(C)=CC(OC2=NN3C(C=4C=C(C)C(C(=O)NC5CC5)=CC=4)=CN=C3C(NCC(C)(C)O)=C2)=N1 MSAAWZOJOVCQSK-UHFFFAOYSA-N 0.000 description 1
- NATXKNFGDCFBGO-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-[(6-methoxypyridin-3-yl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C1=NC(OC)=CC=C1NC1=NN2C(C=3C=C(C)C(C(=O)NC4CC4)=CC=3)=CN=C2C(NCC(C)(C)O)=C1 NATXKNFGDCFBGO-UHFFFAOYSA-N 0.000 description 1
- HVBRXLWSWOPZJG-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-methylsulfonylimidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCC(C)(C)O)C3=NC=2)S(C)(=O)=O)=CC=C1C(=O)NC1CC1 HVBRXLWSWOPZJG-UHFFFAOYSA-N 0.000 description 1
- LZGHVQNONINQGC-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-phenoxyimidazo[1,2-b]pyridazin-3-yl]benzenecarbothioamide Chemical compound N=1N2C(C=3C=CC(=CC=3)C(=S)NC3CC3)=CN=C2C(NCC(C)(O)C)=CC=1OC1=CC=CC=C1 LZGHVQNONINQGC-UHFFFAOYSA-N 0.000 description 1
- XGRRQSZBLSQIGO-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-phenylimidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCC(C)(C)O)C3=NC=2)C=2C=CC=CC=2)=CC=C1C(=O)NC1CC1 XGRRQSZBLSQIGO-UHFFFAOYSA-N 0.000 description 1
- KLXHMRFXAGGFBA-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-phenylimidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound C=1N=C2C(NCC(C)(O)C)=CC(C=3C=CC=CC=3)=NN2C=1C(C=C1)=CC=C1C(=O)NC1CC1 KLXHMRFXAGGFBA-UHFFFAOYSA-N 0.000 description 1
- WAFNAGQJOJKQNE-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-phenylsulfanylimidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4C=CC=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 WAFNAGQJOJKQNE-UHFFFAOYSA-N 0.000 description 1
- MJRYLNDSTCSBGD-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-phenylsulfanylimidazo[1,2-b]pyridazin-3-yl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NC2CC2)=CC=C1C(N1N=2)=CN=C1C(NCC(C)(C)O)=CC=2SC1=CC=CC=C1 MJRYLNDSTCSBGD-UHFFFAOYSA-N 0.000 description 1
- GNDKINGRAQWKOO-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-phenylsulfanylimidazo[1,2-b]pyridazin-3-yl]benzenecarbothioamide Chemical compound N=1N2C(C=3C=CC(=CC=3)C(=S)NC3CC3)=CN=C2C(NCC(C)(O)C)=CC=1SC1=CC=CC=C1 GNDKINGRAQWKOO-UHFFFAOYSA-N 0.000 description 1
- WMSRWNHKWIWIDU-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-pyrazin-2-ylsulfanylimidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4N=CC=NC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 WMSRWNHKWIWIDU-UHFFFAOYSA-N 0.000 description 1
- CRYKFNFMMPOFFW-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-pyridin-2-yloxyimidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4N=CC=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 CRYKFNFMMPOFFW-UHFFFAOYSA-N 0.000 description 1
- CIBIMHDQJNPXDX-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-pyridin-4-ylimidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(C=C(NCC(C)(C)O)C3=NC=2)C=2C=CN=CC=2)=CC=C1C(=O)NC1CC1 CIBIMHDQJNPXDX-UHFFFAOYSA-N 0.000 description 1
- XFADNPZMEDGSFU-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-pyridin-4-ylimidazo[1,2-b]pyridazin-3-yl]benzenecarbothioamide Chemical compound C=1N=C2C(NCC(C)(O)C)=CC(C=3C=CN=CC=3)=NN2C=1C(C=C1)=CC=C1C(=S)NC1CC1 XFADNPZMEDGSFU-UHFFFAOYSA-N 0.000 description 1
- KSYVXHVJULZNME-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-pyrimidin-5-yloxyimidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(OC=4C=NC=NC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 KSYVXHVJULZNME-UHFFFAOYSA-N 0.000 description 1
- JKXPLIMVCPTYIR-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-hydroxy-2-methylpropyl)amino]-6-thiophen-2-ylsulfanylimidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound CC1=CC(C=2N3N=C(SC=4SC=CC=4)C=C(NCC(C)(C)O)C3=NC=2)=CC=C1C(=O)NC1CC1 JKXPLIMVCPTYIR-UHFFFAOYSA-N 0.000 description 1
- MNRYUHYPKWWEKY-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-methoxy-2-methylpropyl)amino]-6-(2-methylpyrazol-3-yl)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C=1N=C2C(NCC(C)(C)OC)=CC(C=3N(N=CC=3)C)=NN2C=1C(C=C1C)=CC=C1C(=O)NC1CC1 MNRYUHYPKWWEKY-UHFFFAOYSA-N 0.000 description 1
- QZHYLIMSSZBNCY-UHFFFAOYSA-N n-cyclopropyl-4-[8-[(2-methoxy-2-methylpropyl)amino]-6-pyridin-4-ylimidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide Chemical compound C=1N=C2C(NCC(C)(C)OC)=CC(C=3C=CN=CC=3)=NN2C=1C(C=C1C)=CC=C1C(=O)NC1CC1 QZHYLIMSSZBNCY-UHFFFAOYSA-N 0.000 description 1
- XVSKYOVKQRDXGH-BJKOFHAPSA-N n-cyclopropyl-4-[8-[[(2s)-2-[(4r)-2,2-dimethyl-1,3-dioxolan-4-yl]-2-hydroxyethyl]amino]-6-(2-methylpyrazol-3-yl)imidazo[1,2-b]pyridazin-3-yl]benzamide Chemical compound CN1N=CC=C1C1=NN2C(C=3C=CC(=CC=3)C(=O)NC3CC3)=CN=C2C(NC[C@H](O)[C@@H]2OC(C)(C)OC2)=C1 XVSKYOVKQRDXGH-BJKOFHAPSA-N 0.000 description 1
- 125000001298 n-hexoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000002560 nitrile group Chemical group 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 125000006574 non-aromatic ring group Chemical group 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- NYGCBQKDTGBHSC-UHFFFAOYSA-N oxan-2-ylmethanamine Chemical compound NCC1CCCCO1 NYGCBQKDTGBHSC-UHFFFAOYSA-N 0.000 description 1
- IPBPLHNLRKRLPJ-UHFFFAOYSA-N oxan-4-ylmethanamine Chemical compound NCC1CCOCC1 IPBPLHNLRKRLPJ-UHFFFAOYSA-N 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000003585 oxepinyl group Chemical group 0.000 description 1
- 125000003566 oxetanyl group Chemical group 0.000 description 1
- HZEQZXCNBJSQCS-UHFFFAOYSA-N oxolan-2-ylmethanethiol Chemical compound SCC1CCCO1 HZEQZXCNBJSQCS-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 1
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 229950007460 patupilone Drugs 0.000 description 1
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000009038 pharmacological inhibition Effects 0.000 description 1
- 125000001791 phenazinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3N=C12)* 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
- 125000001644 phenoxazinyl group Chemical group C1(=CC=CC=2OC3=CC=CC=C3NC12)* 0.000 description 1
- ZJSSCIORWSJOFW-UHFFFAOYSA-N phenoxy(pyrrolidin-2-yl)phosphinic acid Chemical compound C1CCNC1P(=O)(O)OC1=CC=CC=C1 ZJSSCIORWSJOFW-UHFFFAOYSA-N 0.000 description 1
- 125000003884 phenylalkyl group Chemical group 0.000 description 1
- 150000003003 phosphines Chemical class 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- CYQAYERJWZKYML-UHFFFAOYSA-N phosphorus pentasulfide Chemical compound S1P(S2)(=S)SP3(=S)SP1(=S)SP2(=S)S3 CYQAYERJWZKYML-UHFFFAOYSA-N 0.000 description 1
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 1
- 125000005633 phthalidyl group Chemical group 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 150000003057 platinum Chemical class 0.000 description 1
- LZMJNVRJMFMYQS-UHFFFAOYSA-N poseltinib Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC(OC=2C=C(NC(=O)C=C)C=CC=2)=C(OC=C2)C2=N1 LZMJNVRJMFMYQS-UHFFFAOYSA-N 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- CPTBDICYNRMXFX-UHFFFAOYSA-N procarbazine Chemical compound CNNCC1=CC=C(C(=O)NC(C)C)C=C1 CPTBDICYNRMXFX-UHFFFAOYSA-N 0.000 description 1
- 229960000624 procarbazine Drugs 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 description 1
- 125000001042 pteridinyl group Chemical group N1=C(N=CC2=NC=CN=C12)* 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- GPHQHTOMRSGBNZ-UHFFFAOYSA-N pyridine-4-carbonitrile Chemical compound N#CC1=CC=NC=C1 GPHQHTOMRSGBNZ-UHFFFAOYSA-N 0.000 description 1
- 125000005551 pyridylene group Chemical group 0.000 description 1
- LTXJLQINBYSQFU-UHFFFAOYSA-N pyrimidin-5-ol Chemical compound OC1=CN=CN=C1 LTXJLQINBYSQFU-UHFFFAOYSA-N 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- NGXSWUFDCSEIOO-UHFFFAOYSA-N pyrrolidin-3-amine Chemical compound NC1CCNC1 NGXSWUFDCSEIOO-UHFFFAOYSA-N 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000001422 pyrrolinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- YOWAEZWWQFSEJD-UHFFFAOYSA-N quinoxalin-2-amine Chemical class C1=CC=CC2=NC(N)=CN=C21 YOWAEZWWQFSEJD-UHFFFAOYSA-N 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000006268 reductive amination reaction Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 125000006413 ring segment Chemical group 0.000 description 1
- 229960004641 rituximab Drugs 0.000 description 1
- 229950008445 sagopilone Drugs 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- XVSFHIIADLZQJP-UHFFFAOYSA-M sodium;propane-1-thiolate Chemical compound [Na+].CCC[S-] XVSFHIIADLZQJP-UHFFFAOYSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000024355 spindle assembly checkpoint Effects 0.000 description 1
- 230000019130 spindle checkpoint Effects 0.000 description 1
- 230000003019 stabilising effect Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 description 1
- YTZKOQUCBOVLHL-UHFFFAOYSA-N tert-butylbenzene Chemical compound CC(C)(C)C1=CC=CC=C1 YTZKOQUCBOVLHL-UHFFFAOYSA-N 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 125000005329 tetralinyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- AWCWSADJWHZJOL-UHFFFAOYSA-N thian-4-ylmethanamine Chemical compound NCC1CCSCC1 AWCWSADJWHZJOL-UHFFFAOYSA-N 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000005556 thienylene group Chemical group 0.000 description 1
- 150000007944 thiolates Chemical class 0.000 description 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 1
- FKKJJPMGAWGYPN-UHFFFAOYSA-N thiophen-2-ylmethanamine Chemical compound NCC1=CC=CS1 FKKJJPMGAWGYPN-UHFFFAOYSA-N 0.000 description 1
- MNRILEROXIRVNJ-UHFFFAOYSA-N tioguanine Chemical compound N1C(N)=NC(=S)C2=NC=N[C]21 MNRILEROXIRVNJ-UHFFFAOYSA-N 0.000 description 1
- 229960003087 tioguanine Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- 150000003852 triazoles Chemical group 0.000 description 1
- OVCXRBARSPBVMC-UHFFFAOYSA-N triazolopyridine Chemical compound C=1N2C(C(C)C)=NN=C2C=CC=1C=1OC=NC=1C1=CC=C(F)C=C1 OVCXRBARSPBVMC-UHFFFAOYSA-N 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- 125000005951 trifluoromethanesulfonyloxy group Chemical group 0.000 description 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
- WRECIMRULFAWHA-UHFFFAOYSA-N trimethyl borate Chemical compound COB(OC)OC WRECIMRULFAWHA-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- COIOYMYWGDAQPM-UHFFFAOYSA-N tris(2-methylphenyl)phosphane Chemical compound CC1=CC=CC=C1P(C=1C(=CC=CC=1)C)C1=CC=CC=C1C COIOYMYWGDAQPM-UHFFFAOYSA-N 0.000 description 1
- 125000005455 trithianyl group Chemical group 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 1
- JXLYSJRDGCGARV-CFWMRBGOSA-N vinblastine Chemical compound C([C@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-CFWMRBGOSA-N 0.000 description 1
- 229960003048 vinblastine Drugs 0.000 description 1
- 229960004528 vincristine Drugs 0.000 description 1
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 125000001834 xanthenyl group Chemical group C1=CC=CC=2OC3=CC=CC=C3C(C12)* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Paper (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10176134 | 2010-09-10 | ||
| EP11075022 | 2011-02-04 | ||
| EP11170775 | 2011-06-21 | ||
| EP11170771 | 2011-06-21 | ||
| PCT/EP2011/065368 WO2012032031A1 (en) | 2010-09-10 | 2011-09-06 | Substituted imidazopyridazines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL225058A true IL225058A (en) | 2017-03-30 |
Family
ID=44545741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL225058A IL225058A (en) | 2010-09-10 | 2013-03-05 | Converted imidazopyridazines, methods for their preparation and pharmaceutical preparations containing them |
Country Status (38)
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI541243B (zh) | 2010-09-10 | 2016-07-11 | 拜耳知識產權公司 | 經取代咪唑并嗒 |
| WO2012088266A2 (en) | 2010-12-22 | 2012-06-28 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3 |
| ES2671748T3 (es) | 2011-07-21 | 2018-06-08 | Tolero Pharmaceuticals, Inc. | Inhibidores heterocíclicos de proteína quinasas |
| US9512126B2 (en) | 2012-03-14 | 2016-12-06 | Bayer Intellectual Property Gmbh | Substituted imidazopyridazines |
| UA125503C2 (uk) | 2012-06-13 | 2022-04-13 | Інсайт Холдинґс Корпорейшн | Заміщені трициклічні сполуки як інгібітори fgfr |
| WO2014020043A1 (en) | 2012-08-02 | 2014-02-06 | Bayer Pharma Aktiengesellschaft | Combinations for the treatment of cancer |
| WO2014020041A1 (en) | 2012-08-02 | 2014-02-06 | Bayer Pharma Aktiengesellschaft | Combinations for the treatment of cancer |
| US9388185B2 (en) | 2012-08-10 | 2016-07-12 | Incyte Holdings Corporation | Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors |
| AU2013344716B2 (en) | 2012-11-16 | 2018-03-01 | University Health Network | Pyrazolopyrimidine compounds |
| US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
| TW201437211A (zh) * | 2013-03-01 | 2014-10-01 | Bayer Pharma AG | 經取代咪唑并嗒□ |
| MY181497A (en) | 2013-04-19 | 2020-12-23 | Incyte Holdings Corp | Bicyclic heterocycles as fgfr inhibitors |
| AP2015008898A0 (en) | 2013-06-11 | 2015-12-31 | Bayer Pharma AG | Prodrug derivatives of substituted triazolopyridines |
| EP3007698A1 (en) * | 2013-06-13 | 2016-04-20 | Bayer Pharma Aktiengesellschaft | Combination of a imidazopyridazine derivative and a mitotic agent for the treatment of cancer |
| CN103360399B (zh) * | 2013-08-02 | 2016-03-02 | 北京大学 | 6-芳基取代-咪唑-[1,2-b]哒嗪类衍生物,其制备方法及用途 |
| GB201321734D0 (en) | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic Agents |
| JP6506313B2 (ja) * | 2014-02-21 | 2019-04-24 | フロスト バイオロジック,インコーポレーテッド | 癌及び増殖性疾患の治療のための抗有糸分裂性アミド |
| WO2015157955A1 (en) | 2014-04-17 | 2015-10-22 | Abbvie Inc. | Heterocyclic btk inhibit ors |
| TW201613927A (en) * | 2014-09-01 | 2016-04-16 | Bayer Pharma AG | Method for preparation of substituted imidazopyridazines |
| US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
| MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
| US9580423B2 (en) | 2015-02-20 | 2017-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
| CR20170390A (es) | 2015-02-20 | 2017-10-23 | Incyte Holdings Corp | Heterociclos biciclicos como inhibidores de fgfr |
| JP6993233B2 (ja) | 2015-04-17 | 2022-01-13 | ネザーランズ トランスレーショナル リサーチ センター ビー.ブイ. | Ttk阻害剤化学療法の為の予後バイオマーカー |
| WO2016187028A1 (en) * | 2015-05-15 | 2016-11-24 | Celgene Avilomics Research, Inc. | Heteroaryl compounds, synthesis thereof, and intermediates thereto |
| JP6778749B2 (ja) * | 2015-12-04 | 2020-11-04 | エクソンモービル リサーチ アンド エンジニアリング カンパニーExxon Research And Engineering Company | Emm−28、新規合成結晶性材料、その製造および使用 |
| WO2018013430A2 (en) | 2016-07-12 | 2018-01-18 | Arisan Therapeutics Inc. | Heterocyclic compounds for the treatment of arenavirus infection |
| KR102700233B1 (ko) | 2016-07-18 | 2024-08-28 | 유니버시티 헬스 네트워크 | 고체 형태의 ttk 억제제 |
| EP3609547B1 (en) * | 2017-04-11 | 2021-10-06 | Straumann Holding AG | Dental implant |
| AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
| BR112020022392A2 (pt) | 2018-05-04 | 2021-02-02 | Incyte Corporation | formas sólidas de um inibidor de fgfr e processos para preparação das mesmas |
| PE20210919A1 (es) | 2018-05-04 | 2021-05-19 | Incyte Corp | Sales de un inhibidor de fgfr |
| HUE068695T2 (hu) | 2018-05-08 | 2025-01-28 | Nippon Shinyaku Co Ltd | Azabenzimidazol vegyületek és gyógyszerek |
| US12419865B2 (en) | 2018-12-06 | 2025-09-23 | Arisan Therapeutics Inc. | Compounds for the treatment of arenavirus infection |
| CA3127502A1 (en) | 2019-02-12 | 2020-08-20 | Sumitomo Dainippon Pharma Oncology, Inc. | Formulations comprising heterocyclic protein kinase inhibitors |
| US11628162B2 (en) | 2019-03-08 | 2023-04-18 | Incyte Corporation | Methods of treating cancer with an FGFR inhibitor |
| CN111978325B (zh) * | 2019-05-22 | 2023-11-17 | 中国药科大学 | 咪唑并哒嗪类mnk1/mnk2激酶抑制剂及其制备方法和应用 |
| US11591329B2 (en) | 2019-07-09 | 2023-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| US12122767B2 (en) | 2019-10-01 | 2024-10-22 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| GEP20247679B (en) | 2019-10-14 | 2024-10-10 | Incyte Corp | Bicyclic heterocycles as fgfr inhibitors |
| WO2021076728A1 (en) | 2019-10-16 | 2021-04-22 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
| PE20221504A1 (es) | 2019-12-04 | 2022-09-30 | Incyte Corp | Derivados de un inhibidor de fgfr |
| JP7720840B2 (ja) | 2019-12-04 | 2025-08-08 | インサイト・コーポレイション | Fgfr阻害剤としての三環式複素環 |
| WO2021146424A1 (en) | 2020-01-15 | 2021-07-22 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
| TW202304459A (zh) | 2021-04-12 | 2023-02-01 | 美商英塞特公司 | 包含fgfr抑制劑及nectin-4靶向劑之組合療法 |
| CA3220155A1 (en) | 2021-06-09 | 2022-12-15 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
| TW202313611A (zh) | 2021-06-09 | 2023-04-01 | 美商英塞特公司 | 作為fgfr抑制劑之三環雜環 |
| KR20240107189A (ko) * | 2021-12-15 | 2024-07-08 | 신라젠(주) | 신생물성 질환 치료에 사용하기 위한 약제학적 병용물 |
| EP4651948A1 (en) * | 2023-01-19 | 2025-11-26 | Skyhawk Therapeutics, Inc. | Compositions useful for modulating splicing |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ333302A (en) | 1996-08-28 | 2000-08-25 | Pfizer | Substituted 6,5-hetero-bicyclic derivatives for the prevention or inhibition of a disorder that can be treated by antagonising corticotropin releasing factor |
| CN1173975C (zh) | 2000-04-27 | 2004-11-03 | 山之内制药株式会社 | 咪唑并吡啶衍生物 |
| AR045697A1 (es) | 2003-07-14 | 2005-11-09 | Arena Pharm Inc | Aril y heteroaril derivados fusionados como moduladores del metabolismo y la prevencion y tratamiento de trastornos relacionados con el mismo |
| EP1713784A1 (en) | 2004-02-12 | 2006-10-25 | Neurogen Corporation | Imidazo-pyridazines, triazolo-pyridazines and related benzodiazepine receptor ligands |
| US7306631B2 (en) | 2004-03-30 | 2007-12-11 | The Procter & Gamble Company | Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof |
| WO2007025090A2 (en) | 2005-08-25 | 2007-03-01 | Kalypsys, Inc. | Heterobicyclic and - tricyclic inhibitors of mapk/erk kinase |
| US20070078136A1 (en) * | 2005-09-22 | 2007-04-05 | Bristol-Myers Squibb Company | Fused heterocyclic compounds useful as kinase modulators |
| US7723336B2 (en) | 2005-09-22 | 2010-05-25 | Bristol-Myers Squibb Company | Fused heterocyclic compounds useful as kinase modulators |
| BRPI0618520A2 (pt) * | 2005-11-10 | 2011-09-06 | Schering Corp | imidazopirazinas como inibidores de proteìna cinase |
| TW200840584A (en) * | 2006-12-26 | 2008-10-16 | Gilead Sciences Inc | Pyrido(3,2-d)pyrimidines useful for treating viral infections |
| WO2008130951A1 (en) * | 2007-04-17 | 2008-10-30 | Bristol-Myers Squibb Company | Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type i inhibitors |
| US20110046127A1 (en) | 2007-11-08 | 2011-02-24 | Paolo Pevarello | Imidazopyridazines for Use as Protein Kinase Inhibitors |
| US8389527B2 (en) | 2008-02-06 | 2013-03-05 | Bristol-Myers Squibb Company | Substituted imidazopyridazines useful as kinase inhibitors |
| TWI491610B (zh) | 2008-10-09 | 2015-07-11 | 必治妥美雅史谷比公司 | 作為激酶抑制劑之咪唑并嗒腈 |
| WO2010088518A2 (en) | 2009-01-31 | 2010-08-05 | Kalypsys, Inc. | Heterocyclic modulators of gpr119 for treatment of disease |
| WO2010124826A1 (en) | 2009-04-29 | 2010-11-04 | Bayer Schering Pharma Aktiengesellschaft | Substituted imidazoquinoxalines |
| TW201107329A (en) * | 2009-07-30 | 2011-03-01 | Oncotherapy Science Inc | Fused imidazole derivative having ttk inhibitory action |
| US9340528B2 (en) | 2009-09-04 | 2016-05-17 | Bayer Pharma Aktiengesellschaft | Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors |
| EP2343295A1 (en) | 2009-11-30 | 2011-07-13 | Bayer Schering Pharma AG | Triazolopyridine derivates |
| EP2343294A1 (en) | 2009-11-30 | 2011-07-13 | Bayer Schering Pharma AG | Substituted triazolopyridines |
| EP2343297A1 (en) | 2009-11-30 | 2011-07-13 | Bayer Schering Pharma AG | Triazolopyridines |
| ES2551407T3 (es) | 2010-03-18 | 2015-11-18 | Bayer Intellectual Property Gmbh | Imidazopirazinas |
| EP2576560B1 (en) | 2010-06-01 | 2015-09-30 | Bayer Intellectual Property GmbH | Substituted imidazopyrazines |
| TWI541243B (zh) | 2010-09-10 | 2016-07-11 | 拜耳知識產權公司 | 經取代咪唑并嗒 |
| US20140187548A1 (en) | 2010-12-17 | 2014-07-03 | Bayer Intellectual Property Gmbh | 6 substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders |
| WO2012080229A1 (en) | 2010-12-17 | 2012-06-21 | Bayer Pharma Aktiengesellschaft | Imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment hyperproliferative disorders |
| WO2012080234A1 (en) | 2010-12-17 | 2012-06-21 | Bayer Pharma Aktiengesellschaft | Substituted 6-imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders |
| CA2821837A1 (en) | 2010-12-17 | 2012-06-21 | Bayer Intellectual Property Gmbh | 2-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders |
| US20140135319A1 (en) | 2010-12-17 | 2014-05-15 | Bayer Intellectual Property Gmbh | 6-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders |
| CA2821827A1 (en) | 2010-12-17 | 2012-06-21 | Bayer Intellectual Property Gmbh | 6-thio-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders |
-
2011
- 2011-08-25 TW TW100130542A patent/TWI541243B/zh not_active IP Right Cessation
- 2011-09-06 MX MX2013002713A patent/MX2013002713A/es active IP Right Grant
- 2011-09-06 HR HRP20160360TT patent/HRP20160360T1/hr unknown
- 2011-09-06 NZ NZ607904A patent/NZ607904A/en not_active IP Right Cessation
- 2011-09-06 SG SG2013016480A patent/SG188417A1/en unknown
- 2011-09-06 EP EP11751910.8A patent/EP2614063B1/en active Active
- 2011-09-06 EA EA201390339A patent/EA023420B1/ru not_active IP Right Cessation
- 2011-09-06 KR KR1020137009011A patent/KR20140032337A/ko not_active Ceased
- 2011-09-06 CA CA2810755A patent/CA2810755A1/en not_active Abandoned
- 2011-09-06 WO PCT/EP2011/065368 patent/WO2012032031A1/en not_active Ceased
- 2011-09-06 PE PE2013000392A patent/PE20131164A1/es not_active Application Discontinuation
- 2011-09-06 JP JP2013527575A patent/JP5824050B2/ja not_active Expired - Fee Related
- 2011-09-06 PL PL11751910T patent/PL2614063T3/pl unknown
- 2011-09-06 CN CN201180054217.5A patent/CN103370318B/zh not_active Expired - Fee Related
- 2011-09-06 PH PH1/2013/500454A patent/PH12013500454A1/en unknown
- 2011-09-06 HU HUE11751910A patent/HUE028771T2/en unknown
- 2011-09-06 CU CUP2013000033A patent/CU24187B1/es active IP Right Grant
- 2011-09-06 AP AP2013006790A patent/AP3607A/xx active
- 2011-09-06 ME MEP-2016-63A patent/ME02389B/me unknown
- 2011-09-06 US US13/822,175 patent/US9255100B2/en not_active Expired - Fee Related
- 2011-09-06 MY MYPI2013700375A patent/MY185139A/en unknown
- 2011-09-06 MA MA35720A patent/MA34516B1/fr unknown
- 2011-09-06 ES ES11751910.8T patent/ES2568220T3/es active Active
- 2011-09-06 AU AU2011298844A patent/AU2011298844B2/en not_active Ceased
- 2011-09-06 DK DK11751910.8T patent/DK2614063T3/en active
- 2011-09-06 RS RS20160221A patent/RS54661B1/sr unknown
- 2011-09-06 SI SI201130761A patent/SI2614063T1/sl unknown
- 2011-09-06 BR BR112013005679A patent/BR112013005679A2/pt not_active IP Right Cessation
- 2011-09-07 SA SA111320735A patent/SA111320735B1/ar unknown
- 2011-09-08 UY UY0001033598A patent/UY33598A/es unknown
- 2011-09-09 AR ARP110103294A patent/AR082946A1/es unknown
-
2013
- 2013-03-05 IL IL225058A patent/IL225058A/en active IP Right Grant
- 2013-03-07 ZA ZA2013/01756A patent/ZA201301756B/en unknown
- 2013-03-08 CR CR20130102A patent/CR20130102A/es unknown
- 2013-03-08 DO DO2013000054A patent/DOP2013000054A/es unknown
- 2013-03-08 EC ECSP13012752 patent/ECSP13012752A/es unknown
- 2013-03-08 CO CO13047157A patent/CO6720961A2/es active IP Right Grant
-
2016
- 2016-04-12 CY CY20161100294T patent/CY1117352T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2614063T3 (en) | Substituted imidazopyridaziner | |
| US9284317B2 (en) | Substituted imidazo[1,2-a]pyrazines as MPS-1 inhibitors | |
| US9320737B2 (en) | Substituted imidazopyridazines | |
| US20140135319A1 (en) | 6-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders | |
| WO2012080230A1 (en) | 6 substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders | |
| US9388140B2 (en) | Substituted benzimidazoles | |
| CA2899352A1 (en) | Amidoimidazopyridazines as mknk-1 kinase inhibitors | |
| WO2011151259A1 (en) | Substituted imidazopyrazines | |
| US20140255392A1 (en) | Substituted imidazopyridines and intermediates thereof | |
| EP2651948A1 (en) | Imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment hyperproliferative disorders | |
| EP2651947B1 (en) | 6-thio-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders | |
| US9512126B2 (en) | Substituted imidazopyridazines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |